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Abstract 
 
The co-ordinated degradation of proteins is vital to all aspects of cellular activity. The 
main mechanism of intracellular protein degradation is the ubiquitin proteasome system 
(UPS) which labels target proteins with ubiquitin, thereby marking them for degradation 
by the 26S proteasome. Protein ubiquitination is mediated by three enzymes; E1, E2, E3. 
The largest family of E3’s is the cullin-RING E3 ubiquitin ligases (CRLs). CRLs require 
the cyclic addition and removal of a ubiquitin-like protein called NEDD8 to and from the 
cullin subunit. Removal of NEDD8 (deneddylation) is mediated by the eight subunit 
COP9 signalosome (CSN; CSN1-8). Cullin deneddylation by the CSN has been 
demonstrated to prevent the autocatalytic degradation of the substrate recognition subunit 
(SRS) of CRLs. The CSN has also been shown to associate with deubiquitinase and 
kinase activity and has thus been identified as a highly conserved key regulator of protein 
degradation. CSN subcomplexes have also been identified which function in protein 
degradation, and a direct role for the CSN complex in transcriptional regulation has been 
posited. Although the COP9 signalosome (CSN) has been studied in human cells, little is 
known of its role in haematopoietic cells or of any potential contribution to 
leukaemogenesis.  
 
In this study the deneddylase catalytic subunit CSN5 and the non-catalytic subunit CSN2 
were knocked down in the human haematopoietic cell line and chronic myeloid leukemia 
model, K562.  Both knockdowns had similar consequences for CRL activity whilst 
having divergent effects on the levels of SRS mRNA. Knockdown of either subunit also 
resulted in a common sequential proteasome-dependent loss of SRS proteins, an 
observation that had not been previously described. Although both knockdowns resulted 
in reduced cell proliferation followed by significant cell death, the cellular phenotypes 
and mechanisms of cell death were distinct. CSN5 knockdown was associated with 
mitotic defects, G2/M arrest, and culminated in apoptosis. In contrast, CSN2 knockdown 
resulted in autophagy inhibition and non-apoptotic cell death. This is the first time the 
CSN has been associated with autophagy. CSN2 and CSN5 knockdowns also had 
divergent effects on the intact CSN complex. CSN2 loss resulted in significant reduction 
of the intact CSN whilst, for the first time, the intact CSN complex was shown to be 
retained in CSN5 knockdown cells with loss of only monomeric CSN5. The common 
effect on CRL activity by either knockdown suggests a common loss of deneddylase 
activity, which was explained in CSN2 knockdowns with the loss of the intact CSN 
complex. However, in the case of CSN5 knockdown, in which the intact complex 
remained, the reason for loss of deneddylase activity is less easy to explain. The results of 
this study may indicate for the first time that sustained deneddylase activity is dependent 
on a novel mechanism requiring a pool of CSN5 monomer. Finally, the significance of 
monomeric CSN5 function loss to the differential phenotype of CSN5 knockdown cells 
to cells lacking CSN2 was tested by re-expression of both wild type and deneddylase 
dead CSN5 in a CSN5 knockdown background. Importantly, both approaches rescued the 
cellular phenotype to the same extent. Overall, the findings of this study provide novel 
insight into both the function and potential regulation of the CSN complex, whilst further 
suggesting that the CSN may be a target worthy of investigation in the treatment of 
chronic myeloid leukaemia.   
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Chapter 1.0: 
General Introduction 
 2
1.1 Intracellular protein degradation 
 
The concentration of any protein within the cell at any given time is tightly regulated. 
This regulation is of primary biological importance and is mediated at multiple levels, 
including via gene transcription, mRNA translation and protein degradation. This project 
is concerned with the process of intracellular protein degradation, of which there are two 
key mechanisms within the cell, autophagy and the ubiquitin-proteasome system. These 
systems differentially degrade long-lived and short-lived proteins within cells.  
 
1.1.1 Autophagy 
 
Autophagy is the main mechanism of degradation of long-lived proteins within the cell 
(Doherty and Mayer, 1992, Levine and Klionsky, 2004). Protein degradation by 
autophagy culminates in proteolysis within the (autophago)lysosome, a single membrane 
vesicular structure which contains proteases active at the low pH of the lysosomal lumen 
(Doherty and Mayer, 1992). Macroautophagy, which has been the focus of the majority 
of autophagy research, involves the formation of a double membrane structure around 
cytosolic proteins which, when completed, forms a structure called the autophagosome 
(Levine and Klionsky, 2004). The outer membrane of the autophagosome fuses with the 
lysosome membrane resulting in the formation of a single membrane autophagic body 
within the lumen of the lysosome (figure 1) (Levine and Klionsky, 2004). In the final 
stage of autophagy the single membrane of the autophagic body is broken down and the  
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Autophagosome
Lysosome
AutophagolysosomeMembrane 
breakdown
Protein 
degradation
Figure 1. The autophagy mechanism of protein degradation.
Schematic depicting the process of macroautophagy. In macroautophagy
target proteins are surrounded by a double membrane structure called an 
autophagosome, the outer membrane of which fuses with the lysosome
membrane to yield an autophagolysosome. The inner membrane is then 
broken down, enabling lysosomal protease mediated protein degradation. 
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protein contents degraded by proteases within the lumen of the lysosome (figure 1) 
(Doherty and Mayer, 1992, Levine and Klionsky, 2004). 
 
1.1.2 The ubiquitin-proteasome system 
 
The ubiquitin-proteasome system (UPS) is the main mechanism of degradation of short-
lived proteins within the cell (Doherty and Mayer, 1992, Levine and Klionsky, 2004). 
Proteolysis is carried out by a multicatalytic protease, the 26S proteasome, present in 
both the cytoplasm and nucleus (Doherty and Mayer, 1992). The proteasome consists of a 
20S core particle and two 19S regulatory particles (figure 2). The core particle is a hollow 
cylinder whilst the regulatory particles form caps at either end of the core particle (figure 
2), with proteins being degraded in the hollow compartment which is formed (Alberts, 
2002). Proteins are recognised by the 19S cap and delivered to the 20S core for 
degradation (Alberts, 2002). Unlike autophagy, which tends to carry out bulk protein 
degradation, the UPS carries out specific protein degradation. The specificity of the UPS 
is conferred through specific target labelling with ubiquitin, a signal which is recognised 
by the 19S particle of the proteasome (Alberts, 2002, Doherty and Mayer, 1992).  
 
1.1.3 Protein ubiquitination 
 
Simpson demonstrated the requirement for ATP in protein degradation in 1953 (Simpson, 
1953). Hershko and co-workers later identified a heat-stable polypeptide which was 
essential for ATP-dependent proteolysis in rabbit reticulocytes (Ciehanover et al., 1978).  
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26S 
proteasome
E1 E2
E3
E1 E2
19S
20S
19S
ubiquitin
substrate
ATP 
+
AMP 
+ PPi
Figure 2. The ubiquitin proteasome system.
Schematic depicting the ubiquitin proteasome system. Initially, ubiquitin is 
activated by binding to E1 enzyme via a thiol ester linkage, a reaction 
dependant upon ATP. Ubiquitin is then transferred to an E2 ubiquitin 
conjugating enzyme. A specific E3 ubiquitin ligase then mediates the trans fer 
of ubiquitin from E2 to a specific target protein. Protein ubiquitination signals 
for protein degradation by the 26S proteasome. Target proteins are initially 
deubiquitinated by the lid of the proteasome and the ubiquitin recycled. The 
protein is then partially unfolded before translocation into the proteasome 
core where it is degraded. 
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They then determined that this polypeptide was conjugated to proteins in an ATP-
dependent manner (Ciechanover et al., 1980), and that polypeptide conjugation to 
proteins resulted in their degradation (Hershko et al., 1984). This polypeptide, which was 
determined to be ubiquitin (Wilkinson et al., 1980), was shown to be activated by an E1 
ubiquitin activating enzyme, a process requiring ATP (Ciechanover et al., 1981, Haas et 
al., 1982). Following this, three enzymes required for ubiquitin conjugation to proteins 
were isolated; E1 as above, E2 ubiquitin conjugating enzyme which was shown to 
mediate the transfer of E1 activated ubiquitin to the target protein, and E3 which was 
primarily shown to function in the final, ligation step of ubiquitin conjugation (Hershko 
et al., 1983), and was later shown to be the substrate binding component of the ubiquitin 
conjugating system (Hershko et al., 1986). With this the ubiquitin proteasome system was 
identified, responsible for the majority of protein degradation (Bosu and Kipreos, 2008), 
in which proteins are targeted for 26S proteasome mediated degradation by a three step 
mechanism which covalently attaches ubiquitin molecules to target proteins (figure 2).  
 
As the E3 enzyme interacts with the substrate protein, the E3 is also responsible for 
conferring target specificity to the ubiquitin proteasome system. Two main classes of E3 
ubiquitin ligase have been identified; homologous to E6-associated protein C-terminus 
(HECT) domain and really interesting new gene (RING) ligases. The Cullin-RING E3 
ubiquitin ligases form the largest class of E3 ubiquitin ligases identified to date and 
specifically regulate the degradation of many proteins (Petroski and Deshaies, 2005). In 
the following section, the literature regarding the structure, function and regulation of the 
Cullin-RING E3 ubiquitin ligase family is reviewed. 
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1.2 The Cullin-RING E3 ubiquitin ligase (CRL) family 
 
1.2.1 The CRLs and their component subunits  
 
Cullin-RING E3 ubiquitin ligases (CRLs) comprise multiple subunits including a cullin, a 
RING finger protein and an adaptor protein which binds both the cullin and the variable, 
substrate specific CRL subunit, the substrate recognition subunit (SRS) (Bosu and 
Kipreos, 2008). Nayak et al have demonstrated, using phylogenetic analysis, that there 
are five metazoan cullin families (Cul1-Cul5) (Nayak et al., 2002).    
 
The most studied CRL is that containing Cul1 which, along with the RING finger protein 
Roc1, the adaptor protein S-phase kinase-associated protein 1 (Skp1) and an SRS known 
as an F-box protein, forms an SCF (Skp1, Cul1, F-box protein) complex (Petroski and 
Deshaies, 2005). The crystal structure of the SCF complex demonstrates that Cul1 acts as 
a scaffold for complex formation, binding Roc1 at its C-terminus and Skp1 at its N-
terminus (Zheng et al., 2002b). Roc1 recruits the E2 ubiquitin conjugating enzyme and 
Skp1 binds the F-box protein through an F-box motif. The F-box protein recruits a 
substrate through a substrate interaction motif, bringing the target protein into close 
proximity with the activated ubiquitin molecule (Petroski and Deshaies, 2005) (figure 3). 
The F-box protein is therefore responsible for conferring target specificity to the SCF 
complex. As humans have been shown to have approximately 70 F-box proteins (Jin et 
al., 2004), there is the potential for the formation of multiple SCF complexes with the 
Roc1/Cul1/Skp1 base in order to facilitate the degradation of a diverse array of specific  
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target proteins. Indeed, multiple SCF complexes have been identified which target 
distinct proteins for degradation. These will be reviewed in the following section which 
looks at CRL function.  
 
CRLs containing Cul2 have a structure comparable to that of the SCF complex, with 
Roc1 also binding to the C-terminus of Cul2 and an adaptor binding to the N-terminus 
(Kamura et al., 1999, Pause et al., 1999). However, in the case of Cul2 based CRLs, the 
adaptor is a heterodimer of Elongin B and Elongin C and the SRS is a von Hippel-Lindau 
(VHL)-box protein which is recruited to the CRL by Elongin C through a VHL-box motif 
(Bosu and Kipreos, 2008) (figure 4).  
 
Cul5 containing CRLs have a structure and composition very similar to that of Cul2 
based CRLs, with Cul5 also binding an Elongin B/C heterodimer as an adaptor (Bosu and 
Kipreos, 2008). However, Cul5 recruits target proteins via a suppressor of cytokine 
signaling (SOCS)-box protein which binds to Elongin C through a SOCS-box motif, as 
opposed to the VHL-box protein utilised by Cul2 containing CRLs (Kamura et al., 2004). 
Furthermore, instead of Roc1, Cul5 based CRLs interact with the RING finger protein 
Roc2 (Petroski and Deshaies, 2005) (figure 4).  
 
Cul4 based CRLs continue the generic structure and composition of CRLs, with the 
binding of a Roc protein (Roc1) to Cul4 and the recruitment of an SRS via an adaptor 
protein (Bosu and Kipreos, 2008), although the adaptor has also been shown to recruit 
substrates directly (McCall et al., 2005). The adaptor protein in Cul4 based CRLs is DNA  
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damage binding protein 1 (DDB1), which recruits WD40 proteins (Angers et al., 2006, 
He et al., 2006) (figure 4).  
 
As with the majority of CRLs, CRLs which contain Cul3 utilise Roc1. However, they 
differ from all other cullin containing E3 ligases as they do not require a separate adaptor 
protein and SRS. Rather, SRSs called BTB (broad complex, tramtrack, bric-a-brac) 
proteins both interact directly with Cul3 and recruit target proteins (Geyer et al., 2003, 
Xu et al., 2003) (figure 4).   
 
More recently, a further cullin, Cul7, has been identified and found to form a complex 
with Roc1, Skp1 and the F-box protein Fbx29 (also called FBXW8; F-box and WD 
repeat domain containing 8) (Dias et al., 2002). However, research regarding Cul7 is 
relatively scant and Cul7 is yet to be shown to interact with any other F-box proteins. 
Nonetheless, Tsunematso et al, 2006 have suggested that the abnormalities observed in 
CUL7-/- mice which are not observed in mice lacking Fbx29 are indicative of Fbx29 
independent functions of the Cul7 containing CRL complex (Tsunematsu et al., 2006), 
suggesting that this cullin also interacts with other SRSs.     
 
1.2.2 CRL function 
 
The SCF has been shown to mediate the degradation of multiple cell cycle associated 
proteins, with the SCF complex containing the F-box protein Skp2 (S-phase kinase-
associated protein 2; SCFSkp2) regulating the cell cycle inhibitors p21 (Yu et al., 1998) 
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and p27 (Tsvetkov et al., 1999). In addition, SCFCdc4 (containing the F-box protein Cdc4; 
cell division cycle gene 4) facilitates the degradation of cyclin E, a mediator of the G1 to 
S phase transition of the cell cycle (Koepp et al., 2001), and the cell proliferation 
promoter, c-Myc (Yada et al., 2004). SCFβ-TrCP (containing the F-box protein β-TrCP; 
beta-transducin repeat containing protein) has been shown to ubiquitinate IκBα, an 
inhibitor of the transcription factor NF-κB (nuclear factor kappa-light-chain-enhancer of 
activated B cells), in the presence of E1, E2 and ATP (Yaron et al., 1998). As NF-κB is a 
major regulator of the immune and inflammatory responses, such findings implicate this 
SCF complex in the regulation of both of these processes (Maniatis, 1999).  
 
VHL protein, in complex with elonginB/C, has been identified as a Cul2 interacting 
protein (Pause et al., 1997). This Cul2 based CRL has been shown to mediate the 
ubiquitination and degradation of the alpha subunit of the hypoxia inducible factor (HIF) 
complex in normoxic conditions (Leung and Ohh, 2002). The HIF complex is an integral 
oxygen dependent transcriptional regulator which, in response to conditions of low 
oxygen, activates the transcription of hypoxia inducible genes, including the angiogenic 
protein vascular endothelial growth factor (VEGF) (Leung and Ohh, 2002). Thus, the 
Cul2/VHL CRL is implicated in the regulation of angiogenesis. 
 
Four groups have independently demonstrated the potential function of Cul3 based CRLs 
in regulating oxidative and xenobiotic stress response via Nrf2 (NF-E2-related factor-2) 
degradation (Cullinan et al., 2004, Furukawa and Xiong, 2005, Kobayashi et al., 2004, 
Zhang et al., 2004). Kobayashi et al, 2004 showed that the oxidative stress sensing BTB 
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protein Keap1 (Kelch-like ECH-associated protein 1) binds to both Cul3 and the target 
protein Nrf2 and directly promotes Nrf2 ubiquitination and degradation (Kobayashi et al., 
2004), thereby determining Keap1 and Nrf2 as a Cul3 based CRL SRS and target, 
respectively.  
 
Cul3 based CRLs have also been shown to regulate mitotic processes, including mitotic 
spindle assembly (Pintard et al., 2004), and chromosome alignment in metaphase and 
completion of cytokinesis (Sumara et al., 2007). In C. elegans, the BTB protein MEL-26 
functions as an SRS and is required in a complex with Cul3 for ubiquitin mediated 
degradation of the microtubule severing protein MEI-1 for assembly of the mitotic 
spindle (Pintard et al, 2004). Cul3 knockdown in HeLa cells was demonstrated to result 
in chromosome misalignment, disorganized anaphase spindles and failure to complete 
cytokinesis (Sumara et al., 2007). Furthermore, the BTB proteins KLHL9 and KLHL13 
(Kelch-like protein 9 and 13) were shown to interact with Cul3 and mediate 
ubiquitination of Aurora B protein, a protein which functions in the attachment of the 
mitotic spindle to the centromere, potentially accounting for the mitotic defects observed 
in cells lacking a component of the Cul3/KLHL9/KLHL13 based CRL (Sumara et al., 
2007).    
 
Cul4 based CRLs have been implicated in the maintenance of DNA integrity, with the 
identification of the nucleotide excision repair (NER) proteins DDB2 (damage-specific 
DNA binding protein 2) and CSA (Cockayne syndrome protein A) as SRSs in Cul4 ligase 
complexes (Groisman et al., 2003). Groisman et al demonstrated that the WD40 proteins 
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DDB2 and CSA, which function in global genome repair (GGR) and transcription-
coupled repair (TCR) respectively, are associated with the same protein complex 
(including Cul4, Roc1 and DDB1) via interaction with DDB1. In addition, the DDB2 and 
CSA containing complexes were shown to possess ubiquitin ligase activity and were 
further demonstrated to rescue the GGR and TCR deficient phenotypes, respectively, 
when microinjected into corresponding mutant cells (Groisman et al., 2003).  
 
Cul5 has been demonstrated to function in neuron positioning during cortical 
development by regulation of Disabled-1 (Dab1) protein levels (Feng et al., 2007). The 
authors observed that SOCS proteins can bind specifically to Dab1 protein and that 
expression of SOCS1, SOCS2 or SOCS3 protein induces Dab1 degradation. Furthermore, 
transfection of embryonic cortical neurons with Cul5 shRNA protects Dab1 from 
degradation. This observation was also made in vivo using in utero microinjection and 
electroporation of the lateral ventricles of day 14.5 mouse embryos, with concomitant 
neuron displacement which could be rescued by Dab1 knockdown (Feng et al., 2007). 
Cullin 5 based CRLs have therefore been identified as a regulator of cortical neuron 
migration via, at least in part, degradation of Dab1.  
 
1.2.3 CRL regulation via cullin modification 
 
All of the human cullins analysed so far (Cul1, 2, 3, 4A, 4B and 5 i.e. all except Cul7) 
have been shown to be modified by the addition of a ubiquitin-like protein, Nedd8 
(neural precursor cell expressed, developmentally down-regulated 8) (Hori et al., 1999). 
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The neddylation process requires an E1 to activate Nedd8 and an E2 (UBC12 or UBE2F) 
that transfers Nedd8 to the cullin (Gong and Yeh, 1999, Liakopoulos et al., 1998, Huang 
et al., 2009). Furthermore, the E2 recruiting subunit of CRLs, Roc1, has been shown to 
be required for cullin neddylation (Kamura et al., 1999). More recently, cullin 
neddylation has also been shown to be upregulated by an E3 ligase, Dcn1, which 
promotes neddylation by binding to both the cullin target and UBC12 (Kurz et al., 2008, 
Kurz et al., 2005), thereby bringing the neddylation target into close proximity with the 
active Nedd8; suggesting a scaffold function for Dcn1 comparable to that of cullin based 
E3 ubiquitin ligases.  
 
The neddylation of CRLs increases ubiquitin ligase activity in vitro, with groups 
demonstrating the requirement for cullin neddylation in the ubiquitination of IκBα (Read 
et al., 2000, Wu et al., 2000) and others determining cullin neddylation as a promoter of 
p27 ubiquitination (Morimoto et al., 2000, Podust et al., 2000). Moreover, neddylation 
has been shown to be required for CRL function in vivo, including mammalian cells (Ohh 
et al., 2002).  The mechanisms behind Nedd8 promotion of CRL mediated protein 
ubiquitination have been investigated. Cullin neddylation has been shown to increase 
ubiquitin bound E2 binding to the E3 (Kawakami et al., 2001). Further, Nedd8 has been 
shown to directly interact with E2 ubiquitin conjugating enzyme and thereby recruit the 
E2 to cullin based E3 ligases, possibly in co-operation with Roc1 (Sakata et al., 2007). In 
addition, cullin neddylation has been shown to result in significant conformational 
alterations in the structure of Cul5 C-terminal domain (Cul5ctd)-Roc1 complex and 
Cul1ctd-Roc1 complex, resulting in the release of the Roc1 RING domain from a cullin 
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subdomain and allowing conformational flexibility within these complexes (Duda et al., 
2008). These Nedd8 induced conformational changes and increased flexibility are 
required for CRL activity (Duda et al., 2008), and may enhance E2 binding as above but 
may also bridge the predicted ~60Å gap between the E2 and substrate binding site (Duda 
et al., 2008), thereby enhancing CRL mediated protein ubiquitination.   
 
In addition to promoting CRL activity, cullin neddylation also prevents the binding of 
cullins to CAND1 (cullin-associated and deneddylation-dissociated 1) (Zheng et al., 
2002a), possibly by blocking a CAND1 binding site (Duda et al., 2008). CAND1 is an 
inhibitor protein which, in the absence of neddylation, binds to all cullins (Min et al., 
2003); although Cul7 has yet to be tested (Petroski and Deshaies, 2005). CAND1 has 
been shown to interact with the Cul1-Roc1 complex by wrapping around the cullin, with 
the N-terminus of CAND1 interacting with the C-terminal of the cullin and the C-
terminus of the inhibitor binding to the N-terminal of the cullin, blocking both the 
neddylation and Skp1 interaction sites (Goldenberg et al., 2004). Furthermore, increasing 
CAND1 in an in vitro system has been shown to result in a decreased association of Skp1 
with Cul1 and a concomitant decrease in IκBα ubiquitination (Min et al., 2003), thereby 
directly demonstrating the negative regulatory effect of CAND1 on CRL activity in vitro. 
In addition, a more recent manuscript presents data to suggest that a CAND1 paralogue, 
CAND2, found in mouse cardiac and skeletal muscle, accelerates myogenic 
differentiation of mouse myoblast C2C12 cells by inhibition of Cul1 mediated myogenin 
ubiquitination and subsequent proteasomal degradation (Shiraishi et al., 2007).  
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Overall, cullin neddylation appears to have a positive regulatory role on CRL activity, 
with neddylation promoting CRL activity and preventing interaction with the inhibitor 
CAND. However, as is discussed in the following sections, this is not the full story of 
cullin modification. The neddylation of cullins is reversible, with deneddylation being 
carried out by the COP9 signalosome (CSN) complex. 
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1.3 The COP9 signalosome (CSN) complex 
 
Initial studies by Wei and Deng identified a mutation in the COP9 (constitutive 
photomorphogenesis 9) gene (later identified as the gene encoding CSN8) in Arabidopsis 
thaliana, which resulted in constitutive photomorphogenesis in the absence of light (Wei 
and Deng, 1992). COP9 (CSN8) was then found to be a component of a complex 
(initially called the COP9 complex) identified in A. thaliana as a regulator of light 
controlled development (Wei et al., 1994). The eight subunit ~500kDa complex, now 
termed the COP9 signalosome (CSN), is highly conserved amongst eukaryotes and has 
been studied in a diverse array of organisms including humans (Seeger et al., 1998), mice 
(Lykke-Andersen et al., 2003), Drosophila melanogaster (Freilich et al., 1999, Oren-
Giladi et al., 2008), Aspergillus nidulans (Busch et al., 2003), Dictyostelium discoideum 
(Rosel and Kimmel, 2006), Schizosaccharomyces pombe (Mundt et al., 1999), 
Caenorhabditis elegans (Pintard et al., 2003) and Brassica oleracea (Chamovitz et al., 
1996). The study of this complex in such a wide variety of organisms resulted in a 
confusing array of names for the complex and its subunits such as COPS in mice, Sgn in 
humans and DCH in Drosophila. A unified nomenclature was thus determined in which 
COP9 signalosome was abbreviated to CSN and the subunits were designated CSN1-8 
according to their decreasing molecular mass (Deng et al., 2000a, Deng et al., 2000b) 
(figure 5).  
 
The CSN complex has been shown to be essential for the development of multiple 
organisms. Arabidopsis homozygous for the COP9 (CSN8) mutation do not survive past 
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COP9, Sgn8, COPS8, DCH8, CsnHCSN8
FUS5, Sgn7, COPS7a, COPS7b, 
DCH7, CsnG
CSN7
Subunit 6, Sgn6, hYIP, COPS6, 
DCH6, CsnF
CSN6
AJH1, AJH2, Sgn5, JAB1, DCH5, 
CsnE
CSN5
COP8, FUS4, Sgn4, COPS4, DCH4, 
CsnD
CSN4
Subunit 3, Sgn3, COPS3, DCH3, 
CsnC
CSN3
Subunit 2, Sgn2, TRIP15, ALIEN, 
COPS2, DCH2, CsnB
CSN2
COP11, FUS6, Sgn1, GPS1, COPS1, 
Mfh, DCH1, Caa1, CsnA
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Other namesCSN subunit
Figure 5. Summary of alternative CSN nomenclature.
A table to summarise the alternative names for CSN subunits in Arabidopsis, 
human, mouse, Droshophila, S.pombe and A. nidulans. Adapted from Deng 
et al, 2000. 
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five weeks and do not undergo reproductive development (Wei and Deng, 1992). 
Similarly, homozygous CSN5 gene deletion or P-element insertion in Drosophila, both of 
which result in the loss of CSN5 protein, are lethal, with developmental retardation at the 
third larval or pupal stage (Freilich et al., 1999). Dictyostelium cell lines null for either 
CSN2 or CSN5 could not be recovered, suggesting that loss of the CSN complex in this 
organism is also lethal and that the CSN complex is vital for Dictyostelium development 
(Rosel and Kimmel, 2006). In addition, CSN2, CSN3 or CSN5 knockout in mice is 
associated with developmental defects and early embryonic lethality (Lykke-Andersen et 
al., 2003, Tomoda et al., 2004, Yan et al., 2003). Finally, although not lethal, CSN 
subunit gene deletion in A. nidulans and CSN5 knockdown by RNAi in C. elegans result 
in a block in sexual development and sterility of the organism, respectively (Busch et al., 
2003, Smith et al., 2002, Busch et al., 2007), again indicating the essential function of the 
CSN complex in developmental processes.  
 
Cell proliferation has been shown to be regulated by the CSN complex in several 
organisms. Disruption of CSN2 or CSN5 in mice results in deficient cell proliferation, 
increased levels of cyclin E and accumulation of p53 (Lykke-Andersen et al., 2003, 
Tomoda et al., 2004). In addition, CSN8 has been shown to be essential for antigen 
receptor-induced murine T-cell entry into the cell cycle from quiescence (Menon et al., 
2007). Reduction of CSN subunits 1-6 in C. elegans by RNAi all result in a similar 
phenotype of impaired microtubule function and defective spindle formation and 
orientation, with failure of cytokinesis (Pintard et al., 2003). In addition, Rosel and 
Kimmel demonstrated, using CSN5 RNAi, that reduction of the CSN severely effects the 
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proliferation of Dictyostelium (Rosel and Kimmel, 2006), whilst a function for the CSN 
complex in the regulation of S. pombe proliferation has been demonstrated, with the 
finding that a deletion mutant of CSN1 results in accumulation of cells in S phase (Mundt 
et al., 1999). More recently, the CSN complex has been shown to be integral for 
progression through the G2 phase of the cell cycle in Arabidopsis (Dohmann et al., 
2008). Finally, the CSN complex has been implicated in the positive regulation of human 
cell (HEK293T and HeLa) proliferation, with reduction of either CSN4 or CSN5 in 
human cells resulting in p27 accumulation and a significant reduction in cell proliferation 
(Denti et al., 2006).   
 
Although studies have investigated the subunit-subunit interactions in the CSN complex 
using yeast two-hybrid and filter-binding assays (Kapelari et al., 2000, Rosel and 
Kimmel, 2006, Wei and Deng, 2003), and low resolution electron microscopy images of 
the CSN have been generated (Kapelari et al., 2000), the precise structure of the CSN 
complex remains to be determined. The most recent progress in CSN structure 
delineation used mass spectrometry (MS), tandem MS and the algorithm SUMMIT to 
generate a CSN subunit topology model (figure 6) (Sharon et al., 2009). This model, 
generated from 35 identified subcomplexes, depicts the CSN complex as two 
symmetrical modules containing CSN1, 2, 3 and 8 and CSN4, 5, 6 and 7 which are 
connected through interaction between CSN1 and CSN6 (figure 6A). CSN1 and CSN6 
appear to be the core subunits, each forming interactions with four other subunits, whilst 
CSN2 and CSN5 are peripheral and were found to be the most readily dissociable 
subunits of the complex (figure 6A) (Sharon et al., 2009). The authors suggest that  
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Figure 6. Recently proposed subunit topology of the human CSN 
complex. 
Mass spectrometry (MS) and tandem MS identified a total of 35 CSN 
subcomplexes. This data was applied to the network inference algorithm 
SUMMIT to generate the above interaction network. (A) The interaction 
network shows two symmetrical modules connected by an interaction 
between CSN1 and CSN6. (B) Additional interactions may occur between the 
distinct modules if they were to rotate through the CSN1/CSN6 interaction 
plane. Image adapted from Sharon et al, 2009. 
A
B
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further interactions may occur between the two 4 subunit modules (in accordance with 
earlier findings of yeast two-hybrid studies) if the two units were to rotate as shown in 
figure 6B (Sharon et al., 2009). The authors further suggest that the CSN complex, of 
which the constituent subunits add up to a mass of 321kDa, fractionates at the larger size 
of ~500kDa as a result of the irregular bi-modular shape of the complex (Sharon et al., 
2009). However, the association of the complex with other proteins or post-translational 
modification of CSN subunits may also be contributing factors to this phenomenon.   
 
Although the precise structure of the CSN complex remains undetermined, the 
contribution of each of the subunits to complex stability has been demonstrated. A 
mutation in Arabidopsis CSN1 results in CSN complex destabilisation as measured by 
comparative gel filtration analysis of CSN4, 5, 7 and 8 subunits from wild-type and 
CSN1 mutant seedling extracts (Wang et al., 2002). In addition, CSN3 knockout mice 
lack CSN8, implicating CSN3 in CSN complex stability (Yan et al., 2003). Furthermore, 
genetic mutations of CSN subunits 2, 4, 7 and 8 in Arabidopsis were shown to prevent 
CSN5 incorporation into the complex (Kwok et al., 1998). More recently, CSN5 and 
CSN6 have also been shown to be vital for CSN complex integrity in Arabidopsis 
(Gusmaroli et al., 2007). The requirement of all subunits for CSN complex integrity and 
function is also reflected in the finding that different CSN subunit knockout or mutation 
can result in similar phenotypes. For example, gene deletion of CSN1, 2, 4 or 5 in A. 
nidulans results in identical blocks in fungal fruit body formation (Busch et al., 2007) and 
multiple CSN subunit mutants result in the constitutive photomorphogenic phenotype in 
Arabidopsis (Schwechheimer, 2004, Dohmann et al., 2005).  
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Interestingly, it should be noted that CSN5 has been shown not to be integral for CSN 
complex integrity, both in vitro (Sharon et al., 2009) and in the model organisms 
Arabidopsis (Dohmann et al., 2005) and Drosophila (Oron et al., 2002) and the human 
cell line HeLa (Peth et al., 2007a), with CSN5 mutation or knockdown having no effect 
on the remaining CSN complex lacking CSN5 (Dohmann et al., 2005, Oron et al., 2002, 
Peth et al., 2007a). These data suggest that rather than CSN complex integrity, CSN5 
harbors the fundamental catalytic activity of the CSN complex. Indeed the cullin 
deneddylase activity of the CSN has been shown to reside within a particular domain of 
CSN5 (see next section).   
 
The fact that CSN5 cannot function in deneddylation as a monomer (Cope et al., 2002), 
together with the finding that CSN subunit deficiency in Arabidopsis and human cells 
result in accumulation of neddylated cullins (Denti et al., 2006, Dohmann et al., 2005, 
Schwechheimer et al., 2001) suggests that the phenotypes observed in CSN deficient 
organisms may be attributable to defects in CSN complex mediated CRL regulation. 
Indeed, connections have been made between CSN deficiency associated phenotypes 
such as reduced cell proliferation (Denti et al., 2006, Pintard et al., 2003), auxin 
resistance (Stuttmann et al., 2009) and a block in fungal fruit body formation (Busch et 
al., 2007), and the role of the CSN complex in CRL regulation (Denti et al., 2006, Pintard 
et al., 2003, Stuttmann et al., 2009, Busch et al., 2007).  
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1.4 Regulation of CRLs by the CSN complex 
 
1.4.1 Deneddylation of CRLs by the CSN complex 
 
Lyapina et al, 2001 first demonstrated the cullin deneddylation capability of the CSN 
complex. The authors clearly showed that the CSN associates with cullins (Cul1-3), and 
that disruption of the CSN complex results in accumulation of neddylated Cul1 in S. 
pombe (Lyapina et al., 2001). Furthermore, they demonstrated that purified CSN isolated 
from pig spleen, which deneddylates immunopurified neddylated Cul1, can restore Cul1 
deneddylation in CSN deficient S. pombe cell extracts (Lyapina et al., 2001). CSN5 was 
then shown to contain the deneddylase activity of the CSN complex, with the zinc 
binding Jab1 (Jun activator domain binding protein 1)/MPN (Mpr1p Pad1p N-terminal) 
domain metalloenzyme (JAMM) motif of CSN5 determined to be integral to cullin 
deneddylation (Cope et al., 2002). The addition of the metal chelator ethylene diamine 
tetraacetic acid to S. pombe lysates resulted in the accumulation of neddylated Cul1, and 
mutation in the JAMM motif of CSN5 in S. pombe, although not detrimental to CSN 
complex formation, abolished cullin deneddylation (Cope et al., 2002).     
 
The finding that neddylation enhances CRL activity suggested that deneddylation would 
have an opposing effect. However, studies regarding the effect of CSN mediated CRL 
deneddylation on CRL activity produced contradictory models of cullin regulation, with 
at least two reports suggesting a negative regulatory role for deneddylation and many 
groups reporting a positive function for cullin deneddylation in CRL activity. At least two 
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in vitro studies have presented data which implicate the CSN complex in the negative 
regulation of CRLs. For example, CSA and DDB2-containing CRL complexes lack 
ubiquitin ligase activity when complexed with the CSN complex (Groisman et al., 2003), 
and addition of the CSN complex to an in vitro degradation system results in inhibition of 
SCF mediated p27 ubiquitination and degradation (Yang et al., 2002). However, the vast 
majority of data is indicative of a positive regulatory role for deneddylation in CRL 
activity. For example, deletion of CSN5 in temperature sensitive S. cerevisiae SCF 
mutant strains exacerbated SCF mediated defects such as Sic1 protein turnover (Cope et 
al., 2002), whilst in C. elegans disruption of the CSN complex by RNA interference 
resulted in hyperneddylated Cul3 and accumulation of the Cul3 target protein, MEI-1 
(Pintard et al., 2003). Furthermore, in A. thaliana, the E3 ubiquitin ligases SCFTIR1, 
SCFCOI1 and SCFUFO have been shown to interact with, and be positively regulated by, 
the COP9 signalosome complex (Feng et al., 2003, Schwechheimer et al., 2001, Wang et 
al., 2003).  
 
The above data led to the proposal of a cycling model of CRL regulation in vivo, in which 
cycles of neddylation and deneddylation are required for optimal CRL activity. In an 
initial model, cullin neddylation was suggested to result in the recruitment of a ubiquitin 
loaded E2 enzyme whilst deneddylation was thought to release the non-ubiquitin charged 
E2 and thereby enable the “refreshment” of the CRL complex with another ubiquitin 
loaded E2 (Pintard et al., 2003). However, given that the SCF can ubiquitinate target 
protein in the absence of the CSN in vitro (Petroski and Deshaies, 2003) this cycling 
model was suggested to be unlikely (Cope and Deshaies, 2003). An alternative cycling 
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model was thus proposed by Cope and Deshaies, given the findings that CAND1 also 
functions in the positive regulation of CRLs (Zheng et al., 2002a) and that cullin 
neddylation results in CAND1 dissociation (Liu et al., 2002) and prevents CAND1 
binding to cullin (Zheng et al., 2002a). Unlike the initial model, this model does not 
implicate the CSN in the direct facilitation of protein ubiquitination per se. Rather, this 
model incorporates both cullin neddylation/deneddylation and CAND1 binding as 
requirements for the efficient recycling of CRLs (figure 7). In this model, deneddylation 
inactivates the CRL allowing for CAND1 displacement of Skp1 and the F-box protein. 
Cullin neddylation then occurs, allowing for CAND1 displacement and Skp1 and F-box 
protein recruitment, and enabling another round of substrate ubiquitination prior to cullin 
deneddylation (Cope and Deshaies, 2003) (figure 7). However, it should be noted that, 
with the findings that the deneddylating activity of the CSN complex facilitates CRL 
activity by preventing the autocatalytic degradation of F-box proteins (Galan and Peter, 
1999, Wee et al., 2005), and that cullin neddylation can only occur upon Skp1-F-box 
protein mediated CAND1-cullin dissociation (Bornstein et al., 2006), this cycling model 
could be modified as shown in figure 8.   
 
Interestingly, an alternative model of CRL regulation has been proposed more recently in 
which, rather than a cycle, CRL activity is regulated by two reversible processes; the 
dissociation of CAND1 from the cullin subunit and cullin neddylation (figure 9) 
(Bornstein et al., 2006). In this model, CAND1 dissociation is mediated by the F-box 
protein/adapter complex allowing for subsequent cullin neddylation (figure 9) (Bornstein 
et al., 2006). Further, the presence of substrate inhibits the deneddylase activity of the  
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Figure 7. The cycling model of CRL regulation.
Schematic of the cycling model of CRL regulation in which both cycles of cullin 
neddylation/deneddylation and CAND1 binding are required for efficient CRL 
activity with respect to F-box protein recycling. In this model, neddylation results in 
CAND1 displacement, allowing for F-box protein-adaptor binding. Protein 
degradation takes place within this active complex whilst cullin deneddylation by 
the CSN complex enables CAND1 binding and F-box protein-adaptor 
displacement, yielding an inactive complex. Modified from Cope and Deshaies, 
2003.
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CSN complex (figure 9) (Bornstein et al., 2006) presumably allowing for efficient 
substrate degradation, upon which the CSN complex deneddylates the cullin subunit in 
order to protect F-box proteins from degradation, and enabling CAND1 binding to the 
cullin.   
 
1.4.2 Deubiquitination of CRLs by the CSN complex 
 
F-box proteins have been shown to be unstable, and degraded in a ubiquitin proteasome 
system dependent manner by an autocatalytic mechanism within their cognate SCF 
complex (Galan and Peter, 1999). Furthermore, the CSN complex has been shown to 
recruit the deubiquitinating enzyme Ubp12 in S. pombe, and stabilize F-box proteins. 
Initially, the deubiquitinating activity of CSN-Ubp12 was shown to inhibit S. pombe Cul1 
and Cul3 based CRL activity in vitro as measured by ubiquitin ligase activity assays 
(Zhou et al., 2003). However, also documented in this report was the stabilization of the 
S. pombe F-box protein, Pop1, by CSN-Ubp12, as determined by the decreased half-life 
of Pop1 in CSN5 and Ubp12 mutants (Zhou et al., 2003). Subsequently, Wee et al, 2005 
also demonstrated the destabilization of Pop1 in S. pombe CSN5 and Ubp12 mutants and 
further showed that this destabilization resulted in the increased half-life of the Pop1 
target protein Rum1. In addition, ubiquitination and destabilisation of the Cul3 adaptor 
protein Btb3 was also observed in CSN-Ubp12 deficient cells (Wee et al., 2005). 
Altogether, these data suggest that, although CSN-Ubp12 has been associated with CRL 
inhibition in vitro, the deubiquitinating activity of CSN-Ubp12 facilitates CRL function 
in vivo by counteracting autocatalytic adaptor instability. Thus, cumulatively, data  
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Figure 8. A modified cycling model of CRL regulation.
Schematic of a modified cycling model of CRL regulation in which the more recent 
findings of CAND1 displacement by F-box protein-adaptor and CRL function 
facilitation by the prevention of F-box protein degradation are included. In this 
model, both cycles of cullin neddylation/deneddylation and CAND1 binding are 
required for the efficient functioning of CRLs and prevention of F-box protein 
autocatalytic degradation. Also shown is the CSN mediated deubiquitination of F-
box proteins, the second mechanism by which the CSN prevents F-box 
autocatalytic degradation. 
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indicates that both the deneddylation and deubiquitination activities of the CSN complex 
function to facilitate CRL activity in vivo by stabilising CRL substrate adaptor proteins 
and enabling adaptor protein recycling or switching (figure 8).    
 
It is also noteworthy that the human homolog of Ubp12, USP15, has been shown to 
associate with the CSN complex from human erythrocytes (Hetfeld et al., 2005). 
However, although CSN-USP15 has been shown to deubiquitinate the CRL substrate 
IκBα (Schweitzer et al., 2007), CSN-USP15 mediated stabilisation of F-box proteins is 
yet to be directly determined in human cells.  
 
1.4.3 A third function for the CSN complex in CRL regulation? 
 
Recently, a novel function of the CSN complex in the regulation of CRLs has been 
proposed. This mechanism involves the facilitation of CRL activity via CSN mediated 
dissociation of ubiquitinated substrate from the CRL, allowing for the binding of non-
ubiquitinated substrate (Miyauchi et al., 2008). The data presented suggests that the 
activity of the Cul2/elonginB/C/VHL CRL is enhanced by the CSN complex 
independently of both the deneddylating and USP15 deubiquitinating activities of the 
CSN. Furthermore, they demonstrate that the CSN complex causes the dissociation of 
ubiquitinated substrate from Cul2/elonginB/C/VHL and that CSN knockdown in human 
cells impairs the degradation of the Cul2/elonginB/C/VHL substrate HIF-1α, potentially 
as a result of an increased association between HIF-1α and the Cul2 based CRL complex 
(Miyauchi et al., 2008). However, the contribution of this function of the CSN complex  
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Figure 9. An alternative model of CRL regulation.
A series of reversible protein interactions/modifications has been implicated in the 
regulation of CRLs. In this model, Skp1-F-box protein binding to the cullin 
dissociates CAND1 from the cullin and neddylation follows this. Substrate binding 
ensues and inhibits cullin deneddylation, presumably enabling efficient breakdown 
of substrate, upon which deneddylation can occur to protect the F-box protein from 
autocatalytic degradation. Image adapted from Bornstein et al, 2006. 
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to the regulation of other CRLs remains to be determined. Further, given that proteins can 
be efficiently ubiquitinated both in vitro (Cope and Deshaies, 2003, Miyauchi et al., 
2008) and in vivo (Miyauchi et al., 2008) in the absence of CSN, with the addition of the 
CSN complex having a relatively small effect (Miyauchi et al., 2008), the physiological 
relevance of CSN in the direct facilitation of protein ubiquitination remains to be 
determined.  
 
1.4.4 Consequences of CSN impairment on CRL function 
 
Consistent with the cycling model, impairment of CSN function results in the loss of F-
box proteins. For example, disruption of CSN2 in Neurospora results in the loss of the F-
box protein FWD-1, the β-TrCP homolog (He et al., 2005). This loss is prevented by 
mutation of the F-box motif, through which the F-box protein is recruited into the SCF 
complex. Furthermore, a CSN2 mutant A. thaliana has been identified in which the F-box 
protein TIR1 (transport inhibitor response protein 1) is unstable; an instability dependent 
on the proteasome (Stuttmann et al., 2009). These findings are consistent with the cycling 
model in which the CSN complex facilitates SCF function by preventing autocatalytic F-
box protein degradation within its cognate SCF complex. The proteasome dependent 
degradation of F-box proteins in the absence of CSN activity has also been demonstrated 
in human cells by multiple laboratories. Cumulatively, CSN5 knockdown has been 
shown to result in the loss of the F-box proteins Skp2, Cyclin F, Cdc4 and Fbx7 (F-box 
protein 7), with the addition of the proteasome inhibitor MG132 inhibiting CSN5 
knockdown mediated F-box protein loss (Cope and Deshaies, 2006, Denti et al., 2006). 
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Furthermore, as a consequence of the loss of the F-box proteins Skp2 and Cdc4, the 
target proteins p27, cyclin E and c-myc have been shown to accumulate in cells lacking 
CSN5 (Cope and Deshaies, 2006, Denti et al., 2006).  
 
In addition to the loss of F-box proteins, the stability of other components of the SCF 
complex has been shown to be affected by the loss of CSN function. For example, CSN2 
knockout in Neurospora results in the loss of the adaptor protein Skp1 which links the F-
box protein to the cullin subunit (He et al., 2005). Furthermore, the instability of the 
cullin subunit of the CRL has been observed in cells lacking a CSN subunit. In addition 
to cullin hyperneddylation, knockout of either CSN4 or CSN5 in Drosophila resulted in 
the loss of cullin protein; Cul1 protein was lost in CSN4 knockouts whilst Cul1, Cul3 and 
Cul4 protein was lost as a result of CSN5 knockout (Wu et al., 2005). Interestingly, cullin 
stability was found to be restored with a double knockdown of CSN5 and Nedd8, 
indicating that the intrinsic instability of cullins is conferred by the attachment of Nedd8 
(Wu et al., 2005), and further demonstrating the function of CSN deneddylase activity in 
the stability and recycling of cullins. The instability of Cul1 has also been demonstrated 
in a Neurospora CSN2 knockout (He et al., 2005), whereas a study in human cells 
concluded that there was no effect of CSN knockdown on cullin stability (Cope and 
Deshaies, 2006). However, although there was no reduction in the levels of either Cul1 or 
Cul3 protein in HEK293 cells lacking CSN5 reported in this manuscript, it could be 
argued that the loss of Cul2 observed is indeed significant, particularly if densitometry 
was used to analyse this data set. Finally, loss of the RING finger protein Roc1/Rbx1, 
responsible for E2 recruitment to the E3 ligase, has been reported in HeLa cells lacking 
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CSN5 (Peth et al., 2007a). Cumulatively, data suggests that the CSN complex is not only 
required for the protection of F-box proteins from autocatalytic degradation, but may also 
be fundamental, in a cell type and organism dependent manner, to the stability of all CRL 
components.             
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1.5 Other functions of the CSN complex 
 
1.5.1 The CSN and protein phosphorylation 
 
The CSN complex isolated from human erythrocytes has been demonstrated to mediate 
protein phosphorylation (Seeger et al., 1998). As none of the CSN subunits contain a 
defined kinase domain, this kinase activity was referred to as a CSN associated kinase 
activity (Naumann et al., 1999). The CSN complex was subsequently shown to co-purify 
with inositol 1,3,4-trisphosphate 5/6-kinase (5/6-kinase) from calf brain (Wilson et al., 
2001); an association later identified in human cells (Sun et al., 2002) and Arabidopsis 
(Qin et al., 2005). Further, the protein kinases CK2 and protein kinase D (PKD) have 
been shown to co-purify with the CSN complex from human erythrocytes (Uhle et al., 
2003). These three kinases have been shown to phosphorylate previously described 
targets of CSN associated kinases (Bech-Otschir et al., 2001, Seeger et al., 1998, Sun et 
al., 2002, Uhle et al., 2003), and to be inhibited by curcumin (Sun et al., 2002, Uhle et al., 
2003), the yellow pigment in turmeric which is known to inhibit CSN associated kinases 
(Henke et al., 1999). These data verify that these kinases are indeed CSN associated 
kinases, although they do not rule out the possibility that there are other kinases that 
associate with the CSN complex which remain to be identified.  
 
CSN associated kinase activity has been demonstrated to regulate the function or stability 
of several proteins. For example, c-jun (Naumann et al., 1999, Uhle et al., 2003) and 
microtubule end-binding protein 1 (EB1) (Peth et al., 2007b) phosphorylation by CSN 
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associated kinases results in stabilisation of these proteins and protection from ubiquitin-
proteasome mediated degradation, whilst CSN mediated phosphorylation of p53 and 
estrogen receptor alpha (ERalpha) signals these proteins for degradation (Bech-Otschir et 
al., 2001, Callige et al., 2005). Additionally, Cohen and colleagues have provided data to 
suggest that CSN mediated phosphorylation of interferon consensus sequence-binding 
protein (ICSBP) at serine 260 facilitates the transcriptional repressor activity of ICSBP 
(Cohen et al., 2000).  
 
Multiple observations collectively appear to implicate the requirement of the intact CSN 
complex for kinase activity. Firstly, the CSN associated kinases identified to date, CK2, 
PKD and 5/6-kinase, interact with CSN3/7, CSN3 (Uhle et al., 2003) and CSN1 (Sun et 
al., 2002), respectively. Secondly, p27 (Tomoda et al., 1999), c-jun (Claret et al., 1996), 
p53 (Bech-Otschir et al., 2001), EB1 (Peth et al., 2007b) and ERalpha (Callige et al., 
2005) have been shown to interact with the CSN via CSN5, whilst ICSBP interacts with 
CSN2 (Cohen et al., 2000). Finally, CSN5 expression in a siCSN5 background which 
seems to have no significant effect on the remaining CSN complex rescues c-jun protein 
levels (Peth et al., 2007a), whilst CSN5 expression in a siCSN1 background which has a 
reduced level of intact CSN complex (Peth et al., 2007b) fails to rescue c-jun protein 
(Peth et al., 2007a). It is also noteworthy that the kinase activity of the CSN complex has 
been shown to be independent of CSN deneddylase activity, with the expression of the 
D151N deneddylase dead CSN5 in a siCSN5 background retaining the ability to rescue c-
jun protein (Peth et al., 2007a). 
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1.5.2 The CSN and deubiquitination 
 
The CSN complex has been associated with deubiquitinase activity (Groisman et al., 
2003, Zhou et al., 2003). The CSN complex has also been shown to associate with the 
deubiquitinase Ubp12p in S. pombe (Zhou et al., 2003) and the human ortholog, ubiquitin 
specific protease 15 (USP15) (Hetfeld et al., 2005). Ubp12p has been demonstrated to 
depolymerise polyubiquitin chains in vitro (Zhou et al., 2003), whilst USP15 associated 
CSN purified from human erythrocytes was shown to both depolymerise polyubiquitin 
and cleave ubiquitin from a model substrate of the 26S proteasome (Hetfeld et al., 2005). 
In accordance with this, the human CSN complex was shown to deubiquitinate 
polyubiquitinated Cul4A in vitro to yield non-ubiquitinated Cul4A (Groisman et al., 
2003), suggesting that the CSN mediates both depolymerisation of polyubiquitin and 
cleavage of mono/polyubiquitin from protein substrates.  
 
Interestingly, a deneddylase dead CSN complex, although retaining the ability to 
depolymerise polyubiquitinated Cul4A, failed to cleave monoubiquitin from Cul4A in 
vitro (Groisman et al., 2003). These data suggest that the CSN complex is associated with 
two separate deubiquitinase activities, and further indicate that the metalloprotease 
domain of CSN5, responsible for deneddylation, may also deubiquitinate target proteins 
by a similar mechanism. Similar findings were made in vivo, with an increase in 
ubiquitinated exosomal heat shock protein 70 (HSP70) protein being demonstrated in a 
human cell line transfected with mutant CSN5 expressing plasmid relative to cells 
expressing wild-type CSN5 (Liu et al., 2009). It is noteworthy that this study also 
 39
determined the requirement for the intact CSN complex for deubiquitination, with the 
addition of CSN5 to an in vitro deubiquitination assay yielding no effect on the level of 
ubiquitinated HSP70 protein (Liu et al., 2009). Although a direct function of the CSN 
complex in protein deubiquitination via the metalloprotease domain of CSN5 has been 
suggested, further work would have to be carried out in order to rule out the possibility 
that a yet unidentified deubiquitinase associates with the CSN complex through this 
domain. Nonetheless, the CSN complex has been demonstrated to deubiquitinate multiple 
protein targets, including CRL substrate adapter proteins (Wee et al., 2005) and IκBα 
(Schweitzer et al., 2007), both of which are protected from degradation by 
deubiquitination (Schweitzer et al., 2007, Wee et al., 2005), and HSP70 (Liu et al., 2009).  
 
More recently, the CSN complex has been shown to associate with a lysine 63 (K63) 
specific deubiquitinase, Brcc36 (Cooper et al., 2009). Whilst K48 linked ubiquitin chains 
signal for protein degradation (Pickart, 2004), K63 linked ubiquitin chains have non-
proteolytic functions (Cooper et al., 2009). This association is therefore indicative of a 
role for the CSN associated deubiquitinase activity not only in the regulation of protein 
degradation but also in the modulation of protein function.  
 
1.5.3 The CSN and transcriptional regulation 
 
As a regulator of the function and/or stability of a myriad of proteins, including 
transcription factors, the finding that the CSN complex regulates transcription 
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(Chamovitz, 2009, Su et al., 2009) is not surprising. However, the question remains as to 
whether the nuclear CSN complex can regulate transcription directly (Chamovitz, 2009).  
 
The CSN has been shown in multiple systems to associate with chromatin (Groisman et 
al., 2003, Menon et al., 2007, Ullah et al., 2007), implying a potential direct role for the 
CSN in regulating transcription. In two of these systems the CSN likely functions at 
chromatin to regulate protein function or stability rather than having a direct function in 
transcriptional regulation (Groisman et al., 2003, Ullah et al., 2007). However, the study 
by Menon and colleagues suggests a direct role for the CSN complex in transcriptional 
regulation. CSN8 deficient CD4+ T cells failed to accumulate all G1 cyclins and cyclin 
dependent kinases (CDKs) studied upon T cell antigen receptor (TCR) stimulation 
(Menon et al., 2007). If this finding were attributable to altered protein degradation in the 
absence of CSN8 then proteasome inhibition should restore protein levels of cyclins and 
CDKs. However, this study demonstrated that treatment with the proteasome inhibitor 
MG132 could not rescue these proteins (Menon et al., 2007), indicating a proteasome 
independent function of the CSN complex in the regulation of these proteins. Further, 
given the findings that mRNA levels of cyclins could not be upregulated upon TCR 
stimulation in CSN8 deficient cells and that both CSN1 and CSN8 (and probably the 
entire CSN complex) precipitate with a cyclin promoter in chromatin 
immunoprecipitation (ChIP) assays (Menon et al., 2007), it is probable that the CSN 
complex can function in the direct regulation of transcription via a proteasome 
independent mechanism. It is noteworthy that in this instance an indirect function of the 
CSN complex in transcriptional regulation cannot be completely ruled out. For example, 
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transcription factor activity modification could occur as a result of CSN associated kinase 
activity at the promoter. Nonetheless, these data do implicate the CSN complex in the 
direct regulation of transcription, with the exact mechanism still to be elucidated.     
 
Although CSN subunits have been shown to interact with chromatin, a direct interaction 
between the CSN complex and DNA has not been demonstrated. Interestingly, however, 
the recent elucidation of the structure of CSN7 has demonstrated that the winged helix 
subdomain of the PCI domain has a structure comparable to that of winged helix nucleic 
acid binding proteins (Chamovitz, 2009, Dessau et al., 2008), whilst modelling shows 
that this domain of CSN7 has the potential to interact with DNA (Dessau et al., 2008). 
Although a direct interaction between the CSN complex and DNA remains to be 
demonstrated experimentally, these data suggest that the CSN complex has the potential 
to bind DNA with enhanced affinity via its six PCI domains (Dessau et al., 2008) and 
may therefore directly regulate transcription.      
 
1.5.4 CSN subcomplexes 
 
Although the CSN complex is ~500kDa, a ~100kDa cytoplasmic CSN5 containing 
complex was identified in mammalian cells. The occurrence of this subcomplex was 
inhibited by the nuclear export inhibitor leptomycin B (LMB), suggesting that this 
subcomplex is produced from nuclear COP9 signalosome (Tomoda et al., 2002). 
Immunoprecipitation of this subcomplex with an antibody specific for the subcomplex 
bound CSN5 co-immunoprecipitated CSN4, 6, 7 and 8, but not subunits CSN1, 2 or 3 
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(Tomoda et al., 2002). Several findings implicate this CSN5 containing subcomplex in 
the nuclear export of p27 protein. First, mutation of the nuclear export signal (NES) of 
CSN5 resulted in nuclear accumulation of both CSN5 and p27. Second, expression of a 
dominant negative CSN5 N-terminus (lacking the C-terminus NES), which did not affect 
the intact CSN complex and fractionated in smaller complexes, also resulted in an 
increase in nuclear p27 protein (Tomoda et al., 2002). Third, overexpression of 
components of this subcomplex resulted in reduced p27 protein, and further, CSN7 
overexpression was shown to result in the LMB sensitive redistribution of CSN5 to the 
cytoplasm and loss of nuclear p27 signal (Tomoda et al., 2002). However, it is important 
to note that this study did not address whether CSN5 interacts with the other CSN 
subunits together, or in various combinations to produce multiple subcomplexes. The 
latter is probable as suggested by both the small size of the identified 
subcomplex/subcomplexes and given the finding that overexpression of CSN4, which co-
immunoprecipitated with the CSN5 containing subcomplex, does not affect p27 protein 
(Tomoda et al., 2002). Further, a more recent report has demonstrated using native-PAGE 
that CSN subunits occur in multiple distinct subcomplexes (Fukumoto et al., 
2005).Collectively, these data implicate a CSN5/6/7/8 ~100kDa containing CSN 
subcomplex in the nuclear export of p27 and further suggest the occurrence of other CSN 
subcomplexes with unidentified functions.  
 
A CSN5 containing CSN subcomplex, which negatively regulates p27 protein, has also 
been identified in both chronic myeloid leukaemia (CML) cell lines and primary CMLs 
(Tomoda et al., 2005), although the constituent subunits were not identified. Interestingly, 
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this CSN subcomplex has been shown to be a downstream mediator of BCR-ABL kinase 
activity (Tomoda et al., 2005); this topic is discussed in section 1.8. These data suggest 
that the activity of a CSN subcomplex has the potential to contribute to leukaemogenesis.   
 
The function of a CSN subcomplex in regulating the level of p27 protein has also been 
demonstrated in vivo. Embryonic fibroblasts (MEFs) from CSN5 heterozygous mice, in 
which downstream proteins of the CSN complex including Cul1, Skp2 and p53 were 
unaffected, contained only 40% of the CSN subcomplex relative to wild-type mice and 
demonstrated p27 accumulation (Tomoda et al., 2004). In accordance with this, CSN5 
heterozygous MEFs grew significantly slower than wild-type MEFs and, at 15 weeks, 
heterozygous mice were significantly smaller (~15%) than wild-type mice (Tomoda et 
al., 2004).   
 
Although this is not an exhaustive review of CSN subcomplexes, the above data provides 
strong evidence for both the occurrence and functionality of CSN subcomplexes. In 
addition, many substoichiometric complexes were identified in a recent structural study 
of the CSN complex (Sharon et al., 2009). However, much more work is required to 
determine the precise function, regulation and physiological relevance of CSN 
subcomplexes.    
 
The alternative functions of the CSN/CSN subcomplexes discussed above may explain 
why, in some organisms, different CSN subunit disruption results in divergent 
phenotypes. For instance, CSN4 and CSN5 null mutations in Drosophila result in 
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different phenotypes, with that of CSN4 mutation appearing more severe (Oron et al., 
2002). These differences may be attributable to the fact that these mutations have 
divergent effects on the stability of the intact CSN complex (Oron et al., 2002), and that 
in CSN5 mutants, the retained CSN complex lacking CSN5 possibly still functions in 
deneddylation independent processes such as phosphorylation and deubiquitination. 
Further, although null mutation in CSN subunits 1, 2, 4 and 5 in S. pombe all result in 
hyperneddylated Cul1, CSN4 and CSN5 mutants do not have the same phenotype as 
CSN1 and CSN2 mutants (Mundt et al., 2002), suggesting that CSN1 and CSN2 function 
as a subcomplex independent of CSN4 and CSN5. However, these differences may also 
be explained by the CSN independent functions of CSN subunits (see section 1.7).      
 
1.5.5 The CSN as an alternative lid for the proteasome? 
 
As already discussed, the 19S regulatory particle of the 26S proteasome is important for 
substrate recognition and delivery to the 20S core particle where substrates are 
subsequently degraded. Interestingly, the 19S particle has been shown to be formed from 
two subcomplexes called the base and the lid (Glickman et al., 1998). The base is 
sufficient to activate the protein degradation activity of the 20S core particle but ubiquitin 
mediated protein degradation requires both the base and lid of the regulatory particle 
(Glickman et al., 1998), with the Rpn11 subunit of the lid being responsible for target 
protein deubiquitination prior to proteasomal degradation (Sharon et al., 2009, Verma et 
al., 2002).  
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The CSN complex displays homology to the lid of the proteasome (Glickman et al., 
1998). Further, there is data to suggest that the CSN complex interacts with the 
proteasome in plant (Peng et al., 2003), human (Seeger et al., 1998) and mouse (Huang et 
al., 2005) cells. These observations, together with the findings of both CSN associated 
deubiquitinase activity (see 1.5.2) and a possible competition between the lid and CSN 
complex for proteasome binding (Huang et al., 2005), have led to the suggestion that the 
CSN complex may be an alternative lid of the proteasome (Li and Deng, 2003). 
However, it is important to note that the replacement of the proteasome lid with the CSN 
complex and any functional significance of this replacement remains to be 
experimentally determined in vivo. Nonetheless, the identified interactions of the CSN 
complex with the proteasome and CRLs (Huang et al., 2005, Peng et al., 2003) suggest 
that the CSN may function to bring the processes of protein ubiquitination and 
degradation into close proximity, thereby increasing the efficiency of ubiquitin mediated 
protein degradation, whilst also regulating both of these processes via the identified CSN 
associated deneddylase and deubiquitinase activities.  
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1.6 The regulation of CSN activity 
 
Given the diverse functions of the CSN complex and the plethora of proteins for which 
the CSN regulates stability or activity, it would seem extremely probable that the 
activities of the CSN complex are tightly regulated. However, this topic remains 
relatively unstudied and subsequently, little is known of the mechanisms of CSN activity 
regulation.  
 
Several studies have demonstrated the sequestration of CSN5 by protein interaction, 
suggesting this as a mechanism of CSN activity regulation. CSN5 has been shown by 
yeast-two hybrid, GST pulldown and co-immunoprecipitation assays to interact with the 
integrin LFA-1 (Bianchi et al., 2000), the lutropin/choriogonadotropin receptor (LHR) 
(Li et al., 2000) and the cytokine macrophage inhibitory factor (MIF) (Kleemann et al., 
2000). The sequestration of CSN5 at peripheral membranes by unliganded LFA-1 has 
been demonstrated, whilst CSN5 was redistributed to the nucleus upon LFA-1 
stimulation, with a concomitant increase in AP-1 transcriptional activity (Bianchi et al., 
2000). In addition, CSN5 interacts with the endoplasmic reticulum localised protein 
LHR, an interaction which reduces AP-1 promoter driven luciferase reporter activity (Li 
et al., 2000). Finally, MIF binding to CSN5 in the cytosol has also been shown to reduce 
c-jun mediated transcriptional activity at AP-1 sites, and further result in reduced c-jun 
phosphorylation and inhibition of CSN5 dependent p27 protein degradation (Kleemann et 
al., 2000). Collectively, these data suggest that multiple functions of the CSN and its 
subunits may be downstream mediators of multiple signalling pathways, and that 
 47
cytosolic sequestration of CSN5 may be a mechanism of regulating multiple functions of 
the CSN complex.      
 
Interestingly, double mutation of CSN5 (a reduction of function mutation generated by T-
DNA insertion into a CSN5 intron) and Cul3 in Arabidopsis resulted in an increase in the 
level of CSN5 protein relative to CSN5 mutation alone, and a concomitant increase in 
deneddylation activity (Gusmaroli et al., 2007). Along with the finding that CSN5/Cul3 
double mutation has no significant effect on CSN5 mRNA (Gusmaroli et al., 2007), these 
data suggest that a Cul3 based E3 ubiquitin ligase may mediate the degradation of CSN5 
and thus the activity of the CSN complex. Although this is an interesting possibility, 
particularly given the prospect of a negative feedback mechanism of CRL regulation, 
further work is required to exclude any possible indirect effects of Cul3 loss on CSN5 
protein level and to determine the specific adapter protein responsible for CSN5 protein 
degradation.        
 
Overexpression of 1,3,4-trisphosphate 5/6-kinase (5/6-kinase) in HEK293 cells has been 
shown to result in an increase in CSN5 protein relative to vector control transfected cells 
by western blot analysis, although a loading control was not shown (Sun et al., 2002). 
The authors suggest 5/6-kinase induction of CSN5 as a possible regulatory mechanism 
for CSN5 activity, however much more work would be required to both confirm CSN5 
induction by this kinase and to determine the mechanism by which 5/6-kinase increases 
CSN5 i.e. CSN5 phosphorylation, CSN5 mRNA increase or CSN5 protein stabilisation as 
examples.      
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CSN2 and CSN5 appear to be relatively stable outside of the CSN complex (Gusmaroli et 
al., 2007), are the most readily dissociable subunits of the CSN (Sharon et al., 2009) and 
have well documented CSN independent functions (see 1.7). Thus, a key mechanism of 
CSN/CSN subunit function regulation may be dependent upon the level of other CSN 
subunits and therefore whether CSN2/CSN5 are monomeric or incorporated into the CSN 
complex. The same can also be said for CSN subcomplexes. Although the occurrence, 
composition and function of such subcomplexes remains to be elucidated fully, it is 
plausible that the availability of each of the eight subunits would have great influence on 
CSN/CSN subcomplex formation and therefore CSN function.  
 
Finally, CSN activity may be regulated by post-translational modification of CSN 
subunits. For example, the cleavage of CSN6 has been shown to occur upon apoptosis 
induction in a caspase dependent manner; a modification which increases the 
deneddylase activity of the CSN complex without affecting CSN mediated protein 
deubiquitination or phosphorylation (Hetfeld et al., 2008).  In addition, CSN2 and CSN7 
have been shown to be phosphorylated by CSN associated kinases (Uhle et al., 2003), 
suggesting another potential mechanism of CSN activity regulation. Further, 
phosphorylation sites have also been identified in CSN subunits 1, 3 and 8 (Fang et al., 
2008). Although the possibility of phosphorylation dependent CSN activity regulation 
has not been investigated in detail, curcumin treatment has been shown to result in 
complete loss of the reported CSN subcomplex (Tomoda et al., 2005, Fukumoto et al., 
2005) and the collapse of CSN supercomplexes (Fukumoto et al., 2005), implicating the 
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CSN associated kinases in the regulation of CSN subcomplex/supercomplex formation, 
possibly via CSN subunit phosphorylation. 
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1.7 CSN independent functions of CSN subunits 
 
Individual subunits of the CSN complex have been shown to have alternative functions 
independent of the CSN complex. The discussion here will be of CSN2 and CSN5, as 
these subunits have been suggested to be relatively stable outside of the CSN complex 
(Gusmaroli et al., 2007), have recently been shown to be the most readily dissociable, 
peripheral subunits of the CSN complex (Sharon et al., 2009), and have the most well 
documented CSN independent functions.  
 
1.7.1 CSN2 
 
Two different splice variants are generated from the CSN2 locus, one encoding the 
50kDa CSN2 and the other encoding the ~36kDa Alien protein which consists of the N-
terminal 300 amino acids of CSN2 (Chamovitz, 2009, Tenbaum et al., 2003). 
Interestingly, part of the PCI domain of CSN2 is lacking from Alien (Chamovitz, 2009) 
and the intracellular distribution of Alien has been shown to be distinct from that of CSN 
subunits (Eckey et al., 2007), making incorporation of this isoform into the CSN complex 
unlikely, although not experimentally determined. Any potential CSN independent 
function of CSN2 remains relatively unstudied, whilst the function of Alien has 
undergone significant investigation. Given that the amino acid sequence of Alien is 
identical to the N-terminal of CSN2 and the probable independence of Alien from the 
CSN, it remains possible that CSN2 and Alien have overlapping functions independent of 
the CSN complex. The function of Alien is thus worthy of discussion here.  
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Alien was initially shown to interact with thyroid hormone receptor (TR) by yeast two-
hybrid, GST pull-down and co-immunoprecipitation assays; an interaction shown to be 
thyroid hormone sensitive (Dressel et al., 1999). Further, Alien was shown to enhance TR 
mediated transcriptional repression in the absence of thyroid hormone, thus identifying 
Alien as a transcriptional corepressor (Dressel et al., 1999). Alien has since been 
demonstrated as an interacting partner for multiple nuclear hormone receptors including 
the ecdysone receptor (Dressel et al., 1999), the vitamin D receptor (Polly et al., 2000), 
DAX-1 (Altincicek et al., 2000) and the androgen receptor (Moehren et al., 2007).  
Interestingly, in addition to gene silencing at nuclear hormone receptors, Alien has also 
been shown to both interact with and repress the transcriptional activation activity of the 
transcription factor E2F1 (Tenbaum et al., 2007).  
 
The mechanisms by which Alien mediates transcriptional repression have been 
investigated (Papaioannou et al., 2007). Initially, Alien was shown to interact with a 
known component of a large histone deacetylase complex, SIN3A, by both yeast two-
hybrid and co-immunoprecipitation assays (Dressel et al., 1999) and GST pull-down 
assay (Moehren et al., 2004). Further, co-expression of SIN3A with Alien resulted in 
increased transcriptional repression relative to Alien expression alone (Moehren et al., 
2004). Together with the finding that Alien also interacts with histone deacetylase 
(HDAC) proteins (Papaioannou et al., 2007), these data indicate that one mechanism by 
which Alien mediates transcriptional repression is via recruitment of HDAC machinery. 
However, addition of a HDAC inhibitor reduced Alien mediated transcriptional 
repression only partially (Dressel et al., 1999), suggesting at least a second mechanism by 
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which Alien silences transcription. Indeed, interaction between Alien and nucleosome 
assembly protein 1 (NAP1) has been demonstrated, with the addition of Alien to a 
supercoiling assay resulting in a dose dependent increase in NAP1 mediated DNA 
supercoiling (Eckey et al., 2007). Collectively, these data suggest that Alien mediates 
transcriptional repression by at least two mechanisms, both HDAC dependent and 
independent, and both of which rely upon chromatin modification for DNA compaction.     
 
1.7.2 CSN5    
 
CSN5 was identified in a yeast two hybrid screen of a human B lymphocyte cDNA 
library as a c-jun interacting protein, and this interaction further verified in co-
immunoprecipitation assays (Claret et al., 1996). Subsequently, CSN5 was shown to 
increase DNA binding of the transcription factor c-jun to its cognate AP-1 transcription 
activation sites, and increase c-jun mediated transcriptional activity (Claret et al., 1996). 
Similar findings were also made regarding junD, but not v-jun or junB (Claret et al., 
1996), indicating that, through selective interaction with members of the jun family of 
transcription factors, CSN5 (or jun activation domain binding protein 1; JAB1) increases 
the specificity of transcriptional activation at AP-1 transcription sites. Through this 
function CSN5 has been implicated in both the integrin LFA-1 (Bianchi et al., 2000) and 
the cytokine macrophage migration inhibitory factor (MIF) (Kleemann et al., 2000) 
signalling pathways. In addition to c-jun mediated transcription, CSN5 has also been 
shown to potentiate the hormone dependent transcriptional activation activity of steroid 
hormone nuclear receptors (Chauchereau et al., 2000).  
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CSN5 has been implicated in the nuclear export of proteins such as Smad7 (Kim et al., 
2004), p53 (Oh et al., 2006a) and West Nile virus capsid (WNVCp) (Oh et al., 2006b). 
However, it is important to note with JAB1 associated literature that many publications 
do not discern between CSN5 monomer function and CSN5 function within the CSN 
complex. For example, although Oh and colleagues demonstrated that the fragment of 
CSN5 required for p53 nuclear export does not interact with other CSN subunits, 
suggesting that CSN5 mediated p53 nuclear export is independent of the CSN complex 
(Oh et al., 2006a), others have not investigated whether CSN5 mediated protein nuclear 
export is dependent on the CSN complex/subcomplex rather than monomeric CSN5 (Kim 
et al., 2004, Oh et al., 2006b). Indeed, a CSN subcomplex is implicated in the nuclear 
export of p27 protein (Tomoda et al., 2002).   
 
Similar caution should also be used when interpreting data regarding JAB1 function as a 
transcriptional coactivator. For instance, the increased c-jun dependent AP-1 directed 
transcriptional activity observed in the presence of CSN5/JAB1 (Claret et al., 1996) could 
be attributable to a function of CSN5 within the intact CSN complex as opposed to a 
function of JAB1 monomer. In support of this, the stabilisation of c-jun protein towards 
the ubiquitin-proteasome system by CSN associated kinase mediated c-jun 
phosphorylation has been demonstrated (Uhle et al., 2003). Moreover, the observed 
increase in AP-1 driven luciferase activity in the presence of c-jun and JAB1 (Claret et 
al., 1996, Wang et al., 2004) was reduced to the level of luciferase activity in the 
presence of c-jun alone upon treatment with the CSN associated kinase inhibitor 
curcumin (Wang et al., 2004). Collectively, these data suggest that the positive effect 
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exerted on c-jun mediated transcriptional activation at AP-1 sites by CSN5 may be 
mediated through the CSN complex rather than CSN5/JAB1 function as a monomer.   
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1.8 The CSN and leukaemia 
 
A role for the CSN in cancer is emerging, with aberrant expression of CSN subunits 
identified in multiple cancers (Richardson and Zundel, 2005, Adler et al., 2008, Patil et 
al., 2005, Yan et al., 2007). Indeed, the deneddylase activity of the CSN has been shown 
to be essential for breast epithelial cell transformation and in vivo tumour progression 
(Adler et al., 2008), whilst inhibition of CSN associated kinases resulted in reduced 
pancreatic cell proliferation (Li et al., 2009). However, to date the links between the CSN 
complex and leukaemia are limited. Nevertheless, associations are beginning to be made 
and are therefore of interest for discussion here.  
 
Myeloid leukaemia factor 1 (MLF1) has been shown to regulate the level of p53 via CSN 
subunit 3 (CSN3) (Yoneda-Kato et al., 2005). The NPM (nucleophosmin)/MLF1 fusion 
protein, generated by the chromosomal translocation t(3;5)(q25.1;q34) (Yoneda-Kato et 
al., 1996), is associated with myelodysplastic syndrome, often resulting in progression to 
acute myeloid leukaemia (Raimondi et al., 1989). Yonedo-Kato et al, 2005 demonstrated 
that MLF1 induces p53 mediated cell cycle arrest via CSN3-directed downregulation of 
COP1 (an E3 ligase which targets p53 for degradation). They suggest therefore, that the 
inactivation of MLF1 by formation of the NPM/MLF1 fusion protein would result in 
potentially tumourigenic dysregulated p53 degradation. These data further suggest a 
potential role for CSN3 in leukaemogenesis. However, it remains to be determined 
whether COP1 mediated p53 degradation is regulated via CSN3 alone or as a component 
of the intact CSN complex.  
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A small CSN subcomplex has been shown to be a downstream mediator of BCR-ABL 
kinase activity (Tomoda et al., 2005). BCR-ABL is an oncogenic fusion protein with 
constitutive tyrosine kinase activity, formed as a result of the Philadelphia chromosome 
translocation, which is present in 90% of chronic myeloid leukaemia (CML) patients 
(Rowley, 1980). A 100kDa CSN subcomplex was identified in CML cell lines and 
primary CML samples which was not detectable in other cell lines or primary cells tested. 
This complex was found to be upregulated by BCR-ABL, with BCR-ABL kinase 
inhibition resulting in a reduced level of the CSN subcomplex and a concomitant increase 
in p27. Furthermore, targeted degradation of CSN5, a component of the CSN 
subcomplex, resulted in the loss of BCR-ABL mediated p27 degradation (Tomoda et al., 
2005). Together, these results suggest that the cytoplasmic shuttling and subsequent 
degradation of p27 associated with the CSN subcomplex (Tomoda et al., 2002) is a 
contributing factor to the oncogenic transformation mediated by the BCR-ABL fusion 
protein in CML.  
 
The above observations, along with the recent association of CSN5 with non-Hodgkin’s 
lymphoma (Qi et al., 2006, Wang et al., 2008), are suggestive of a role for the CSN 
complex in haematological malignancy, including leukaemia. However, observations to 
date have been made regarding either a CSN subcomplex or an individual subunit of the 
CSN. The intact CSN complex has not, therefore, been associated with leukaemia per se. 
Nonetheless, with the plethora of proteins known to be degraded by CRLs and the diverse 
cellular processes which they regulate, and given the multitude of activities associated 
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with the CSN complex, it is not difficult to envisage a role for dysregulated CSN 
complex activity in leukaemia.   
 58
1.9 Chronic myeloid leukaemia 
 
Chronic myeloid leukaemia (CML) is a disease of haematopoietic stem cells 
predominantly arising from a genetic aberration called the Philadelphia chromosome 
(Hehlmann et al., 2007). The Philadelphia chromosome is formed from the translocation 
t(9;22)(q34;q11), which results in the production of the BCR-ABL oncogene on 
chromosome 22. This oncogene encodes the BCR-ABL fusion protein, a tyrosine kinase 
with aberrant activity (Hehlmann et al., 2007) which is the underlying cause of CML 
(Weisberg et al., 2007). Therapy targeting the activity of this fusion protein has 
revolutionised CML treatment. Treatment with imatinib, an ABL kinase inhibitor which 
competitively binds at the ATP-binding site, yields good responses in patients with early 
phase, chronic CML (Hehlmann et al., 2007). However, problems have arisen with 
imatinib treatment including the limited response of later stage blast crisis CML to 
imatinib (Sawyers et al., 2002), the development of imatinib resistant disease (Gorre et 
al., 2001) and the insensitivity of CML stem cells to imatinib treatment (Graham et al., 
2002). As a result, other inhibitors of BCR-ABL kinase activity have been developed 
(Weisberg et al., 2007). However, a limited response in blast crisis CML still appears to 
be a problem, and mutations have also been identified which confer resistance to these 
inhibitors (Weisberg et al., 2007).   
 
As the above problems with BCR-ABL targeting in the treatment of CML persist, studies 
have begun into the use of other compounds in combination with imatinib to overcome 
resistant disease, gain greater responses in blast crisis CML, and target the CML stem 
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cell. Three key findings suggest the CSN complex may be a viable target in CML. First, 
one process being targeted in combination with imatinib in CML is intracellular protein 
degradation (Bellodi et al., 2009, Gatto et al., 2003). Second, a CSN subcomplex has 
been shown to be a downstream mediator of BCR-ABL kinase activity in CML (Tomoda 
et al., 2005). Third, ectopic CSN5 expression in mice, shown to incorporate into CSN 
complexes, resulted in progressive myeloid hyperplasia with overproduction of 
granulocytes, resembling chronic phase CML (Mori et al., 2008).  
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1.10 Project aims 
 
As discussed, the CSN is a highly conserved complex with a multitude of functions, and 
is thus studied in a wide variety of organisms. Studies of the CSN complex in human 
cells to date are generally limited to the use of cell lines such as HeLa and HEK293. This 
study aimed to investigate the function of the CSN in a haematological setting and in 
relation to human leukaemia. This study thus used a cell line model of human blast crisis 
CML, K562, derived from a 53 year old female with CML that had progressed to blast 
crisis following splenectomy (Lozzio and Lozzio, 1975).   
 
In order to achieve this aim, first the non-catalytic subunit CSN2 and the deneddylase 
activity containing subunit CSN5 were knocked down in K562 cells using a short hairpin 
RNA (shRNA) technique. Once CSN subunit knockdowns were established, studies were 
carried out in an to attempt to answer the following questions: 
 
1. Does CSN subunit knockdown in K562 result in aberrant CRL activity and if so, 
is this aberrant activity similar to that observed in other organisms and human cell 
lines?  
2. With the emerging function of the CSN in transcriptional regulation, either direct 
or indirect, does CSN subunit disruption in K562 have any effect on the level of 
F-box protein or CSN subunit mRNA? 
3. Given that CSN subunit loss is lethal in higher eukaryotes and that CSN subunit 
disruption has been associated with reduced proliferation and cell death, what are 
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the consequences of CSN subunit knockdown for K562 cell proliferation and 
death?  
4. Are the molecular and cellular effects of CSN2 and CSN5 knockdown in K562 
the same, and if not, what may be the cause of any divergence? 
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Chapter 2.0: 
Materials and Methods 
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2.1 Cell culture and treatments 
 
2.1.1 Maintenance of cell lines 
 
Cell lines were maintained in RPMI 1640 (Invitrogen Gibco, Paisley, U.K.) 
supplemented with 100U/ml penicillin, 100µg/ml streptomycin and 10% v/v foetal 
bovine serum (all Invitrogen Gibco). Cultures were maintained at 37oC with 5% CO2. 
Cells were diluted one part in three parts media every 48 hours to maintain a cell density 
between 2x105 and 1x106 cells/ml, to maintain cells in exponential growth. 
 
2.1.2 Storage of cell lines in liquid nitrogen 
 
1x107 cells were harvested by centrifugation at 1500 rpm for 5 minutes (FALCON 6/300, 
MSE, London, U.K.). The supernatant was discarded, the cell pellet resuspended in 1ml 
freezing mix (95% FBS, 5% DMSO) and the cell suspension transferred to a cryovial. 
Cells were slowly frozen by placing the vials in a sealed polystyrene container and 
incubating this at -20oC for 60 minutes and -80oC overnight. Cells were stored in liquid 
nitrogen thereafter.  
 
2.1.3 Recovery of cell lines from liquid nitrogen 
 
A vial containing 1x107 cells (see above) was removed from liquid nitrogen and thawed 
rapidly in water (50oC) for 2-3 minutes. Cells were transferred to a 25ml universal and 
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0.5, 1, 2, 5 and 10ml aliquots of cold media added drop wise to gradually dilute the 
freezing mix and prevent apoptotic shock. The cell suspension was centrifuged at 1500 
rpm for 5 minutes (FALCON 6/300, MSE) and the supernatant discarded. The cell pellet 
was resuspended in 2ml cold media, transferred to a 24 well plate and maintained as in 
2.1.1.  
 
2.1.4 Treatment of cells with MG132 
 
Transfected cells were set at a density of 3x105 cells/ml in a total volume of 4ml and this 
volume split equally into two wells of a 24 well plate. DMSO (0.2µl) was added to the 
control well and 10µM MG132 (BIOMOL, Exeter, U.K.; 0.2µl of a 100mM stock in 
DMSO) added to the other. Cells were cultured for 18 hours with treatment before being 
harvested for western blot analysis. Time points for MG132 treatment are as indicated in 
the results sections. 
 
2.1.5 Treatment of cells with 3-methyladenine  
 
3-methyladenine (3-MA, Sigma, Dorset, U.K.) powder was added to media and this mix 
incubated at 100oC for 10 minutes to give a 1x stock solution (10mM). Control media 
was also incubated at 100oC for 10 minutes. Day 3 post transfection, 2.4x106 transfected 
cells were pelletted by centrifugation at 1500rpm for 5 minutes (FALCON 6/300, MSE) 
and the supernatant discarded. Half of the cells were resuspended in 3ml control media 
(see 2.1.1) and the other half resuspended in 3ml media supplemented with 10mM 3-MA. 
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Cells were plated in a 12 well plate and all cells/treatments maintained in the same 
volume and same size culture vessel until they were harvested day 7 post transfection.   
 
2.1.6 Treatment of cells with Bafilomycin A1 
 
To determine optimal concentrations to be used, wild-type K562 cells were plated at 
4x105 cells/ml in 4ml in a 12 well plate and treated with either DMSO (control), 1nM, 
10nM, 100nM or 1µM Bafilomycin A1 (Axxora, Nottingham, U.K.; 1mM stock in 
DMSO). Cells were cultured for 48 hours until harvested for analysis.  
 
In subsequent experiments, day 5 post transfection, transfected cells were plated at 4x105 
cells/ml in 2ml in a 24 well plate and either DMSO (control) or 1µM Bafilomycin A1 
(1mM stock in DMSO) added. Cells were cultured for 48 hours until harvested for 
analysis.   
 
2.1.7 Treatment of cells with rapamycin 
 
Wild-type K562 cells were set at 4x105 cells/ml in 6ml in a 25cm2 flask and treated with 
either DMSO (control), 20nM, 50nM or 100nM rapamycin (Sigma; 200µM stock in 
DMSO). Cells were cultured as in 2.1.1 for six days, with rapamycin supplementation 
into the media as appropriate, and then cells harvested for analysis.  
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2.2 shRNA construct production 
 
2.2.1 shRNA sequence design 
 
Knockdown sequences were designed using a QIAGEN siRNA tool 
(http://www1.qiagen.com/products/genesilencing/customsirna/sirnadesigner.aspx). These 
sequences (shown in bold below), flanked by the appropriate hairpin and restriction site 
sequences were ordered from Sigma Genosys (Sigma). 
Vector control scramble: 5’GTACCAAGCGGGATTCAGTAGTTACGTTCAAGAG 
ACGTAACTACTGAATCCCGCTTTTTTTGGAAAT 3’ (Forward),  
5’CTAGATTTCCAAAAAAAGCGGGATTCAGTAGTTACGTCTCTTGAACGTAA
CTACTGAATCCCGCTTG 3’ (Reverse),  
shCSN2: 5’GTACCAAGCGGCATTAAGCAGTTTCCTTCAAGAGAGGAAACTG 
CTTAATGCCGCTTTTTTTGGAAAT 3’ (Forward), 
5’CTAGATTTCCAAAAAAAGCGGCATTAAGCAGTTTCCTCTCTTGAAGGAAA
CTGCTTAATGCCGCTTG 3’ (Reverse),  
shCSN5: 5’GTACCAAGGGCTACAAACCTCCTGATTTCAAGAGAATCAGGAG 
GTTTGTAGCCCTTTTTTTGGAAAT 3’ (Forward), 
5’CTAGATTTCCAAAAAAAGGGCTACAAACCTCCTGATTCTCTTGAAATCAG
GAGGTTTGTAGCCCTTG 3’ (Reverse).   
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2.2.2 Oligonucleotide annealing 
 
Lyophilised oligonucleotides (Sigma Genosys, see above) were reconstituted to 100µM 
stock concentration in TE pH8 (10mM Tris HCl pH 8, 1mM EDTA pH 8, in distilled 
water). An annealed oligonucleotide stock (10µM) was produced by mixing 5µl of each 
oligonucleotide with 40µl TE pH 8, heating the mix to 70oC for 10 minutes and allowing 
them to cool slowly by incubating at room temperature for 45 minutes.  
 
2.2.3 Vector preparation 
 
Multi-core buffer (5µl) was mixed with 2.5µl Acc65I, 2.5µl XbaI (all from Promega, 
Southampton, U.K.), 6µg vector DNA (modified pcDNA3.1 vector developed by Heiko 
Lickert (Kunath et al., 2003) and the volume made up to 50µl with DNase RNase free 
water (Invitrogen Gibco). Vector was digested by 3 hour incubation at 37oC.  
 
Digestion products (40µl) were mixed with 10µl 5x DNA gel loading buffer (Bioline, 
London, U.K.) and samples separated by electrophoresis on a 1.5% agarose (Invitrogen, 
Paisley, U.K.) gel with 0.4µg/ml ethidium bromide (Sigma). 5µl each of Hyperladder I 
(Bioline) and Hyperladder IV (Bioline) markers were used and the gel electrophoresed in 
1xTBE (89mM Tris, 89mM boric acid and 2mM EDTA pH8 in distilled water) at 70V 
for 30 minutes. DNA was visualised under UV transillumination with a Geneflash 
Syngene Bio Imager (Geneflow, Fradley, U.K.).  
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The linear vector DNA fragment was excised from the gel and the DNA extracted using a 
QIAquick gel extraction kit (Qiagen, Crawley, U.K.). Briefly, the gel slice was weighed, 
three volumes of buffer QG added and the gel slice incubated at 50oC for 10 minutes. 
One volume of isopropanol was added, the sample mixed and applied to a QIA quick 
column. The column was centrifuged for 1 minute at 14,000 rpm (Centrifuge 5415C, 
Eppendorf, Cambridge, U.K.) and the flow through discarded. 0.75ml of buffer PE was 
added to the column and the column centrifuged as previous. The flow through was 
discarded and the tube spun as previous. The column was placed into a 1.5ml centrifuge 
tube, 50µl water applied to the column and the column spun as previous. DNA was 
quantified as in 2.2.8 and stored at -20oC.  
 
2.2.4 Ligation of linear vector and shRNA insert 
 
The ligation reaction was set up in a final volume of 10µl as follows: 
 
Vector only Vector plus insert 
                            (annealed oligos) 
10x ligase buffer (Invitrogen)          1                         1 
Vector             5   5 
Annealed oligos (10µM)          0   2 
DNase RNase free water          3   1 
T4 DNA ligase (Invitrogen)          1   1 
 
The reaction mix was incubated overnight at 4oC.  
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Ligation reactions were monitored by agarose gel electrophoresis. 2µl ligation product 
was mixed with 0.5µl 5x DNA gel loading buffer and samples separated by 
electrophoresis on a 1% agarose gel with 0.4µg/ml ethidium bromide. 5µl each of 
Hyperladder I and Hyperladder IV markers were used and the gel electrophoresed in 
1xTBE at 70V for 30 minutes. DNA was visualised under UV transillumination with a 
Geneflash Syngene Bio Imager.  
 
2.2.5 Bacterial transformation with plasmid DNA 
 
An aliquot of the competent bacterial strain DH5α (50µl, Novogen, Windsor, U.K.) was 
added to plasmid DNA (100ng), mixed and incubated on ice for an hour. Bacterial cells 
were heat shocked at 37oC for 20 seconds, transferred to ice for 5 minutes and 1ml L-
Broth added (L-Broth; 20.6g LB Broth (Sigma) in 1L distilled water). Cells were 
incubated at 37oC for 1 hour with shaking (225rpm), centrifuged at 14,000rpm for 1 
minute (Centrifuge 5415C, Eppendorf) and the supernatant removed. The pellet was 
resuspended in 50µl L-Broth and the cells spread onto an ampicillin containing agar plate 
(Agar; 20.6g LB Broth, 15g Agar technical (Oxoid, Basingstoke, U.K.) in 1L distilled 
water containing 1ml 1000x stock ampicillin (Sigma) to a final concentration of 
100µg/ml) using aseptic technique. Plates were incubated at 37oC overnight.  
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2.2.6 Amplification of plasmid DNA 
 
A single colony was picked and used to inoculate 3ml LB medium containing ampicillin 
(100µg/ml) and incubated for 6 hours at 37oC with shaking (225rpm). This starter culture 
(250µl) was subsequently added to 250ml LB supplemented with 100µg/ml ampicillin in 
a 2L flask, and incubated overnight at 37oC with shaking (225rpm).  
 
2.2.7 Isolation of plasmid DNA  
 
Cells were harvested by centrifugation at 6000rpm for 15 minutes at 4oC (Mistral 300i, 
MSE). Isolation of plasmid DNA from bacterial cells was carried out using a QIAfilter 
Plasmid Purification Kit (Qiagen) according to manufacturer instructions. Briefly, the 
bacterial pellet was resuspended in 10ml buffer P1, 10ml buffer P2 added, mixed 
thoroughly and incubated at room temperature for 5 minutes. 10ml chilled buffer P3 was 
added, the tube inverted vigorously and the lysate poured into the barrel of the QIAfilter 
cartridge, with incubation at room temperature for 10 minutes. A QIAGEN-tip 100 was 
equilibrated with the addition of 10ml buffer QBT. The plunger was inserted into the 
QIAfilter cartridge and the lysate filtered into the pre-equilibrated QIAGEN-tip 100. 
Once the lysate had cleared the tip was washed with 2 x 30ml buffer QC. The DNA was 
eluted with the addition of 15ml buffer QF and the DNA precipitated with the addition of 
10.5ml isopropanol. After mixing, the mix was centrifuged at 6000g for 30 minutes at 
4oC (Mistral 300i, MSE), and the supernatant removed. The pellet was washed with 5ml 
70% ethanol and centrifuged at 6000g for 10 minutes (Mistral 300i, MSE). The 
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supernatant was removed, the pellet air-dried for 10 minutes and the DNA resuspended in 
300µl RNase-DNase free water.  
 
2.2.8 Quantification of plasmid DNA  
 
Samples were diluted 1 in 20 with DNase RNase free water in a total of 100µl. The 
absorbance was determined at both 260 and 280 nm. The purity of the plasmid 
preparation was determined by dividing the value at 260nm by the value at 280nm. A 
figure between 1.8 and 2.0 defines a pure plasmid preparation. The concentration of 
plasmid was determined as follows: 
 
Plasmid concentration (µg/µl) = (OD260 x dilution factor x 50)/1000 
 
2.2.9 Plasmid sequencing 
 
0.5µg plasmid DNA and 3.2pmol BGH reverse primer (Alta Bioscience, Birmingham, 
U.K.) were mixed and made up to 10µl with DNase RNase free water. Sequencing was 
carried out by the proteomics service at the University of Birmingham. Briefly, Big Dye 
Terminator Kit V3.1 was added to the DNA/primer mix, the PCR cycle carried out and 
samples purified for sequencing. Labelled DNA was loaded into the analyser and 
sequencing carried out using an ABI 3700 sequencer (Applied Biosystems, California, 
USA). Sequencing data was analysed using Chromas Pro software.   
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2.3 CSN5 protein expression construct production  
 
2.3.1 CSN5 coding sequence primer design 
 
Webcutter software was used to determine which restriction sites do not occur in CSN5 
protein coding sequence and two restriction sites (BamHI and EcoRI) were selected for 
use in CSN5 protein coding sequence (cds) primer design and subsequent ligation of 
CSN5 coding sequence with pcDNA3.1 plasmid. Primers used were as follows: 
 
      Cap  BamHI site   First 17 bases of CSN5 cds  
5’ GCAGGGATCCATGGCGGCGTCCGGGAG 3’ (Forward) 
 
      Cap   EcoRI site   Rev. Comp. of final 26 bases of CSN5 cds 
5’ GCAGGAATTCTTAAGAGATGTTAATTTGATTAAACA 3’ (Reverse)  
 
The melting temperatures of the primers were calculated to determine similarity and 
sequences ordered from SigmaGenosys. 
 
2.3.2 CSN5 coding sequence amplification  
 
CSN5 coding sequence was amplified from oligo dT cDNA (provided by Dr Farhat 
Khanim) in a 50µl reaction containing 1x Accuzyme buffer (Bioline), 2µl cDNA, 400µM 
dNTPs (Bioline), 2mM MgCl2 (Bioline), 400nM forward primer, 400nM reverse primer 
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and 5U Accuzyme DNA polymerase (Bioline). The PCR reaction included initial 
incubation at 94oC for 5 minutes, 10 cycles of 94oC for 30 seconds, 54oC for 30 seconds 
and 72oC for 1 minute 45 seconds, 30 cycles of 94oC for 30 seconds, 68oC for 30 seconds 
and 72oC for 1 minute 45 seconds and a final incubation of 72oC for 7 minutes. PCR 
products were separated by electrophoresis on an agarose gel and the band corresponding 
to the length of the CSN5 coding sequence was identified, cut out and the DNA 
extracted, all as in 2.2.3.  
 
2.3.3 CSN5 coding sequence PCR product digestion 
 
The isolated CSN5 coding sequence was digested in a 30µl reaction containing 1x multi-
core buffer (Promega), 20µl DNA, 10U BamHI (Fermentas) and 10U EcoRI (Fermentas), 
and this mix incubated for 2 hours at 37oC.  
 
2.3.4 pcDNA3.1 plasmid digestion 
 
pcDNA3.1 was digested in a 20µl reaction containing 1x multi-core buffer (Promega), 
5µl DNA, 10U BamHI (Fermentas) and 10U EcoRI (Fermentas), and this mix incubated 
for 2 hours at 37oC. Calf intestinal phosphatase (New England Biolabs; 10U) was added 
for 40 minutes at 37oC and the phosphatase removed using the gel extraction kit as in 
2.2.3.  
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2.3.5 Ligation of CSN5 coding sequence with pcDNA3.1 
 
Ligation was carried out in a 10µl reaction containing 1x ligation buffer (Invitrogen), 1µl 
T4 DNA ligase (Invitrogen), 3µl digested plasmid and 3µl digested insert, with overnight 
incubation at 4oC. Ligated plasmid was then transformed into DH5α and plasmid DNA 
amplified, isolated, quantified and sequenced as in 2.2.5-2.2.9.  
 
2.3.6 CSN5 shRNA/deneddylase mutation primer design 
 
Primers were designed according to QuikChange XL Site-Directed Mutagenesis Kit 
manufacturer instructions (Stratagene, California, USA). Briefly, selected codons were 
mutated (shown in bold below) to give a codon with a comparable usage value. This 
sequence was made up to ~45 bases with extension either side of the mutated region and 
the sequence checked by blast analysis (http://www.ncbi.nlm.nih.gov/blast/Blast.cgi? 
PAGE=Nucleotides&PROGRAM=blastn&MEGABLAST=on&BLAST_PROGRAMS=
megaBlast&PAGE_TYPE=BlastSearch&SHOW_DEFAULTS=on) to ensure gene 
specificity. Finally, primer melting temperatures were determined and optimised as per 
manufacturer instructions and the following sequences (forward and reverse complement) 
ordered from SigmaGenosys: 
shRNA sequence mutation primers: 5’ AGGACATACCCAAAGGGATACAAGCCA 
CCAGATGAAGGACCTTC 3’ (Forward), 
5’ GAAGGTCCTTCATCTGGTGGCTTGTATCCCTTTGGGTATGTCCT 3’ (Reverse 
complement),  
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Deneddylase dead mutation primers: 5’ CTGCTGGCTTTCTGGGATTAATGTTAG 
TACTCAGATGCTC 3’ (Forward), 
5’ GAGCATCTGAGTACTAACATTAATCCCAGAAAGCCAGCAG 3’ (Reverse 
complement).    
 
2.3.7 CSN5 expression plasmid mutation 
 
Plasmid mutation was carried out according to QuikChange XL Site-Directed 
Mutagenesis Kit manufacturer instructions (Stratagene). Briefly, plasmid mutation was 
carried out in a 50µl PCR reaction containing 1x reaction buffer (Stratagene), 5ng 
plasmid DNA, 125ng forward primer, 125ng reverse primer, 1µl dNTP mix (Stratagene) 
and 3µl QuikSolution (Stratagene), which was mixed before the addition of 2.5U Pfu 
Turbo DNA polymerase (Stratagene). The PCR reaction included initial incubation at 
95oC for 1 minute, 18 cycles of 95oCfor 50 seconds, 60oC for 50 seconds and 68oC for 6 
minutes, and a final incubation of 68oC for 7 minutes. The reaction was then incubated on 
ice for 2 minutes and 10U Dpn1 restriction enzyme (Stratagene) added before mixing and 
incubation at 37oC for 1 hour.  
 
2.3.8 Mutated CSN5 expression plasmid transformation into XL10-Gold cells 
 
Transformation of XL10-Gold Ultracompetent cells was carried out according to 
QuikChange XL Site-Directed Mutagenesis Kit manufacturer instructions (Stratagene). 
Briefly, XL10-Gold Ultracompetent cells (Stratagene; 45µl) were mixed with 2µl β-
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mercaptoethanol and incubated on ice for 15 minutes with mixing every 2 minutes. 
Mutation PCR product (2µl) was added and the mix incubated on ice for 30 minutes. The 
mix was heated to 42oC for 30 seconds and incubated on ice for 2 minutes before the 
addition of 0.5ml prewarmed NZY+ broth. Cells were incubated at 37oC with shaking 
(225rpm) for 1hour and cells spread onto an ampicillin plate as in 2.2.5. Plasmid DNA 
was amplified, isolated, quantified and sequenced as in 2.2.6-2.2.9.  
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2.4 Co-transfection of cell lines 
 
2.4.1 Cell preparation 
 
Three days prior to transfection, cells were counted and set at a density of 2.5x105 
cells/ml. Cells were diluted 1:1 in media the following day and cells counted and set back 
to 2.5x105 cells/ml the day before transfection.  
 
2.4.2 Cell transfection 
 
A cell count was taken and 5x106 cells harvested by centrifugation at 1500rpm for 5 
minutes (FALCON 6/300, MSE), and the resultant pellet washed in 1ml PBS and 
centrifuged as previous. The supernatant was discarded and cells resuspended in 100µl 
Solution V (Amaxa, Cologne, Germany). For co-transfection, pMACS Kk.II plasmid 
(5µg) and 10µg shVC, shCSN2 or shCSN5 plasmid were aliquotted into an 
electroporation cuvette (Amaxa) and 100µl cell suspension added. For double 
knockdown transfections, 2.5µg pMACS Kk.II plasmid was used with either 10µg shVC 
or 5µg each of shCSN2 and shCSN5 plasmid. For CSN5 re-expression transfections, 
2.5µg pMACS Kk.II plasmid was used with either 10µg shVC, 10µg shCSN5, or 5µg 
each of shCSN5 and wild-type/deneddylase dead CSN5 re-expression plasmid. Cells 
were electroporated using programme T-16 on Nucleofector I (Amaxa). Prewarmed 
media (0.5ml) was added to the cuvette and the mix transferred to 1.5ml media in a 24 
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well plate. Four hours post transfection, cells were transferred to a 12 well plate and 2ml 
media added. 
 
2.4.3 Analysis of transfection efficiency  
 
24 hours post transfection an 80µl aliquot of transfected cells was mixed with 5µl anti-H-
2Kk-FITC antibody (Miltenyi Biotec, Surrey, U.K.) and incubated at room temperature 
for 15 minutes.  3ml PBS was added and cells centrifuged at 1500 rpm for 5 minutes 
(FALCON 6/300, MSE), the supernatant removed and the cells resuspended in 300µl 
FACS fix (1% formaldehyde (v/v) and 2% FBS (v/v) in PBS). Staining was analysed by 
FACS flow cytometry using FACS Calibur and Cell Quest Pro software (Becton 
Dickinson, Oxford, U.K.) within two weeks.  
 
2.4.4 Cell sorting 
 
A schematic of the co-transfection and cell sorting techniques is shown in figure 10. 
Transfected cells were sorted 24 hours post transfection using MACSelect microbeads 
(Miltenyi Biotec) according to manufacturer instructions. Briefly, cells were harvested by 
centrifugation at 1500 rpm for 5 minutes (FALCON 6/300, MSE) followed by a PBS 
wash and centrifugation as previous. The pellet was resuspended in 320µl PBE (PBS plus 
2mM EDTA) and 80µl MACSelect microbeads added to the suspension. This mix was 
incubated for 15 minutes on ice and the volume adjusted to 2ml with PBE. A MACS 
column MS (Miltenyi Biotec) was placed in the magnetic field of a MACS separator  
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Figure 10. Schematic of the co-transfection and cell sorting technique s. 
K562 cells are co-transfected with two plasmids, one encoding the shRNA of 
interest and the other encoding a truncated murine cell surface protein (HKK). 
Trans fected cells transiently express this protein on the cell surface. An 
antibody specific for this protein with a bead attached is used to label 
transfected cells. Cells are then applied to a column placed in a magnet, with 
the labelled cells being retained and the unlabelled, untransfected cells being 
washed through the column. The column is then removed from the magnet 
and the trans fected cells eluted.  
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magnet (Miltenyi Biotec) and 500µl PBE applied to the column. The cell suspension was 
then added to the column and the negative fraction discarded. The column was washed 
four times with 500µl PBE. The column was removed from the magnetic field and placed 
into a collection tube. 1ml PBE was added to the column, the plunger firmly applied and 
the positive fraction collected in the tube. A cell count was taken, the cells harvested by 
centrifugation at 1500 rpm for 5 minutes (FALCON 6/300, MSE) and the cells 
resuspended in the appropriate volume of media to set the cells at a density of 3x105/ml. 
Cells were cultured as in 2.1.1 and harvested for analysis at the appropriate time point. 
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2.5 Assessment of cell proliferation and death 
 
2.5.1 Cumulative cell growth 
 
All co-transfections were maintained in the same size culture vessel and same volume 
throughout culture. Cell counts were taken and cultures set back to 3x105 cells/ml daily. 
Cumulative cell growth for each time point was determined by multiplying cell count by 
both culture volume and the cumulative dilution factor. The average cumulative cell 
growth of three co-transfections and the standard error of this average were calculated 
using Microsoft Office Excel. The significance of any difference in cumulative cell 
growth between vector control and knockdown cells was also determined using the t-test 
function in Microsoft Excel. This data was then plotted using SigmaPlot.  
 
2.5.2 Cell cycle analysis 
 
200µl cells were transferred to a FACS tube and 2ml PBS added. Cells were pelletted by 
centrifugation at 1500rpm for 5 minutes (FALCON 6/300, MSE). The supernatant was 
removed and cells resuspended in 300µl cell cycle buffer (10µg/ml propidium iodide, 
0.1% triton X100, 0.1mM NaCl, in distilled water). Staining was analysed using a FACS 
Calibur (Becton Dickinson) within 24 hours (samples were stored at 4oC if staining was 
analysed the next day) and data evaluated using Cell Quest Pro software (Becton 
Dickinson).  
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2.5.3 Thymidine incorporation assay 
 
2x104 cells were transferred to a 96 well plate in triplicate wells and the volume made up 
to 200µl with media. Cells were incubated at 37oC with 5% CO2 for 2 hours prior to the 
addition of 2µCi/ml tritiated thymidine (20µCi/ml stock in RPMI 1640, Amersham, 
Buckinghamshire, U.K.). Cells were further incubated for 18 hours and the plate then 
stored at -20oC. Samples were transferred to a filter mat (Wallac, Massachusetts, USA) 
using a Skatron cell harvester (Skatron Instruments, Bath, U.K.) and readings taken using 
a Beta-Plate scintillation counter (Skatron Instruments). The average thymidine 
incorporation of three co-transfections and the standard error of this average were 
calculated using Microsoft Office Excel. The significance of any difference between 
thymidine incorporation in vector control and knockdown cells was also determined 
using the t-test function in Microsoft Excel. This data was then plotted using SigmaPlot.  
 
2.5.4 Annexin V staining 
 
1x105 cells were transferred to a FACS tube and 1ml cold PBS added. Cells were 
centrifuged for 5 minutes at 1500rpm (FALCON 6/300, MSE). The supernatant was 
removed and cells were washed again in PBS as previous. Annexin V binding buffer (BD 
Biosciences, Oxford, U.K.) was diluted 1 in 10 in distilled water and cells resuspended in 
100µl of this buffer. 5µl each of annexin V FITC and Propidium Iodide stain (both BD 
Biosciences) were added to the cells prior to incubation at room temperature for 15 
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minutes. Staining was analysed using a FACS Calibur (Becton Dickinson) within 1 hour 
and data evaluated using Cell Quest Pro software (Becton Dickinson).  
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2.6 Morphological analysis of cells 
 
2.6.1 Cytospins 
 
Cytospins were produced using a Shandon Cytospin3 (Thermo, Loughborough, U.K.), 
Shandon filter cards (Thermo) and glass slides (VWR, Lutterworth, U.K.) according to 
manufacturer instructions. 5x104 cells were spun onto a slide by spinning at 500rpm for 3 
minutes. Slides were then allowed to dry at room temperature for 15 minutes.  
  
2.6.2 Jenner-Giemsa staining 
 
Slides were fixed in methanol for 5 minutes at room temperature. Giemsa buffer (200mM 
sodium phosphate pH5.6) was diluted 1 in 25 in distilled water and this diluted buffer 
used to dilute Jenner stain (VWR) 1 in 3 and Giemsa stain (VWR) 1 in 20. Diluted Jenner 
stain was applied to the slides and incubated at room temperature for 5 minutes. Jenner 
stain was washed off with distilled water and Giemsa stain applied to the slides and 
incubated for 10 minutes at room temperature. Giemsa stain was washed off with distilled 
water, slides wiped to remove excess liquid and allowed to dry for 15 minutes at room 
temperature. Slides were mounted with 20µl DePeX mounting medium (VWR) and 
22mm x 22mm cover slips (VWR). Jenner-Giemsa staining was viewed using an 
Olympus BX40 microscope (Olympus, Watford, U.K.) and images captured using an 
Olympus Chameleon digital SLR camera (Olympus).   
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2.6.3 Immunofluorescent staining 
 
Slides were fixed in 4% paraformaldehyde in PBS for 10 minutes at room temperature. 
Slides were washed twice in PBS and incubated for 10 minutes in room temperature 
ammonium chloride (50mM in PBS). Slides were washed twice more in PBS and 
incubated in 0.1% Triton X-100 in PBS for 4 minutes at room temperature. Cells were 
rinsed in PBS and staining carried out.  
 
Primary anti-tubulin antibody (Sigma) was diluted 1 in 500 in PBS and 40µl applied to 
the cell spot. Slides were incubated at room temperature for 1 hour in a humid chamber 
and then washed three times in PBS. Secondary antibody (FITC conjugated anti-mouse; 
Jackson Laboratories) was diluted 1 in 500 in PBS and Hoechst (Sigma) added to a final 
dilution of 1 in 1000 (1mg/ml stock and 1µg/ml final concentration). Excess liquid was 
removed from slides and 40µl secondary antibody/Hoechst mix applied to the cell spot. 
Slides were incubated at room temperature for 40 minutes and washed three times in 
PBS. Excess liquid was removed and slides were allowed to dry for 15 minutes at room 
temperature, prior to mounting with 5µl Moviol mounting medium (6g glycerol, 2.4g 
Moviol-4-88, 12ml 0.2M Tris HCl pH8.5, 6ml dH2O, three p-phenyldiamine crystals) and 
22mm x 22mm cover slips (VWR). Immunofluorescent staining was visualised using an 
Axioskop2 microscope (Zeiss, Hertfordshire, U.K.) and images captured with a 
Qimaging 12-bit QICAM camera (Media Cybernetics, Bethesda, USA) and Openlab 
software (Improvision, Coventry, U.K.).  
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2.6.4 Monodansylcadaverine staining 
 
5x104 cells were centrifuged for 15 seconds at 14,000 rpm (Centrifuge 5415C, 
Eppendorf), resuspended in 300µl PBS and incubated with 0.05mM 
monodansylcadaverine (Sigma; 5mM stock in DMSO) at 370C for 10 minutes. Cells were 
washed 4 times by centrifugation for 15 seconds at 14,000 rpm (Centrifuge 5415C, 
Eppendorf) and resuspension in 0.5ml PBS. Cells were resuspended in 100µl PBS and 
cytospins made as above. Staining was analysed immediately using a DMIRE2 system 
(Leica, Milton Keynes, U.K.). Analysis of this staining was carried out by Dr Simon 
Johnston.  
 
2.6.5 Visualisation of propidium iodide retention in cells 
 
1x105 cells were transferred to a FACS tube and 1ml cold PBS added. Cells were 
centrifuged for 5 minutes at 1500rpm (FALCON 6/300, MSE). The supernatant was 
removed and cells were washed again in PBS as previous. Annexin V binding buffer (BD 
Biosciences, Oxford, U.K.) was diluted 1 in 10 in distilled water and cells resuspended in 
100µl of this buffer. 5µl of Propidium Iodide stain (BD Biosciences) was added to the 
cells prior to incubation at room temperature for 15 minutes. Cytospins were then made 
as in 2.6.1 and propidium iodide retention visualised using a DMIRE2 system (Leica, 
Milton Keynes, U.K.). Analysis of this staining was carried out by Simon Johnston. 
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2.7 Protein analysis: Western blotting and Blue Native gels  
 
2.7.1 Protein extraction and quantification 
 
For protein extraction, 1-3x106 cells were resuspended in 50µl lysis buffer (10% 10x 
complete protease inhibitor (Roche diagnostics, West Sussex, U.K.), 90% RIPA buffer 
(1% v/v NP40, 0.5% w/v sodium deoxycholate, 0.1% w/v SDS in distilled water)). Cells 
were incubated for 30 minutes on ice, centrifuged at 14,000rpm at 4oC for 10 minutes 
(Hawk 15/05, Sanyo, Watford, U.K.) and the supernatant transferred to a 1.5ml 
centrifuge tube (eppendorf).  
 
For protein quantification, the Dc protein assay protocol was followed according to 
manufacturer instructions (Bio-Rad, Hemel Hempstead, U.K.). Briefly, 5µl standards (0, 
0.625, 1.25, 2.5, 5 and 10mg/ml BSA in distilled water) were added to duplicate wells 
and 2µl of each protein sample was added to 3µl distilled water in replicate wells. 20µl 
reagent S was added to each ml of reagent A required to make solution A’, and 25µl A’ 
added to each well. 200µl reagent B was then added to each well, the wells mixed, and 
the reaction allowed to develop for 15 minutes before the optical density was measured at 
645nm using a plate reader (BIO-TEK, Vermont, USA) and KC4 software (BIO-TEK). 
These readings were transferred to Microsoft Excel and used to calculate sample protein 
concentration.   
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2.7.2 Calculating the amount of protein per cell 
 
The total amount of protein in the extract was determined by multiplying the extraction 
volume by the protein concentration. The final cell count before cell harvesting was 
multiplied by the culture volume harvested to determine the total number of cells from 
which protein was extracted. Total protein was then divided by total cell number to give 
protein per cell. The average and standard error of the mean of three vector control and 
three knockdown samples was determined and this data plotted using Sigma Plot. The 
significance of any difference between protein levels in vector control and knockdown 
cells was also determined using the t-test function in Microsoft Excel.  
 
2.7.3 Sample preparation and protein separation by SDS PAGE 
 
Protein samples (20-40µg) were mixed in a 3:1 ratio with 4x SDS gel loading buffer 
(62.5mM Tris HCl pH6.8, 25% v/v glycerol, 2% SDS, 5% 2-β-ME, Bromophenol Blue, 
in distilled water), heated to 100oC for 10 minutes and centrifuged for 15 seconds at 
14,000rpm (Centrifuge 5415C, Eppendorf).  
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Resolving gel mixes (10ml final volume) were prepared as follows: 
       10%  12.5%  15% 
30% Acrylamide/Bis-Acrylamide 37.5:1 (Geneflow)3.3ml  4.2ml  5.0ml 
1.5M Tris HCl pH8.8      2.5ml  2.5ml  2.5ml    
10% Sodium dodecyl sulphate                                   0.1ml  0.1ml  0.1ml 
(SDS; Fisher Scientific)       
distilled water      4.1ml  3.2ml  2.4ml 
10% Ammonium persulphate (APS; Sigma)  60µl  60µl  60µl 
TEMED (VWR international)   4.5µl  4.5µl  4.5µl 
 
Once the resolving gel was set a stacking gel was added. The stacking gel consisted of 
the following: 
30 % Bis/Acrylamide   440µl 
0.5M Tris HCl pH6.8    830µl 
10% SDS        33µl 
distilled water              2.03ml 
10% APS              16.7µl 
TEMED     1.7µl 
 
Protein samples, and 5µl prestained precision blue markers (Bio-Rad) were loaded onto 
the gel and separated by electrophoresis at 120V with 1x SDS gel running buffer (25mM 
Tris, 192mM glycine, 3.5mM SDS in distilled water) for 90 minutes.   
 
2.7.4 Protein transfer 
 
PVDF membrane (Millipore, Watford, U.K.) was soaked in methanol for 15 seconds, 
dH2O for 2 minutes and equilibrated in transfer buffer (25mM Tris, 192mM glycine, 20% 
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Methanol in distilled water) for 10 minutes. Then layered onto the black side of the 
transfer cassette was the following: 
 
Blotting pad 
Wet 3mm filter paper 
The gel with the stacking gel removed 
PVDF membrane 
Wet 3mm filter paper 
Blotting pad 
 
The transfer was carried out using a Mini-Protean transfer tank (Bio-Rad) at 80V for 1 
hour with cooling.  
 
2.7.5 Immunodetection of proteins 
 
The membrane was rinsed in TBS-T (137mM NaCl, 20mM Tris HCl pH 7.6, 0.2% 
Tween20 in distilled water) and then blocked for 45 minutes in 5% dried milk solution 
(5% milk powder (Marvel) in TBS-T). Primary antibodies were diluted 1 in 1000 (except 
for the anti β-actin antibody (Sigma) which was diluted 1 in 10,000) in 5% milk, and the 
membrane incubated for an hour in this solution at room temperature. The membrane was 
washed three times in TBS-T, each wash for 5 minutes, the secondary antibody 
(horseradish peroxidase (HRP) conjugated anti-rabbit, Pierce (Illinois, USA) or HRP 
conjugated anti-mouse, Sigma) diluted 1 in 1000 (except for when following incubation 
with anti β-actin antibody when secondary antibody was diluted 1 in 10,000) in 5% milk 
and the membrane incubated for 45 minutes in this solution at room temperature. The 
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membrane was washed as above and signal developed using Supersignal West Pico 
Chemiluminescent substrate (Pierce) and signal detected by exposure to Xomat scientific 
imaging film (Kodak, Sigma) for 5 minutes. Films were developed using an AGFA 
CURIX 60 (Agfa, Mortsel, Belgium).  
 
2.7.6 Western blot densitometry 
 
Quantitative analysis of western blots was carried out using Image J software 
(http://rsb.info.nih.gov/ij/download.html) and Microsoft Office Excel. Briefly, the density 
of each band was measured and background density subtracted. The ratio of protein band 
density to corresponding β-actin band density was then calculated to give a value 
corrected for loading. The appropriate ratios of corrected band density in control and 
treated cells were then calculated, and the average and standard error of the mean of three 
vector control and three knockdown samples determined. This data was then plotted, 
along with the standard error of the mean, using Sigma Plot. The significance of any 
difference between protein levels in vector control and knockdown cells was also 
determined using the t-test function in Microsoft Excel.  
 
2.7.7 Blue native gels 
 
Blue native gels were carried out using a NativePAGE Novex Bis-Tris Gel System 
(Invitrogen) according to manufacturer instructions. Briefly, 1 x 106 cells were 
resuspended in 100µl mild lysis buffer (1x NativePAGE sample buffer (Invitrogen), 1% 
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digitonin (Sigma), 1x protease inhibitor, in distilled water), incubated on ice for 30 
minutes, centrifuged for 20 minutes at 14,000 rpm and 4oC (Hawk 15/05, Sanyo), and the 
supernatant collected. A final concentration of 0.25% NativePAGE 5% G-250 sample 
additive (Invitrogen) was added to native protein extract, 25µl sample loaded onto a 
NativePAGE Novex 3-12% Bis-Tris gel (Invitrogen), and 10µl NativeMARK protein 
markers (Invitrogen) loaded onto the gel. Samples were separated by electrophoresis for 
45 minutes at 150V with 1x NativePAGE Anode Buffer (1x NativePAGE Running 
Buffer (Invitrogen) in distilled water) and dark blue NativePAGE Cathode Buffer (1x 
NativePAGE Running Buffer (Invitrogen) and 1x NativePAGE Cathode additive 
(Invitrogen) in distilled water), followed by 45 minutes electrophoresis at 250V with 
anode buffer as above and light blue NativePAGE Cathode Buffer (1x NativePAGE 
Running Buffer (Invitrogen) and 0.1x NativePAGE Cathode additive (Invitrogen) in 
distilled water). The western protocol was then followed from 2.7.4 with the addition of a 
10 minute incubation of the membrane in 100% methanol between the transfer and 
blocking steps to prevent the interference of coomassie with protein immunodetection.   
  
2.7.8 2-Dimensional blue native gels 
 
A schematic of the 2-dimensional NativePAGE/SDS-PAGE technique is shown in figure 
11. The first dimension was carried out as in 2.6.9 and the gel cut into individual lanes. 
The native gel slice was incubated in 1x SDS gel loading buffer (15.6mM Tris HCl 
pH6.8, 6.25% glycerol, 0.5% SDS, 1.25% 2-β-ME, Bromophenol Blue in distilled water) 
for 30 minutes at room temperature, the gel slice placed horizontally onto a 12.5% SDS  
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Figure 11. The NativePAGE/SDS PAGE 2-D gel analysis technique.
Native proteins are extracted from cells and electrophoresed on a non-
denaturing gel in order to separate proteins on the basis of their complexed, 
native state in the first dimension. This gel is then cut into individual lanes and 
proteins denatured. Each individual gel lane is rotated by ninety degrees and 
lay onto an SDS gel. Proteins are thus electrophoresed in the second 
dimension based on monomeric size.  
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gel and overlaid with 1ml 1x SDS gel loading buffer. 5µl prestained precision blue 
markers (Bio-Rad) were loaded onto the SDS gel, proteins separated by electrophoresis 
as in 2.7.3 and the western protocol followed from 2.7.4.  
 
The NativeMARK lane of the native gel was coomassie stained. Briefly, the gel was 
stained with coomassie stain (50% methanol, 0.05% coomassie, 10% acetic acid, in 
distilled water) for 2 hours at room temperature and incubated in destain (7% acetic acid, 
5% methanol, in distilled water) overnight at room temperature.   
 
2.7.9 2-Dimensional blue native gel densitometry  
 
Quantitative analysis of 2-D gels was carried out using Image J software 
(http://rsb.info.nih.gov/ij/download.html) and Microsoft Office Excel. Briefly, the density 
of each band was measured and background density subtracted. The ratio of protein band 
density in knockdown cells to that of vector control cells was calculated and this value 
converted to percent by multiplication by 100. The average and standard error of the 
mean of three CSN2 and three CSN5 knockdown samples were then determined and data 
plotted using Sigma Plot. The significance of any difference between protein levels in 
vector control and knockdown cells was also determined using the t-test function in 
Microsoft Excel.  
 95
2.8 mRNA analysis: Quantitative real-time polymerase chain reaction 
(QRT-PCR) 
 
2.8.1 RNA extraction 
 
RNA was extracted from a pellet of 2x106 cells using a Qiagen RNeasy mini kit 
according to the manufacturer instructions. Briefly, cells were resuspended in 350µl 
buffer RLT (plus β-mercaptoethanol). The sample was then homogenized using a 
QIAshredder spin column (Qiagen). One volume of 70% ethanol was added to the 
homogenized sample and 700µl of this mixture added to an RNeasy mini column. The 
column was centrifuged for 15 seconds at 14,000 rpm (Centrifuge 5415C, Eppendorf). 
On column DNA removal was carried out using the RNase-Free DNase set (Qiagen). 
350µl buffer RW1 was added to the column and the column centrifuged for 15 seconds at 
14,000 rpm (Centrifuge 5415C, Eppendorf). The DNase I stock solution was added to 
buffer RDD according to manufacturer instructions and 80µl of this mix added to the 
column and incubated for 15 minutes at room temperature. 350µl buffer RW1 was added 
to the column and the column centrifuged for 15 seconds at 14,000 rpm (Centrifuge 
5415C, Eppendorf). Buffer RPE (500µl) was added to the column and centrifuged for 15 
seconds at 14,000 rpm (Centrifuge 5415C, Eppendorf). Another 500µl RPE was applied 
to the column and the column centrifuged for 2 minutes at 14,000 rpm (Centrifuge 
5415C, Eppendorf). The RNeasy column was transferred to a 1.5ml collection tube, RNA 
eluted with the addition of 30µl RNase-free water and centrifugation for 1 minute at 
14,000 rpm (Centrifuge 5415C, Eppendorf), and RNA stored at -20oC.  
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2.8.2 RNA quantification 
 
RNA samples were diluted 1 in 50 in RNase-free water in a total volume of 100µl. The 
absorbance at 260nm was measured using a spectrophotometer and the RNA 
concentration calculated using the following equation: 
 
RNA concentration (µg/µl) = (OD260 x 40 x dilution factor)/1000 
 
2.8.3 Reverse transcriptase PCR  
 
cDNA was produced from 1µg RNA using reverse transcription. All constituents were 
obtained from Invitrogen and the procedure carried out as follows: 1µl of both random 
primers (Promega, 500µg/ml) and dNTP's (Bioline, 10mM stock) were added to 1µg 
RNA, the volume made up to 12µl with DNase RNase free water, and the mix heated to 
65oC for 5mins, transferred to ice and centrifuged for 15 seconds at 14,000rpm 
(Centrifuge 5415C, Eppendorf). A master mix was made as follows: 
      1x (µl) 
5xbuffer (Invitrogen)    4   
0.1M DTT (Invitrogen)   2 
RNase Out (Promega, 40U/µl)  1 
Superscript (Invitrogen, 200U/µl)  1 
 
After centrifugation, 8µl of master mix was added to the RNA, primer, dNTP mix. The 
mix was incubated at 25oC for 10 minutes, 42oC for 90 minutes and 70oC for 15 minutes.  
 
 97
2.8.4 β-actin PCR 
 
All constituents were obtained from Bioline with the exception of the primers which were 
obtained from Alta Biosciences (The University of Birmingham). The sequence of these 
primers is as follows: 
 
Forward 5’ GTCACCAACTGGGACGACA  3' 
Reverse 5’ TGGCCATCTCTTGCTCGAA  3' 
 
The reaction mix was set up as follows: 
            1x (µl) 
10x Taq buffer  5 
Primers (33µM)  1 
dNTP's (10mM)  1 
MgCl2 (50mM)  1 
DNase RNase free water 40 
Taq polymerase (1U/µl) 1 
cDNA    1 
 
The PCR cycle included an initial denaturation step (95oC for 2 minutes) followed by 38 
cycles of 94oC for 20 seconds, 55oC for 30 seconds and 72oC for 60 seconds. The cycle 
was completed with a final incubation at 72oC for 5 minutes.  
 
β-actin PCR products were separated by electrophoresis on a 1% agarose gel with 
0.4µg/ml ethidium bromide. The sample (6µl) was mixed with 2µl 5x DNA gel loading 
buffer and 8µl loaded into the well. Gels were electrophoresed in 1xTBE at 60V for 45 
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minutes and products visualised under UV transillumination with a Geneflash Syngene 
Bio Imager. 
 
2.8.5 Neomycin PCR 
 
All constituents were obtained from Bioline with the exception of the primers which were 
obtained from Alta Biosciences (The University of Birmingham). The sequence of these 
primers is as follows: 
 
Forward 5’ ATGAACTGCAAGACGAGGCAG  3’ 
Reverse 5’ CATTGCATCAGCCATGATGGAT  3' 
 
A 50µl reaction was set up as follows: 
                                  1x (µl) 
10x Taq buffer  5 
Primers (10µM)  2 
dNTP's (10mM)  1 
MgCl2 (50mM)  1 
DNase RNase free water         37 
Taq polymerase (1U/µl) 1 
cDNA    3 
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The PCR cycle was as follows (temperatures are in oC): 
94 – 3mins 
94 – 20secs 
58 – 20secs          x 35 
72 – 60secs 
72 – 7mins 
4 – hold  
 
Neomycin PCR products were separated by electrophoresis on a 1% agarose gel with 
0.4µg/ml ethidium bromide. The sample (6µl) was mixed with 2µl 5x DNA gel loading 
buffer and 8µl loaded into the well. Gels were electrophoresed in 1xTBE at 60V for 45 
minutes and products visualised under UV transillumination with a Geneflash Syngene 
Bio Imager.   
 
2.8.6 QRT-PCR primer and probe design and verification 
 
QRT-PCR primers and probes were designed using Primer Express software (Applied 
Biosystems). Briefly, the coding sequence of the gene of interest was copied into Primer 
Express and potential primer/probe sequences identified. These sequences were checked 
by blast analysis (http://www.ncbi.nlm.nih.gov/blast/Blast.cgi?PAGE=Nucleotides& 
PROGRAM=blastn&MEGABLAST=on&BLAST_PROGRAMS=megaBlast&PAGE_T
YPE=BlastSearch&SHOW_DEFAULTS=on) to ensure gene specificity, and a set of 
primers and probe selected which crossed an exon boundary. Primers were ordered from 
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either Alta Bioscience at the University of Birmingham or Sigma Genosys, and 
FAM/TAMRA labelled probes were ordered from Eurogentec (Southampton, U.K.).   
 
Primers were tested in the following 20µl reaction: 
    1x  
2x master mix   10 
(Eurogentec, containing dNTP/dUTP, HotGoldStar, UNG, MgCl2, stabilizers and ROX 
passive reference) 
Forward primer (9µM) 2 
Reverse primer (9µM) 2 
cDNA    1 
DNase RNase free water 5  
 
The PCR cycle included an initial hot start step (50oC for 2 minutes) followed by 95oC 
for 10 minutes. This was followed by 44 cycles of 95oC for 15 seconds and 60oC for 60 
seconds.  
 
Sample (6µl) was mixed with 2µl 5x DNA gel loading buffer and 8µl loaded into the 
well. Gels were electrophoresed in 1xTBE at 60V for 45 minutes and products visualised 
under UV transillumination with a Geneflash Syngene Bio Imager.  
 
2.8.7 Optimisation of primers and probe for QRT-PCR 
 
In order to optimise the amount of probe for use in QRT-PCR, reactions were set up as 
follows: 
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                     1x (µl) 
2x master mix   10 
Forward primer (9µM) 2 
Reverse primer (9µM) 2 
cDNA    1 
 
µl probe (1.25µM stock) µl DNase RNase free water 
0    5 
0.5    4.5 
1    4 
1.5    3.5 
2    3 
2.5    2.5 
3    2 
3.5    1.5 
 
Each amount of probe was tested in triplicate in a total reaction volume of 20µl. The PCR 
cycle included an initial hot start step (50oC for 2 minutes) followed by 95oC for 10 
minutes. This was followed by 44 cycles of 95oC for 15 seconds and 60oC for 60 seconds.  
 
2.8.8 Verifying primers and probe can be multiplexed with 18S internal control 
 
In order to verify primers and probe can be multiplexed with 18S control reactions were 
set up as follows: 
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18S alone: 
      1x (µl) 
2x master mix     10 
18S  mix      1 
(50nM forward primer, 50nM reverse primer, 200nM probe, Applied Biosystems)   
 
µl cDNA  µl DNase RNase free water 
0.25   8.75 
0.5   8.5 
1   8 
2   7 
3   6 
4   5 
 
Gene of interest alone:  
    1x (µl) 
2x master mix   10 
Forward primer (9µM) 2 
Reverse primer (9µM) 2 
Probe (1.25µM)  2 
 
µl cDNA  µl DNase RNase free water 
0.25   3.75 
0.5   3.5 
1   3 
2   2 
3   1 
4   0 
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18S and gene of interest combined: 
    1x (µl) 
2x master mix   10 
Forward primer (9µM) 2 
Reverse primer (9µM) 2 
Probe (1.25µM)  2 
18S mix   1 
 
µl cDNA  µl DNase RNase free water 
0.25   2.75 
0.5   2.5 
1   2 
2   1 
3   0 
4   0 
 
Each cDNA amount was carried out in duplicate in a total volume of 20µl. The PCR 
cycle included an initial hot start step (50oC for 2mins) to activate the polymerase, 
followed by 95oC for 10 minutes to denature DNA. This was followed by 44 cycles of 
95oC for 15 seconds and 60oC for 60 seconds, which denature DNA and anneal and 
extend primers, respectively.  
 
2.8.9 TAQMAN based QRT-PCR 
 
For TAQMAN assays, QRT-PCR was carried out in duplicate 20µl reactions containing 
1x qPCR Mastermix Plus (Eurogentec), 20-40ng cDNA, 18pmoles each primer and the 
 104
optimal concentration of FAM/TAMRA dual labeled probes (see 2.7.7). QRT-PCR was 
carried out in a 96 well optical plate and a plastic seal used to cover the plate. 
 
QRT-PCR was performed using an ABI Prism 7000 (Applied Biosystems) according to 
manufacturer instructions. The PCR cycle included incubation at 50oC for 2 minutes 
followed by incubation at 95oC for 10 minutes. QRT-PCR was completed with 44 cycles 
of 95oC for 15 seconds and 60oC for 60 seconds.   
 
The following primers (Sigma Genosys) and FAM/TAMRA labeled probes (Eurogentec) 
were used in TAQMAN QRT-PCR:  
CSN2: 5’-CCTCATCCACTGATTATGGGAGT-3’ (forward),  
5’-CATCATAATTCTTGAAGGCTTCAAAA-3’ (reverse),  
5’-CCCTCAAGTGCATTTTACCACCACATTCTCT-3’ (probe);  
CSN5: 5’-ATATCCGCAGGGAAAG-3’ (forward),  
5’-GGTCCTTCATCAGGAGGTTTGT-3’ (reverse), 
5’- TGGCGCCTTTAGGACATACCCAAAGG-3’ (probe). 
 
Preoptimised primers and probes to 18S ribosomal RNA were used as internal standards 
in TAQMAN QRT-PCR (Applied Biosystems). 
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2.8.10 SYBR-Green based QRT-PCR 
 
For SYBR-Green based assays, QRT-PCR was carried out in duplicate 25µl reactions 
containing 1x Sensimix (Quantace), 20-40ng cDNA, 9pmoles each primer, 1x SYBR-
Green solution (Quantace), 4mM MgCl2 and 0.5 units UNG (Quantace). QRT-PCR was 
carried out in a 96 well optical plate and a plastic seal used to cover the plate. 
 
QRT-PCR was performed using an ABI Prism 7000 (Applied Biosystems) according to 
manufacturer instructions. The PCR cycle included incubation at 37oC for 10 minutes 
followed by incubation at 95oC for 10 minutes. QRT-PCR was completed with 40 cycles 
of 95oC for 15 seconds, 58oC for 30 seconds and 72oC for 30 seconds.  
 
The following primers (Sigma Genosys) were used in SYBR-Green based QRT-PCR:  
Skp2: 5’-CGCTGCCCACGATCATTT-3’ (forward),  
5’-CCATGTGCTGTACACGAAAAGG-3’ (reverse);  
Cdc4: 5’-ACGACGCCGAATTACATCTGT-3’ (forward),  
5’-ACTCCAGCTCTGAAACATTTTTAGC-3’ (reverse); 
β-TrCP: 5’-GAGGCATTGCCTGTTTGCA-3’ (forward) 
5’-TGTCCCATAATCTGATAGTGTTGTCA-3’ (reverse) 
18S: 5’-GCCGCTAGAGGTGAAATTCTTG-3’ (forward), 
5’-CATTCTTGGCAAATGCTTTCG-3’ (reverse).  
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2.8.11 QRT-PCR data analysis 
 
QRT-PCR data was first analysed using ABI Prism 7000 software (Applied Biosystems) 
according to manufacturer guidelines. Briefly, cycle threshold (Ct) values were 
determined for both 18S internal control and gene of interest in each sample by placing a 
threshold line through the exponential phase of the PCR cycle profiles. This data was 
then exported to Microsoft Office Excel where the average Ct values were calculated 
from the duplicates. The 18S internal control value was then subtracted from the value 
for the gene of interest to give ∆Ct values. A control transfection ∆Ct value was 
subtracted from sample ∆Ct values to give ∆∆Ct values. This value was converted to fold 
change in gene expression relative to control using the equation: fold change=2-∆∆Ct, and 
fold change converted to percentage expression relative to control via multiplication by 
100. The average and standard error of the mean of three vector control and three 
knockdown samples was calculated and data plotted as a bar chart using Sigma Plot. The 
significance of any difference between gene expression in vector control and knockdown 
cells was also determined using the t-test function in Microsoft Excel. 
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2.9 Statistical Analysis of data 
 
The average and standard error of the mean of n=3 experiments was determined using 
Microsoft Excel. Data was plotted as the average ± standard error of the mean using 
Sigma Plot. The significance of any differences between control and treated cells was 
determined using the t-test function in Microsoft Excel. 
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Chapter 3.0: 
Analysis of the molecular and cellular 
effects of CSN2 knockdown 
 109
3.1 Introduction 
 
In order to answer the questions set out in the project aims, interfering RNA approaches 
were used to generate CSN subunit knockdown in the CML cell line K562. However, as 
K562 cells have a relatively low transfection efficiency, this study began with the 
generation of highly efficient shRNA mediated CSN subunit knockdown using a co-
transfection technique. This chapter describes the development of this procedure and the 
molecular and cellular consequences of using this approach to knockdown expression of 
CSN2 in K562 cells. 
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3.2 Results  
 
3.2.1 Construction of plasmid encoding CSN subunit specific shRNA 
 
Due to the relatively low transfection efficiency of K562 cells a technique was required 
to permit the isolation of homogenous knockdown populations. To do this a dual 
transfection approach was used in which shRNAs targeted against either CSN2 or CSN5 
were delivered together with the pMACS Kk.II vector. The pMACS Kk.II plasmid 
produces a truncated murine MHC class I cell surface protein, H-2Kk that is transiently 
expressed on the cell surface of transfected cells. The cell surface expression of this 
protein allows for the purification of transfected cells as described in materials and 
methods.   
 
Figure 12 A & B show representations of the human H1 promoter modified pcDNA3.1 
plasmid used to deliver shRNAs and the pMACS Kk.II plasmid (hereafter called HKK) 
respectively. In order to clone the silencing sequences into pcDNA3.1-H1, shRNA 
forward and reverse oligonucleotide sequences targeting CSN2 or CSN5 were first 
designed, incorporating the loop sequence (shown for CSN2 in figure 12C) and flanked 
by Acc65I and XbaI sites, and the oligonucleotides annealed. pcDNA3.1-H1 (figure 12A) 
was then digested using the restriction enzymes Acc65I and XbaI, and efficient digestion 
verified (figure 13A). The annealed targeting oligos and digested vector were ligated and 
the ligation verified (figure 13B). The plasmid was then transformed into dH5α and  
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Figure 12. Schematic diagram of plasmids and short hairpin structure.
A, Human H1 promoter modified pcDNA3.1 plasmid into which the required 
shRNA sequence is cloned at the Acc65I and XbaI restriction sites. Image 
generated using pDRAW32 software. B, pMACS Kk.II plasmid which encodes the 
truncated H-2Kk cell surface protein. Image obtained from www.miltenyibiotec.co
m/pid/ProductGroupImageView.aspx?id=26&l=1&opid=16624. C, The 9 base 
sequence which forms the hairpin and an example target sequence specific for 
CSN2.    
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Figure 13. Short hairpin vector preparation and validation.
A, Modified pcDNA3.1 vector was digested and the products separated by 
electrophoresis on a 1% agarose gel along with positive and negative controls to 
determine plasmid digestion. B, Annealed oligonucleotides and digested vector 
were ligated and the products separated by electrophoresis on a 1% agarose gel 
along with a negative control to determine oligo and digested plasmid ligation. C, 
Following amplification of plasmid DNA in DH5α, plasmid DNA was isolated and 
sequenced. The shCSN5 plasmid insert sequence is shown. Images shown are 
representative of several digestions, ligations and sequencing reactions. 
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colonies screened for correct sequence insertion by sequencing of purified plasmid DNA 
(figure 13C).  
 
3.2.2 Determination of transfection efficiency and verification of co-transfection  
 
The truncated murine major histocompatibility (MHC) class I cell surface protein, H-2Kk, 
is transiently expressed on the cell surface of transfected cells between 6 and 48 hours 
post-transfection with HKK plasmid. The transfection efficiency of K562 cells was 
therefore determined by flow cytometry following H-2Kk staining of mock transfected 
and HKK transfected cells 24 hours post transfection. As can be seen in figure 14A, a 
significant proportion of HKK transfected cells stained positive for the cell surface 
protein relative to mock transfected cells, demonstrating that, prior to H-2Kk mediated 
cell sorting, the HKK plasmid was present in around 27% of K562 cells.  
 
As a co-transfection technique was being used, it was important to verify that both 
plasmids had been efficiently transfected into cells. Post enrichment for H-2Kk positive 
cells by magnetic bead sorting, cells were harvested, RNA extracted and quantified, and 
cDNA produced using 1µg RNA. As the pcDNA3.1-H1 plasmid contains the neomycin 
resistance gene, PCR was carried out in order to detect the presence of this gene in 
transfected cells. Figure 14B shows that mock transfected cells and cells transfected with 
HKK alone do not contain the neomycin resistance gene, whereas those cells co-
transfected with HKK and pcDNA3.1-H1 are positive for the neomycin resistance PCR  
 114
M
o
c
k
H
KK
Ve
c
to
r 
c
o
n
tr
o
l
Ve
c
to
r 
c
o
n
tr
o
l
K
n
o
c
kd
o
w
n
K
n
o
c
kd
o
w
n
N
e
ga
tiv
e
 
c
o
n
tr
o
l
Po
s
iti
v
e 
c
o
n
tr
o
l
HKK FITC
Co
u
n
ts
 HKK transfectant
Mock transfectant
Figure 14. Validation of K562 cell co-transfection.
Data demonstrating how efficient K562 co-trans fection was determined. A, A 
representative histogram is shown of flow cytometry data demonstrating the HKK 
positive staining of K562 cells trans fected with HKK plasmid relative to mock 
transfected cells. Data shown is the average of n=5 trans fections ±SEM. B, PCR 
for the neomycin resistance gene was carried out on mock, HKK and co-
transfected K562 cells, and products separated by electrophoresis on a 2% 
agarose gel along with both a positive and negative control. K562 cells co-
transfected with the modified pcDNA3.1 plasmid (either vector cont rol or plasmid 
containing short hairpin insert ) were positive for the neomycin resistance gene 
product. Images shown are representative of n=5 transfections. 
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product, thereby demonstrating successful co-transfection of cells with both the HKK and 
pcDNA3.1-H1 plasmids.  
 
3.2.3 Assessment of cDNA quality and optimization of primers and probe for QRT-PCR 
 
Prior to mRNA quantification by QRT-PCR, the quality and relative quantities of cDNA 
in each sample was assessed by performing β-actin PCR. As can be seen in figure 15, the 
amount of PCR product produced was relatively equal between samples, indicating that 
cDNA generation had occurred with relatively equal efficiency between samples and that 
the cDNA was of sufficient quality to continue to QRT-PCR. 
 
QRT-PCR primers and probes were designed, verified and optimised prior to 
measurement of gene expression in samples. First, the primers were demonstrated to 
amplify only one specific product of the correct size (figure 16A). Secondly, the optimum 
amount of probe for use in QRT-PCR was determined. This was achieved by adding 
increasing amounts of probe to the QRT-PCR mastermix, and plotting cycle threshold 
(Ct) values against volume of probe. As can be seen in figure 16B, increasing the amount 
of probe in a QRT-PCR reaction reduced the Ct value obtained. The optimal volume of 
probe was identified as the point where the graph reaches a plateau. Finally, the effect of 
multiplexing the gene of interest primer/probe mix with the primer/probe mix for the 18S 
internal control was determined. The highest accuracy is achieved in QRT-PCR by 
measuring the expression of the internal control gene and gene of interest in the same 
reaction mix, known as multiplexing. However, not all primers and probes can be  
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Figure 15. Asse ssment of cDNA quality using β-actin PCR.
Trans fected cells were harvested, RNA extracted, cDNA generated and β-actin
PCR carried out. A representative image of β-actin PCR products separated by 
electrophoresis on a 1% agarose gel is shown. 
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Figure 16. Validation and optimisation of QRT-PCR primers and probe.
A, Primers for the gene of interest were designed, a PCR carried out using these 
primers and the PCR products separated by electrophoresis on a 2% agarose 
gel. A representative image is shown. B, QRT-PCR was carried out using the 
pre-validated primers and 0.5, 1, 1.5, 2, 2.5 and 3µl probe and average cycle 
threshold (CT) values plotted against amount of probe. C, QRT-PCR was carried 
out using the validated primers, the optimised amount of probe and increasing 
amounts of cDNA. The validated primers/probe and 18S internal control 
primers/probe mix were tested both individually and in combination and average 
CT values plotted against amount of cDNA. Representative graphs are shown in 
B and C. 
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multiplexed with 18S primers/probe. In order to determine whether a primers/probe mix 
can be multiplexed, 18S and gene of interest primers and probe were used in both 
singleplex and multiplex QRT-PCR reactions with increasing amounts of cDNA, and Ct 
values plotted against volume of cDNA (figure 16C). The incompatibility of a 
primers/probe set with multiplexing is determined by significant alteration in the 
multiplex Ct values obtained with increasing cDNA compared to singleplex reactions. As 
can be seen in figure 16C, no significant changes in Ct values were observed, indicating 
that the gene of interest primers/probe set can be multiplexed with 18S internal control.    
  
3.2.4 Assessment of target mRNA knockdown 
 
The knockdown plasmids used here produce a specific short hairpin RNA (an example is 
shown in figure 12C), which is processed in the cell by DICER to remove the loop 
sequence, and is in turn integrated into the RISC complex where the resulting double 
stranded RNA sequence targets complementary cellular mRNA sequences for 
degradation. This degradation subsequently results in the loss of the cellular protein 
encoded by this mRNA, thereby generating a knockdown. In order to determine CSN2 
mRNA levels in mock, vector control and shCSN2 K562 cells, cells were harvested day 6 
post transfection, RNA extracted, quantified and cDNA produced using 1µg RNA. Once 
the quality of the sample cDNA was determined and the QRT-PCR protocol optimised, 
CSN2 expression was determined. Co-transfection of cells with HKK and empty vector 
had no significant effect on the expression of CSN2 (figure 17A) relative to expression in 
mock transfected cells. However, co-transfection with HKK and shCSN2 resulted in a  
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Figure 17. Determination of CSN2 mRNA and protein knockdown.
A, Mock, vector control and CSN2 knockdown transfected cells were harvested 
day 6 post transfection, RNA extracted, cDNA generated and QRT-PCR carried 
out. Data shown is the mean CSN2 mRNA expression relative to mock 
transfected cells of n=3 transfections ±SEM. * indicates p<0.05. B, Transfected 
cells were harvested day 6 post transfection, protein extracted and CSN2 protein 
levels in mock, HKK alone, vector control and CSN2 knockdown cell extracts 
determined by western blot. Even loading was determined by β-actin western 
blot. The image shown is representative of five sets of n=3 transfections. 
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significant reduction in the level of CSN2 mRNA (figure 17A; P=0.001), with only 0.5% 
CSN2 mRNA remaining in CSN2 knockdowns.   
 
3.2.5 Assessment of target protein knockdown 
 
In order to determine CSN2 protein knockdown, shCSN2 cells were harvested day 6 post 
transfection, protein extracted, quantified, and 20µg used in western blot analyses. 
Importantly, transfection of cells with HKK alone or co-transfection with HKK and 
empty vector (shVC) had no effect on the level of CSN2 protein relative to mock 
transfected cells (figure 17B). However, when cells were co-transfected with HKK and 
shCSN2, CSN2 protein could not be detected, indicating a highly efficient knockdown at 
the protein level (figure 17B).  
 
3.2.6 Assessment of the effect of CSN2 knockdown in K562 cells on SCF components and 
activity 
 
CSN mediated cullin deneddylation has been shown to stabilise F-box proteins and 
protect them against autocatalytic degradation within their respective SCF complex (Wee 
et al., 2005). In accordance with this, knockdown of either CSN4 or CSN5 in human cells 
resulted in an increase in the level of neddylated Cul1, reduction of the F-box protein 
Skp2 and accumulation of the SCFSkp2 target protein p27 (Denti et al., 2006). As CSN2 
has been shown to be integral to the integrity of the CSN complex (Kwok et al., 1998), it 
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was predicted that the CSN2 knockdown achieved in K562 cells would result in similar 
alterations to SCFSkp2 and its target p27.  
 
In order to determine the effect of CSN2 loss on the level of Cul1, Skp2 and p27 proteins, 
vector control and CSN2 knockdown cells were harvested 6 days post transfection, 
protein extracted and the level of proteins in these samples determined by western blot 
analysis.  As shown in figure 18A, knockdown of CSN2 caused a marked increase in 
neddylated Cul1 relative to vector control cells, at the expense of the deneddylated form 
of Cul1. This was confirmed using densitometry which demonstrated that the 
Cul1:Neddylated Cul1 ratio in cells lacking CSN2 was significantly less than that of 
vector controls (figure 18B; P=0.008). Furthermore, western blot analysis of Skp2 protein 
levels showed apparent total loss of Skp2 in cells lacking CSN2 (figure 18C), whilst p27 
western blot analysis demonstrated p27 accumulation in CSN2 knockdown cells relative 
to vector control cells (figure 18D). This data suggests that loss of CSN2 results in 
deregulation of Cul1 neddylation and therefore, aberrant SCFSkp2 activity in K562 cells.  
 
The stability of cullin proteins has also been shown to be dependent on CSN mediated 
cullin deneddylation (Wu et al., 2005). The effect of CSN2 loss on the level of both Cul1 
and Cul3 protein was therefore studied. In this case transfected cells were harvested at the 
later time point of day 9 post transfection and the level of Cul1 protein determined by 
western blot. In accordance with published data, Cul1 protein was significantly decreased 
in CSN2 knockdown cells relative to vector control cells day 9 post transfection (figure 
19). Furthermore, Cul3 protein was also reduced in cells lacking CSN2 compared to  
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Cul1
shVC shCSN2
Nedd8 Cul1
β-actin
Figure 18. CSN2 knockdown results in accumulation of neddylated Cul1, 
loss of the F-box protein Skp2 and accumulation of p27.
Trans fected cells were harvested day 6 post transfection, protein extracted and 
Cul1 (A), Skp2 (C) and p27 (D) protein levels in vector control and CSN2 
knockdown cell extracts determined by western blot. Even loading was 
determined by β-actin western blot. The images shown are representative of 
three sets of n=3 trans fections. B, Densitometry was carried out on the Cul-1 
western blot and the Cul-1 to neddylated Cul-1 ratios of vector control and CSN2 
knockdown cells calculated. Data shown is the average of n=3 transfections 
±SEM. * indicates p<0.05. 
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Figure 19. CSN2 knockdown results in significant loss of Cul1 protein.
Trans fected cells were harvested day 9 post transfection, protein extracted and 
Cul1 protein levels in vector control and CSN2 knockdown cell extracts 
determined by western blot. Even loading was determined by β-actin western 
blot. The image shown is of three independent vector control and CSN2 
knockdown transfections.
β-actin
Cul1
shVC shCSN2
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vector controls at day 6 post transfection (figure 20A). Densitometry of this western blot 
demonstrated that this loss in total Cul3 protein is significant (figure 20B; P=0.0007), 
whilst densitometry also showed that there was a significant reduction in the 
Cul3:Neddylated Cul3 ratio as observed for Cul1 (figure 20C; P=0.0009). These data 
confirm that the CSN is vital for cullin protein stability and further suggest that loss of 
CSN2 affects multiple cullins/CRL complexes and therefore the degradation of a plethora 
of proteins.  
 
3.2.7 Assessment of the effect of CSN2 knockdown on the level of F-box proteins 
 
There appear to be discrepancies within the literature with respect to the effect of CSN 
disruption on the level of particular F-box proteins. For example, the stability of the 
Neurospora β-TrCP homolog, FWD-1, has been shown to be dependent on CSN activity, 
with CSN2 knockout resulting in a significant increase in FWD-1 protein degradation 
(He et al., 2005), whilst others have reported no effect of CSN disruption on the level of 
this F-box protein in HEK293 cells (Su et al., 2008). In order to compare the effect of 
CSN2 knockdown on the level of multiple F-box proteins, protein levels of Skp2, Cdc4 
and β-TrCP were determined over time following knockdown of CSN2 in K562 cells. 
Vector control and CSN2 knockdown cells were harvested 2, 3, 6 and 9 days post 
transfection, proteins extracted and the levels of F-box proteins determined by western 
blot analyses. By day 9 post transfection, all three F-box proteins were undetectable in 
the CSN2 knockdown cells (Figure 21). However, the loss of these F-box proteins was 
found to occur sequentially. Densitometry was carried out on all F-box protein westerns  
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Figure 20. CSN2 knockdown results in a significant decrease in the 
Cul3:Nedd8 Cul3 ratio and loss of Cul3 protein.
A, Transfected cells were harvested day 6 post transfection, protein extracted 
and Cul3 protein levels in vector control and CSN2 knockdown cell extracts 
determined by western blot. Even loading was determined by β-actin western 
blot. The image shown is of three independent vector control and CSN2 
knockdown transfections. Densitometry was carried out on the Cul3 western blot 
and the total Cul3 protein (B) and the Cul3 to neddylated Cul3 ratio (C) of vector 
control and CSN2 knockdown cells calculated. Data shown is the average of n=3 
transfections ±SEM. * indicates p<0.05. 
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Figure 21. CSN2 knockdown results in the sequential loss of F-box 
proteins.
A, Trans fected cells were harvested day 6 and day 9 post-transfection, protein 
extracted and Skp2, Cdc4 and β-TrCP protein levels in vector control and CSN2 
knockdown cell extracts determined by western blot. Even loading was 
determined by β-actin western blot. B, Transfected cells were harvested day 2, 3, 
6 and 9 post-transfection, protein extracted and Skp2, Cdc4 and β-TrCP protein 
levels in vector control and CSN2 knockdown cell extracts determined by western 
blot. Densitometry was used to determine the level of each of the proteins, 
normalised for loading using β-actin, in CSN2 knockdowns at each time point. 
Data was normalised to protein levels in vector control cells and the data plotted 
as the mean ±SEM. 
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at all time points assessed, with normalization to β-actin signal for loading correction. 
Values obtained for CSN2 knockdown samples were normalized to vector control values 
and the data plotted as a line graph ± the standard error of the mean (figure 21B). Skp2 
protein was reduced by ~60% by day 2 and over 90% by day 6, whereas Cdc4 was lost at 
a slower rate with 30-40% lost by day 3 increasing to ~70% by day 6 post transfection 
(Figure 21B). Loss of β-TrCP was still more retarded with ~70% protein remaining at 
day 6 (Figure 21B). Importantly, treatment of shCSN2 cells with the proteasome inhibitor 
MG132 (10µM; (Naujokat et al., 2000, Su et al., 2008)) resulted in the rescue of F-box 
protein levels in these cells relative to vector controls (figure 22). This data suggests that 
these F-box proteins are, at least in part, degraded by the 26S proteasome in the absence 
of CSN2; degradation which is most likely mediated by the autocatalytic degradation 
mechanism reported previously (Wee et al., 2005, Galan and Peter, 1999).  
 
3.2.8 Assessment of the effect of CSN2 knockdown on F-box protein mRNA 
 
Although proteasome inhibition rescued F-box proteins in CSN2 knockdown cells, rescue 
was only partial, suggesting that CSN2 loss may also affect F-box protein expression as 
well as degradation. The effect of CSN2 knockdown on the level of F-box protein mRNA 
was therefore investigated. Vector control and shCSN2 cells were harvested at the time 
points indicated and Skp2, Cdc4 and β-TrCP mRNA measured by QRT-PCR. Skp2 
mRNA was significantly reduced at all time points studied, whilst Cdc4 and β-TrCP 
mRNA were significantly increased at day 3 and day 6 post transfection, respectively 
(figure 23). These data suggest that both decreased transcription and increased protein  
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Figure 22. F-box protein loss in CSN2 knockdowns is rescued with the 
addition of the proteasome inhibitor MG132. 
Transfected cells were treated with either DMSO (control) or 10µM MG132 for the 
final 18 hours of culturing and cells harvested, protein extracted and Skp2, Cdc4 
and β-TrCP protein levels in cell extracts determined by western blot. Even 
loading was determined by β-actin western blot. 
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Figure 23. CSN2 knockdown results in significant alteration to the level of 
F-box mRNA.  
The level of Skp2, Cdc4 and β-TrCP mRNA in shCSN2 cells was determined at 
each time point post transfection relative to expression in vector cont rol scramble 
cells by QRT-PCR. Data shown is the mean ± SEM of n=3 transfections.         * 
indicates significant difference to vector controls with p<0.05.
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degradation contribute to the reduced Skp2 protein level in CSN2 knockdown cells, 
whilst indicating that loss of Cdc4 and β-TrCP protein is not attributable to altered 
transcription. Finally, these data suggest a role, either direct or indirect, for the CSN 
complex in the regulation of F-box protein expression.  
 
3.2.9 Assessment of the effect of CSN2 knockdown on cell growth and cell death 
 
In order to determine the effects of CSN2 loss on cell growth and viability, cell counts 
were taken day 2-7 and day 9 post transfection, the cumulative cell growth for both 
vector control and CSN2 knockdown cells was calculated and the data plotted ± the 
standard error of the mean of n=3 transfections. Knockdown of CSN2 caused 
dramatically reduced cell growth followed by loss of cell numbers mediated by loss of 
cell viability (Figure 24). The proliferation of cells lacking CSN2 was significantly less 
than that of shVC by day 4 post transfection (Figure 24, P=0.034), as determined using 
the t-test. These findings were corroborated by thymidine incorporation data. At day 3 
post-transfection, there was no significant difference in the incorporation of tritiated 
thymidine into cellular DNA between shVC and CSN2 knockdown cells (Figure 25; 
P=0.195). However, by day 5 the CSN2 knockdown cells demonstrated a significant 
decrease in thymidine incorporation (P=0.007) which decreased even further by day 7 
post transfection (Figure 25; P=1.1x10-5).   
 
The cumulative growth profile of CSN2 knockdown cells (figure 24. Insert) suggests that 
the absence of CSN2 results in either slower passage through the cell cycle or cell cycle   
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Figure 24. CSN2 knockdown results in significantly reduced cell growth.
Cell counts were taken daily and the cumulative growth calculated. The 
cumulative growth of CSN2 knockdowns and vector controls is shown. The insert 
shows the CSN2 knockdown cumulative growth profile in the absence of vector 
control data. Data shown are the mean ± SEM of n=3. * indicates a significant 
difference to vector control cell growth with p<0.05. 
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Figure 25. CSN2 knockdown results in significantly reduced thymidine 
incorporation into cellular DNA.
Thymidine incorporation in shCSN2 and vector control cells was measured day 3, 
5 and 7 post transfection. Data shown are the mean ± SEM of n=3 transfections.
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inhibition. In order to discern between these two possibilities, the cell cycle profiles of 
both vector control cells and cells lacking CSN2 were determined day 6 post transfection 
(figure 26). The percentage of cells in subG1, G1, S, and G2M in vector control and 
CSN2 knockdown cells was determined using flow cytometry and plotted as pie charts. 
Data shown is the mean ± the standard error of the mean of n=3 transfections. The 
significance of any differences was determined using the t-test. As can be seen in figure 
26, the cell cycle profiles of vector control and CSN2 knockdown cells were relatively 
similar, with no significant differences detected in the G1, S or G2M phases of the cell 
cycle. However, an approximately twofold increase in subG1 cells relative to vector 
control cells was observed (figure 26B; P=0.0003). As accumulation of cells in subG1 is 
indicative of cell death, this finding is in accordance with the onset of cell death at day 6 
post transfection observed from the cumulative growth data. Together, the cumulative 
growth, thymidine incorporation and cell cycle flow cytometry data suggest that loss of 
CSN2 results in a slowed cell proliferation rate of K562s followed by cell death.    
 
3.2.10 Determination of the mechanism of CSN2 knockdown induced cell death 
 
In order to determine whether the loss of viability in CSN2 knockdown cells was due to 
apoptosis, vector control and CSN2 knockdown cells were harvested day 6 post 
transfection, protein extracted and caspase-9 cleavage determined by western blot 
analysis. As can be seen in figure 27, equivalent amounts of caspase-9 were present in 
vector control and CSN2 knockdown cells, and no caspase-9 cleavage product was 
detected. As a second measure of apoptosis, cells were co-analysed for annexin V  
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Figure 26. CSN2 knockdown has no significant effect on the cell cycle.
A, A representative image of CSN2 knockdown (black line) cell cycle profiles day 
6 post transfection relative to vector control (light grey in fill). B, Statistical 
analysis of cell cycle data is shown as pie charts. Data shown are the mean ± 
SEM of n=3. * indicates p<0.05.
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β-actin
Pro Caspase-9
Caspase-9
Figure 27. CSN2 knockdown has no effect on ca spase-9 activation.
Trans fected cells were harvested day 6 post transfection, protein extracted and 
caspase-9 protein levels in vector control and CSN2 knockdown cell extracts 
determined by western blot. Even loading was determined by β-actin western 
blot. The image shown is of three independent vector control and CSN2 
knockdown transfections.
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staining and propidium iodide uptake day 7 and day 9 post transfection (Figure 28). 
Annexin V binds phosphatidylserine, a phospholipid which is translocated from the inner 
to the outer leaflet of the plasma membrane during apoptosis; annexin V staining is 
therefore a measure of apoptosis. Propidium iodide is taken up by all cells but is 
efficiently effluxed by viable cells, whereas dead/dying cells remain PI-positive. In K562 
cells, knockdown of CSN2 led to an increase in late apoptotic (annexin V+ve:PI+ve) cells 
(12.5%±0.9; P=0.023) compared to shVC cells (5.5%±2.2; figure 28A) day 7 post 
transfection, and resulted in no change in the proportion of early apoptotic (annexin 
V+ve:PI-ve) cells relative to vector control cells (5.5%±0.8 and 5.9%±1.9, respectively, 
P=0.826; figure 28A). However, by day 9 post transfection over two thirds of cells 
lacking CSN2 were annexin V positive (52%±2.4 annexin V+ve:PI+ve; P=4.1x10-5, and 
16.8±1.8 annexin V+ve:PI-ve; P=0.001), indicative of significant apoptosis in these cells 
relative to vector control cells (7.2%±1.5 late apoptotic and 5%±0.2 early apoptotic, 
figure 28B). Although CSN2 loss resulted in a dramatic increase in the proportion of 
apoptotic cells by day 9 post transfection, the cell death apparent in CSN2 knockdown 
cells between days 5 and 7 (37.2%±6.6; P=0.015, figure 24) cannot be adequately 
accounted for by increased apoptosis during this time as measured by caspase-9 western 
and annexin V staining (figures 27 & 28A). Together, these data suggest that the cell 
death which ensues as a consequence of CSN2 loss involves a mix of both apoptotic and 
non-apoptotic cell death.    
 
Annexin V and propidium iodide staining of CSN2 knockdown cells demonstrated that 
there was a significant shift to greater PI positivity in annexin V negative cells resulting  
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Figure 28. CSN2 knockdown results in a significant increase in annexin V 
positivity.
Binding of Annexin V and uptake of propidium iodide in vector control (left) and 
CSN2 knockdown (right) cells day 7 (A) and day 9 (B) post transfection was 
analysed by flow cytometry. The lower left quadrant encompasses the viable 
population of cells, the lower right quadrant contains early apoptotic cells, the 
upper right quadrant contains late apoptotic cells and the upper left quadrant 
contains the necrotic cell population. Dot plots shown are representative of n=3 
transfections. The mean of three data sets was taken and the values shown in the 
corresponding quadrant ± SEM. * indicates significance with p<0.05. 
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in a significant increase in cells arising in the upper left quadrant relative to vector 
controls day 7 post transfection (6.5%±0.1 in CSN2 knockdowns compared to 0.5%±0.02 
in vector controls, P=0.0018; figure 28A). This shift was also observed day 9 post 
transfection (figure 28B). These data are better displayed as a histogram of cell count 
against propidium iodide, in which only the annexin V negative population is considered. 
This analysis demonstrates that over 25% of annexin V negative CSN2 knockdown cells 
were propidium iodide positive by day 7 post transfection (figure 29A; P=3.3x10-5). This 
shift increased by day 9 post transfection, with over half of annexin V negative CSN2 
knockdown cells retaining propidium iodide (figure 29B; P=5.5x10-6). CSN2 knockdown 
cells were also associated with the formation of large vacuoles (see below) which raised 
the possibility that the accumulation of propidium iodide (PI) positive cells in a 
population lacking CSN2 was an artifact of PI retention within vacuoles. However, 
visualization of PI stained shCSN2 cells demonstrated there was no PI retention within 
vacuoles (figure 29C). These data are further indicative of the occurrence of both non-
apoptotic and apoptotic cell death in cells lacking CSN2.  
 
3.2.11 Morphological analyses of CSN2 knock down in K562 cells 
 
Both vector control and CSN2 knockdown cell cytospins were stained with Jenner-
Giemsa in order to observe cell morphology. This staining identified large vacuoles in a 
significant proportion of CSN2 knockdown cells which were not present in vector control 
cells (figure 30A). It was considered that these vacuoles may be autophagosomes. To test 
this, cells were stained with the autophagosome marker monodansylcadaverine (MDC).  
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Figure 29. CSN2 knockdown results in a significant increase in the 
proportion of propidium iodide+ve:annexin V-ve cells, not caused by 
propidium iodide retention within vacuoles. 
The histograms shown are representative of the propidium iodide+v e:annexin V-v e
staining of n=3 vector controls (light grey in fill) and CSN2 knockdowns (black 
line) day 6 (A) and day 9 (B) post transfection. The mean percentage of 
propidium iodide positive staining in annexin V-v e shCSN2 cells is shown ±SEM.   
* indicates p<0.05. C, shCSN2 cells were stained with propidium iodide and 
cytospins made to determine any retention of the stain within the vacuoles of 
shCSN2 cells day 6 post transfection. The image shown is representative of n=3 
transfections.
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Figure 30. CSN2 knockdown cells contain autophagosomes. 
A, Cytospins were stained with Jenner-Giemsa for visualisation of vector control 
and shCSN2 cell morphology day 6 post transfection. B, Vector control and 
shCSN2 cells were stained with the autophagosome marker 
monodansylcadaverine day 6 post transfection and cytospins made for the 
visualisation of autophagosomes. All images shown are representative of n=3 
transfections. 
shVC shCSN2
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B
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MDC staining and DIC imaging identified these vacuoles as autophagosomes, whilst the 
staining of vector control cells with MDC was minimal (figure 30B). To further validate 
the association of autophagy with CSN2 knockdown cells, both vector control and CSN2 
knockdown cells were harvested day 6 post transfection, protein extracted and the level 
of the autophagy marker protein light chain 3-II (LC3-II) determined by western blot 
analysis. As shown in figure 31, there was a highly significant accumulation of LC3-II 
protein in cells deficient in CSN2 relative to vector control cells. Thus, CSN2 knockdown 
cells were associated with autophagy.  
 
3.2.12 Autophagy inhibition recapitulates shCSN2 cell growth, morphology and LC3-II 
accumulation 
 
Although the observed significant loss of cell viability, MDC+ve vacuolar morphology 
and LC3-II accumulation in CSN2 knockdowns suggests that these cells were undergoing 
autophagic cell death, current literature indicates that the large vacuoles and LC3-II 
accumulation observed in shCSN2 cells could be attributable to either autophagy 
induction or inhibition (Mizushima and Yoshimori, 2007, Klionsky et al., 2008). 
Autophagy inhibitors (3-methyl adenine, 3-MA; Bafilomycin A1, Baf A1) and an inducer 
(rapamycin) were therefore used in order to provide insight into the phenotype observed 
in shCSN2 cells.  
 
The concentration of 3-MA used was determined from associated literature (Yan et al., 
2006). Surprisingly, treatment of vector control cells with the early stage autophagy  
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LC3-II
β-actin
shCSN2shVC
Figure 31. CSN2 knockdown results in accumulation of the autophagy 
marker protein LC3-II.
Transfected cells were harvested day 6 post transfection, protein extracted and 
LC3-II protein levels in vector control and CSN2 knockdown cell extracts 
determined by western blot. Even loading was determined by β-actin western 
blot. The image shown is representative of three sets of n=3 transfections.
LC3-I
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inhibitor 3-MA recapitulated the cumulative cell growth kinetics of shCSN2 cells, whilst 
having a relatively small effect on the growth of shCSN2 cells (figure 32). These findings 
suggested that CSN2 loss may result in autophagy inhibition. For this to be consistent 
with the occurrence of large vacuoles in shCSN2 cells, such autophagy inhibition would 
have to be occurring at a late stage. The late stage autophagy inhibitor Baf A1 was thus 
used to further investigate the possibility of late stage autophagy inhibition in shCSN2 
cells. The concentration of Baf A1 to be used had to first be determined experimentally 
due to variation in the literature (Fader et al., 2008, Jones et al., 1999, Savina et al., 2003, 
Shacka et al., 2006). Treatment of wild-type K562 cells for 48 hours with either 10nM, 
100nM or 1µM Baf A1 resulted in a significant amount of apoptotic cell death at this 
time point (figure 33A) with a significant reduction in cell number (figure 33B), most 
likely attributable to the associated toxicity of the compound. It was therefore concluded 
that, rather than a time course, a 48 hour treatment would be optimal. Interestingly, it was 
observed during dose titration experiments that treatment of wild-type K562 cells for 48 
hours with 1µM Baf A1 resulted in a dramatic accumulation of LC3-II protein (figure 
33C) and the formation of large vacuoles (figure 33D). This finding was also confirmed 
in vector control cells, with treatment of shVC cells with 1µM Baf A1 for 48 hours also 
recapitulating both the vacuolar morphology (figure 34A) and the LC3-II protein 
accumulation (figure 34B) observed in shCSN2 cells. Cumulatively, autophagy inhibitor 
data suggests that cells lacking CSN2 undergo autophagy inhibition at a late stage.  
 
For further indication of the effect of CSN2 loss on autophagy, the autophagy inducer 
rapamycin was also used. Cells were treated with three different concentrations of  
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Figure 32. Treatment of vector control cells with 3-methyladenine 
recapitulates the cell growth pattern of CSN2 knockdown cells, whilst 
having little effect on cells lacking CSN2. 
Cell counts were taken daily and the cumulative growth calculated. The 
cumulative growth of vector controls and CSN2 knockdowns treated with either 
DMSO (cont rol) or the autophagy inhibitor 3-ma is shown. The insert has had the 
DMSO treated vector control data removed. Data shown are the mean ± SEM of 
n=3.
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Figure 33. Dose titration of bafilomycin A1. 
K562 cells were treated for 48 hours with either DMSO (control) or bafilomycin A1 
and Annexin V flow cytometry (A), cell counts (B) LC3-II western blotting (C) and 
Jenner-Giemsa staining (D) carried out. Data shown is representative of n=3.       
* indicates p<0.05. 
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Figure 34. Treatment of vector control cells with bafilomycin A1 
recapitulates the vacuolar morphology and LC3-II accumulation observed 
in shCSN2 cells. 
A, Jenner-Giemsa staining of shVC +/- 48 hour 1µM bafilomycin A1 treatment. 
Images shown are representative of n=3 trans fections. B, Vector control cells 
treated with either DMSO (cont rol) or the autophagy inhibitor bafilomycin A1 for 
48 hours were harvested and the level of LC3-II and β-actin protein determined 
by western blot. 
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rapamycin for 6 days and the level of LC3 protein determined by western blot. The data 
demonstrates that no accumulation of LC3-II occurs with rapamycin treatment (figure 
35). However, a dose dependent increase in the LC3-II precursor protein LC3-I was 
observed, demonstrating that the compound is functional with respect to autophagy 
induction (figure 35). Collectively, these data imply strongly that CSN2 knockdown 
results in autophagy inhibition followed by apoptotic or non-apoptotic cell death.  
 
It was hypothesized that the inhibition of autophagy in CSN2 knockdown cells may result 
in the accumulation of cellular protein, particularly in the absence of functional CRL 
complexes. To test this hypothesis, vector control and CSN2 knockdown cells were 
harvested day 6 post transfection and the amount of protein per cell calculated. Data was 
plotted as the average of n=3 transfections ± the standard error of the mean and the 
significance of any changes determined using the t-test (figure 36). As can be seen in 
figure 36, there was a significant increase in the amount of cellular protein in cells 
lacking CSN2 compared to vector control cells (P=0.017).    
 
3.2.13 Analysis of the effect of a vector control scramble sequence 
 
The use of interfering RNA has been associated with off target effects (Fedorov et al, 
2006). In order to demonstrate that the knockdowns generated here are due to the 
presence of a specific shRNA sequence, a vector control scramble sequence which 
encodes a non-targeting shRNA was generated, cloned into pcDNA3.1-H1 and co-
transfected into cells together with HKK. Figure 37A demonstrates that there is no effect  
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Figure 35. Treatment of K562 cells with the autophagy inducer rapamycin 
does not recapitulate the LC3-II accumulation observed in shCSN2 cells. 
K562 cells were treated with either DMSO (control) or the autophagy inducer 
rapamycin for 6 days and the level of LC3-I, LC3-II and β-actin protein 
determined by western blot. 
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Figure 36. CSN2 knockdown results in a significant increase in total cellular 
protein.
Trans fected cells were counted, harvested day 6 post transfection and protein 
extracted and quantified. The amount of protein per cell in both vector control and 
CSN2 knockdown cells was determined. Data shown is the mean ±SEM of n=3 
transfections. * indicates p<0.05. 
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Figure 37. A vector control scramble sequence has no signi ficant effect on 
the level of CSN2 or CSN5 protein or mRNA.
A, Trans fected cells were harvested day 9 post transfection, protein extracted 
and CSN2 and CSN5 protein levels in empty vector and vector control scramble 
cell extracts determined by western blot. Even loading was determined by β-actin
western blot. The image shown is of three independent empty vector and vector 
control scramble transfections. B, Empty vector and vector control scramble 
transfected cells were harvested day 9 post transfection, RNA extracted, cDNA
generated and QRT-PCR carried out. CSN2 and CSN5 mRNA expression in 
vector control scramble cells relative to empty vector transfected cells is shown. 
Data is the mean of n=3 trans fections ±SEM.
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on the level of CSN2 or CSN5 protein in vector control scramble cells relative to empty 
vector, determined by western blot. Furthermore, relative to empty vector, no significant 
effect is seen on CSN2 or CSN5 mRNA levels in vector control scramble cells as 
measured by QRT-PCR (figure 37B; P=0.826 and 0.684 respectively). These data clearly 
show that the high level of CSN2 and CSN5 protein and mRNA knockdown generated 
here are the result of the presence of a specific shRNA and not due to off target effects.  
 
It was also important to assess any effect of non-targeting scramble sequence on K562 
cell growth and death, and SCF activity, relative to empty vector control. Cell counts of 
empty vector and vector control scramble transfected cells were taken daily (day 3-9 post 
transfection) and the cumulative growth calculated. The data was plotted as a line graph ± 
the standard error of the mean of n=3 transfections (figure 38). As can be seen in figure 
38, there was no significant difference between the cumulative cell growth of empty 
vector and vector control scramble transfected cells, indicating that a non-targeting 
shRNA had no effect on cell growth or death.  
 
In order to determine any effect of non-targeting shRNA on CRL activity, transfected 
cells were harvested day 9 post transfection, protein extracted and the level of Cul1, 
Skp2, p27 and protein determined by western blotting. Figure 39 demonstrates that the 
introduction of a non-targeting shRNA into K562 cells had no significant effect on the 
levels of these proteins. Conversely to CSN subunit targeting shRNA, the vector control 
scramble sequence did not increase the level of neddylated Cul1 and did not result in 
reduction of Skp2 or accumulation of p27 protein (figure 39). These data indicate that the 
 152
findings made following knockdown of CSN subunits in K562 cells are attributable to 
CSN subunit deficiency in these cells, and are not mediated by off target effects of the 
shRNA.   
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Figure 38. A vector control scramble sequence has no signi ficant effect on 
cell growth.
Cell counts were taken daily and the cumulative growth calculated. The 
cumulative growth of empty vector and vector control scramble sequence 
transfected cells is shown. Data shown are the mean ± SEM of n=3 transfections. 
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Figure 39. A vector control scramble sequence has no effect on the SCF or 
the SCF target p27.
Trans fected cells were harvested day 9 post transfection, protein extracted and 
Cul1, Skp2, and p27 protein levels in empty vector and vector control scramble 
cell extracts determined by western blot. Even loading was determined by β-actin
western blot. The image shown is of three independent empty vector and vector 
control scramble transfections.
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Chapter 4.0: 
Analysis of the molecular and cellular 
effects of CSN5 knockdown 
 156
4.1 Introduction 
 
Although the loss of CSN deneddylase activity was confirmed in shCSN2 cells, it was 
possible that the cellular phenotype of these cells was not attributable to the loss of cullin 
deneddylation. Indeed, although both resulting in defective cullin deneddylation, a S. 
pombe CSN2 null mutant does not share the same phenotype as a CSN5 null mutant 
(Mundt et al., 2002). It was thus important to determine whether loss of CSN5, which 
contains the cullin deneddylase activity of the CSN (Cope et al., 2002), resulted in the 
same phenotype as that observed in shCSN2 cells. To this end, CSN5 was targeted in 
K562 cells and the same analyses carried out as in the previous chapter.      
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4.2 Results 
 
4.2.1 Assessment of target mRNA knockdown 
 
In order to determine CSN5 mRNA levels in mock, vector control and shCSN5 cells, 
transfected cells were harvested day 4 post transfection, RNA extracted, quantified and 
cDNA produced using 1µg RNA. Once the quality of the sample cDNA was determined 
and the QRT-PCR protocol optimised (see 3.2.3), CSN5 expression was then determined. 
As shown in figure 40A, co-transfection of cells with HKK and empty vector had no 
significant effect on the expression of CSN5 relative to expression in mock transfected 
cells. However, co-transfection with HKK and shCSN5 resulted in only 5% CSN5 
mRNA remaining relative to mock transfected cells (figure 40A; P=3.12x10-5).        
 
4.2.2 Assessment of target protein knockdown 
 
In order to determine CSN5 protein knockdown, vector control and shCSN5 cells were 
harvested day 4 post transfection, protein extracted, quantified, and 20µg protein used in 
western blot analyses. K562 cells co-transfected with HKK and shCSN5 plasmids had 
significantly less CSN5 protein than HKK and vector control plasmid transfected cells, 
with CSN5 protein undetectable in CSN5 knockdown cells (figure 40B). These data 
indicate a highly efficient knockdown at the protein level.  
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Figure 40. Determination of CSN5 mRNA and protein knockdown.
A, Mock, vector control and CSN5 knockdown transfected cells were harvested 
day 4 post transfection, RNA extracted, cDNA generated and used in QRT-PCR. 
Data shown is the mean CSN5 mRNA expression relative to mock transfected 
cells of n=3 transfections ±SEM. * indicates p<0.05. B, Transfected cells were 
harvested day 4 post trans fection, protein extracted and CSN5 protein levels in 
vector control and CSN5 knockdown cell extracts determined by western blot. 
Even loading was determined by β-actin western blot. The image shown is 
representative of three sets of n=3 transfections.
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4.2.3 Assessment of the effect of CSN5 knockdown on SCF components and activity 
 
In order to determine the effect of CSN5 loss on the level of Cul1, Skp2 and p27 proteins, 
vector control and CSN5 knockdown cells were harvested day 4 post transfection, protein 
extracted and the level of proteins in these samples determined by western blot analysis. 
As seen in figure 41A, knockdown of CSN5 resulted in an increase in neddylated Cul1 
relative to vector control cells, at the expense of the deneddylated form of Cul1. This was 
confirmed by densitometry which demonstrated that the Cul1:Neddylated Cul1 ratio in 
cells lacking CSN5 was significantly less than that of vector controls (P=0.010; figure 
41B). 
  
Western blot analysis of Skp2 protein levels showed a complete loss of detectable Skp2 
in cells lacking CSN5 (figure 41C), whilst p27 western blot analysis demonstrated 
significant p27 accumulation in CSN5 knockdown cells relative to vector control cells 
(figure 41D). As seen in CSN2 knockdowns, this data suggests that loss of CSN5 in 
K562 cells also results in deregulation of Cul1 neddylation and therefore, aberrant 
SCFSkp2 activity in K562 cells. 
 
The effect of CSN5 loss on Cul3 protein was also investigated. CSN5 knockdown 
resulted in the marked accumulation of neddylated Cul3 protein relative to vector control 
cells (figure 42A). Quantitative analysis of this data demonstrated a significant reduction 
in the Cul3:Neddylated Cul3 ratio in cells lacking CSN5 (figure 42B; P=0.012). 
Furthermore, densitometric analysis also revealed a relatively small but significant loss of  
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Figure 41. CSN5 knockdown results in accumulation of neddylated Cul1, 
loss of Skp2 and accumulation of p27.
Transfected cells were harvested day 4 post transfection, protein extracted and 
Cul1 (A), Skp2 (C) and p27 (D) protein levels in vector control and CSN5 
knockdown cell extracts determined by western blot. Even loading was 
determined by β-actin western blot. The images shown are representative of 
three sets of n=3 transfections. B, Densitometry was carried out on the Cul-1 
western blot and the Cul-1 to neddylated Cul-1 ratios of vector control and CSN5 
knockdown cells calculated. Data shown is the average of n=3 trans fections 
±SEM. * indicates p<0.05. 
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Figure 42. CSN5 knockdown results in the significant accumulation of 
neddylated Cul3 protein and loss of Cul3 protein.
A, Transfected cells were harvested day 4 post transfection, protein extracted 
and Cul3 protein levels in vector control and CSN5 knockdown cell extracts 
determined by western blot. Even loading was determined by β-actin western 
blot. The image shown is of three independent vector control and CSN5 
knockdown transfections. Densitometry was carried out on the Cul3 western blot 
and the Cul3 to neddylated Cul3 ratios (B) and total Cul3 protein (C) of vector 
control and CSN5 knockdown cells calculated. Data shown is the average of n=3 
transfections ±SEM. * indicates p<0.05. 
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total Cul3 protein in shCSN5 cells (figure 42C; P=0.035). Collectively, these data suggest 
that, as in CSN2 knockdown cells, CSN5 loss results in the defective deneddylation of 
cullins, thus potentially altering the activity of multiple CRLs and therefore the 
degradation of many proteins. It is also important to note that the similar results obtained 
with CSN2 and CSN5 knockdowns with respect to CRL activity suggests that both 
knockdowns have the same effect on CSN deneddylase activity.  
 
4.2.4 Assessment of the effect of CSN5 knockdown on the level of F-box proteins 
 
In order to assess the effect of CSN5 knockdown on the level of multiple F-box proteins, 
protein levels of Skp2, Cdc4 and β-TrCP were determined day 4 post transfection. Figure 
43 demonstrates the differential loss of F-box proteins in CSN5 knockdowns relative to 
vector control cells. At day 4 post transfection, Skp2 protein was undetectable in cells 
lacking CSN5 whilst Cdc4 protein was reduced by an average of 82%, as determined by 
densitometry. Furthermore, no significant effect on the level of β-TrCP protein was 
observed at this time point (figure 43). Addition of the proteasome inhibitor MG132 to 
cells at a time point at which these F-box proteins were found to be reduced restored the 
level of these proteins at least partially (figure 44; For Skp2, Cdc4 and β-TrCP protein 
rescue experiments vector control and CSN5 knockdown cells were treated with 10µM 
MG132 for 18 hours day 1, 3 and 6, respectively). These data suggest, in accordance with 
the CSN2 knockdown data, that F-box proteins are degraded in K562 cells in the absence 
of CSN deneddylase activity.     
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Skp2
Cdc4
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shVC shCSN5
Figure 43. CSN5 knockdown results in the sequential loss of F-box 
proteins.
Trans fected cells were harvested day 4 post-transfection, protein extracted and 
Skp2, Cdc4 and β-TrCP protein levels in vector control and CSN5 knockdown cell 
extracts determined by western blot. Even loading was determined by β-actin
western blot. The image shown is of three independent vector cont rol and CSN5 
knockdown transfections.
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Figure 44. F-box protein loss in CSN5 knockdowns is rescued with the 
addition of the proteasome inhibitor MG132. 
Transfected cells were treated with either DMSO (control) or 10µM MG132 for the 
final 18 hours of culturing. For Skp2, Cdc4 and β-TrCP protein rescue 
experiments vector control and CSN5 knockdown cells were treated day 1, 3 and 
6, respectively. Cells were harvested, protein extracted and Skp2, Cdc4 and β-
TrCP protein levels in cell extracts determined by western blot. Even loading was 
determined by β-actin western blot. 
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4.2.5 Assessment of the effect of CSN5 knockdown on F-box mRNA 
 
Recently, a novel function of the CSN complex in the regulation of transcription has been 
suggested (Su et al., 2008, Ullah et al., 2007). The effect of CSN5 knockdown on the 
level of F-box protein mRNA was therefore investigated. Vector control and shCSN5 
cells were harvested days 2, 3 and 6 and Skp2, Cdc4 and β-TrCP mRNA measured by 
QRT-PCR. β-TrCP mRNA was significantly reduced at all time points studied (figure 45; 
P= 0.015, 0.027 and 0.015 for day 2, 3 and 6, respectively) even though no difference in 
β-TrCP protein was observed by day 4 (figure 43), whilst Skp2 and Cdc4 mRNA were 
significantly reduced at day 6 post transfection (figure 45; P=0.009 and P=0.044, 
respectively). These data suggest that reduced F-box mRNA expression may in part 
account for the observed reduction in F-box proteins in CSN5 knockdown cells, and 
further implicate CSN5 or indeed the CSN complex in the regulation of F-box protein 
expression.  
 
4.2.6 Assessment of the effect of CSN5 knockdown on cell growth and cell death   
 
In order to determine the effects of CSN5 loss on cell growth and viability, cell counts 
were taken day 2-7 post transfection, the cumulative cell growth for both vector control 
and CSN5 knockdown cells was calculated and the data plotted ± the standard error of 
the mean of n=3 transfections. The results demonstrate that knockdown of CSN5 resulted 
in the substantial reduction of cell growth followed by loss of cell viability (Figure 46).  
Analysis of cumulative growth demonstrated that proliferation of cells lacking CSN5 was  
 166
Day
0 2 4 6 8 10Pe
rc
e
n
ta
ge
 
F-
bo
x
 
m
RN
A 
ex
pr
e
ss
io
n
 
in
 
s
hC
SN
5 
ce
lls
 
re
la
tiv
e
 
to
 
v
ec
to
r 
c
o
n
tr
o
l s
cr
a
m
bl
e 
ce
lls
0
50
100
150
200
Skp2 
Cdc4 
B-TrCP 
* *
*
*
*
Figure 45. CSN5 knockdown results in significant alteration to the level of 
F-box mRNA.  
The level of Skp2, Cdc4 and β-TrCP mRNA in shCSN5 cells was determined at 
each time point post transfection relative to expression in vector cont rol scramble 
cells by QRT-PCR. Data shown is the mean ± SEM of n=3 transfections.         
* indicates a significant difference to vector controls with p<0.05.
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Figure 46. CSN5 knockdown results in significantly reduced cell growth.
Cell counts were taken daily and the cumulative growth calculated. The 
cumulative growth of CSN5 knockdowns and vector controls is shown. The insert 
shows a close up of the CSN5 knockdown cumulative growth profile in the 
absence of vector cont rol data. Data shown are the mean ± SEM of n=3.              
* indicates a significant difference to vector control cell growth with p<0.05.
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significantly less than that of shVC by day 4 post transfection (Figure 46, P=0.0002), as 
determined using the t-test. This data was corroborated by thymidine incorporation data 
which shows that, at day 3 post-transfection, there was a significant reduction in the 
incorporation of tritiated thymidine into cellular DNA between shVC and CSN5 
knockdown cells (P=0.001), which decreased even further by day 4 post transfection 
(Figure 47; P=0.007).  
 
The cell cycle profiles of both vector control cells and cells lacking CSN5 were 
determined day 4 post transfection (figure 48). The percentage of cells in subG1, G1, S, 
and G2M in vector control and CSN5 knockdown cells was calculated, plotted as pie 
charts and the significance of any differences determined using the t-test. As can be seen 
in figure 48, the cell cycle profile of CSN5 knockdown cells differed significantly to that 
of vector control cells in all phases. Differences included an increase in the subG1 
fraction (P=0.0005), a significant reduction in the proportion of cells in the G1 and S 
phases of the cell cycle in CSN5 knockdowns (P=0.004 and 3.4x10-6, respectively) and 
an accumulation of CSN5 knockdown cells in G2M (P=0.001; figure 48). This data 
suggests that cells deficient in CSN5 are subject to a block in mitosis, thereby 
corroborating the cumulative growth data. Furthermore, the cumulative growth profile 
and subG1 accumulation of CSN5 knockdown cells indicates reduced viability of CSN5 
cells, which may potentially ensue as a consequence of the observed mitotic block.   
 
In order to investigate the apparent mitotic block in CSN5 knockdown cells further, 
vector control and CSN5 knockdown cell cytospins were Jenner-Giemsa stained to  
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Figure 47. CSN5 knockdown results in significantly reduced thymidine
incorporation into cellular DNA.
Thymidine incorporation in shCSN5 and vector control cells was measured day 3 
and 4 post transfection. Data shown are the mean ± SEM of n=3. * indicates 
p<0.05.
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Figure 48. CSN5 knockdown results in significant changes in cell cycle.
A, A representative image of CSN5 knockdown (black line) cell cycle profiles day 
4 post transfection relative to vector control (light grey in fill). B, Statistical 
analysis of cell cycle data is also shown as pie charts. Data shown are the mean 
± SEM of n=3 transfections. * indicates p<0.05.
A
B
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observe cell morphology. This staining clearly shows a significant number of cells in the 
CSN5 knockdown population which contained condensed, misaligned chromosomes, 
which were not present in the vector control population (figure 49A). To investigate this 
phenomenon further, vector control and CSN5 knockdown cells were immunostained for 
tubulin. As can be seen in figure 49B, shVC cells retained the ability to form a mitotic 
spindle and correctly aligned chromosomes at various stages of mitosis were observed. In 
contrast, the majority of cells lacking CSN5 demonstrated either aberrant or absent 
microtubule structures. In these cells, the condensed chromatids appeared to be either 
misaligned or indeed not associated with the spindle structures at all (figure 49B). The 
substantial numbers of cells showing this morphology are consistent with cell cycle arrest 
at G2/M. Altogether, this data suggests that loss of CSN5 in K562 cells results in reduced 
cell proliferation and subsequent cell death as a consequence of a mitotic block, possibly 
caused by aberrant mitotic spindle formation.   
 
4.2.7 Determination of the mechanism of CSN5 knockdown induced cell death 
 
To assess whether cell death in CSN5 knockdowns occurred via an apoptotic mechanism, 
vector control and CSN5 knockdown cells were harvested day 4 post transfection, protein 
extracted and caspase-9 protein levels determined by western blot analysis. As shown in 
figure 50, the caspase-9 cleavage product (indicative of apoptosis) is readily detectable in 
CSN5 knockdown cell extracts, the production of which occurs at the expense of the 
uncleaved form, whereas no caspase-9 cleavage is detectable in vector control cells 
(figure 50). To further validate apoptosis as the mechanism of CSN5 deficient cell death,  
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Figure 49. CSN5 knockdown results in altered cell morphology and aberrant 
mitotic spindle formation.
A, Cytospins were stained by Jenner-Giemsa for visualisation of vector control 
and shCSN5 cell morphology day 4 post transfection. B, Cytospins were stained 
with mouse anti-tubulin primary antibody, anti-mouse FITC secondary antibody 
and Hoescht for visualisation of both tubulin and DNA in vector control and 
shCSN5 cells day 4 post transfection. All images shown are representative of n=3 
transfections. 
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Figure 50. CSN5 knockdown results in caspase-9 activation.
Transfected cells were harvested day 4 post transfection, protein extracted and 
caspase-9 protein levels in vector control and CSN5 knockdown cell extracts 
determined by western blot. Even loading was determined by β-actin western 
blot. The image shown is of three independent vector control and CSN5 
knockdown transfections.
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cells were co-analysed for annexin V staining and propidium iodide uptake day 6 post 
transfection (Figure 51). CSN5 knockdown resulted in a large and highly significant 
increase in both early (annexin V+ve:PI-ve) and late (annexin V+ve:PI+ve) apoptotic cells 
relative to vector control cells (P=0.0015 and 0.0006, respectively; figure 51). Altogether, 
these data indicate that K562 cells lacking CSN5 die by apoptosis.  
 
Annexin V and propidium iodide staining of CSN5 knockdown cells demonstrated that, 
contrary to the observations made in CSN2 knockdown cells, there was no shift to greater 
PI positivity in the annexin V negative cell population (figure 51). These data are better 
displayed as a histogram of cell count against propidium iodide, in which only the 
annexin V negative population is considered (figure 52). To further demonstrate the 
distinction between the phenotypes which occurred as a result of CSN2 and CSN5 
knockdown, LC3-II protein levels day 4 post transfection were determined in vector 
control and CSN5 knockdown cells. Indeed, there was no accumulation of the autophagy 
marker protein LC3-II in CSN5 knockdown cells compared to vector controls (figure 53). 
It is important to note that the exposure time in figure 53 is 12 hours, compared to an 
exposure time of 1 minute in figure 31. Conversely to CSN2 knockdown cells (figure 31), 
an exposure time of 1 minute detected no LC3-II protein in CSN5 knockdown cells (data 
not shown). A longer exposure was therefore carried out in order to determine that there 
was no accumulation of LC3-II in shCSN5 cells relative to vector controls (figure 53). 
Cumulatively, these data indicate that, conversely to CSN2 knockdown cells, cells 
lacking CSN5 are not associated with autophagy and do not undergo non-apoptotic cell 
death but are instead subject to a mitotic block and die by apoptosis.        
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Figure 51. CSN5 knockdown results in a significant increase in annexin V 
positivity.
Binding of Annexin V and uptake of propidium iodide in vector control (left) and 
CSN5 knockdown (right) cells day 6 post transfection was analysed by flow 
cytometry. The lower left quadrant encompasses the viable population of cells, 
the lower right quadrant contains early apoptotic cells, the upper right quadrant 
contains late apoptotic cells and the upper left quadrant contains the necrotic cell 
population. Dot plots shown are representative of n=3 transfections. The mean of 
three data sets was taken and the values shown in the corresponding quadrant ± 
SEM. * indicates significance with p<0.05. 
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Figure 52. CSN5 knockdown has no significant effect on propidium
iodide+ve:annexin V-ve staining.
The histogram shown is representative of the propidium iodide staining within the 
annexin V negative fraction of n=3 vector controls (light grey in fill) and CSN5 
knockdowns (black line) day 6 post transfection. 
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shVC shCSN5
LC3-II
β-actin
Figure 53. CSN5 knockdown has no effect on the level of the autophagy 
marker protein LC3-II. 
Transfected cells were harvested day 4 post transfection, protein extracted and 
LC3-II protein levels in vector control and CSN5 knockdown cell extracts 
determined by western blot. Even loading was determined by β-actin western 
blot. The image shown is of three independent vector control and CSN5 
knockdown transfections. Note that the exposure time used to generate figure 31 
was 1 minute whilst the exposure time used here was much longer (12 hours). 
This longer exposure time was used here to permit detection of LC3-II in both 
vector control and CSN5 knockdown cells, whilst the short exposure time was 
used previously in figure 31 to show the clear accumulation of LC3-II in shCSN2 
cells. 
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Chapter 5.0: 
Analysis of the effect of CSN2 and CSN5 
knockdown on CSN complex integrity 
 179
5.1 Introduction  
 
The knockdown of CSN2 and CSN5 in K562 cells produced distinct phenotypes despite 
having comparable effects on cullin deneddylation. Similar findings have been reported 
previously in organisms such as S. pombe (Mundt et al., 2002) and Drosophila (Oron et 
al., 2002). The authors of these manuscripts suggested that the divergent phenotypes may 
be attributable to the fact that CSN subunits may function in distinct subcomplexes 
(Mundt et al., 2002) or may be due to the activity of a retained CSN complex (lacking 
CSN5) in the absence of CSN5 (Oron et al., 2002). In order to assess this possibility in 
K562 cells, a 2-dimensional gel technique was optimised for the study of the intact CSN 
complex and any CSN subcomplexes in shCSN2 and shCSN5 cells. A CSN subcomplex 
was identified in cells lacking CSN2 whilst shCSN5 cells were shown to retain the CSN 
complex and lose only monomeric CSN5. The contribution of these identified complexes 
to the phenotype of shCSN2 and shCSN5 cells was assessed by CSN2/CSN5 double 
knockdown experiments.      
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5.2 Results 
 
5.2.1 Optimisation of the 2-Dimensional NativePAGE/SDS-PAGE gel electrophoresis 
protocol 
 
A 2-D gel analysis technique was developed, in which proteins were separated in their 
native, complexed state in the first dimension, to enable assessment of the effect of CSN 
subunit knockdown on CSN complex integrity. In order to ensure that any variation in 2-
D gel analysis was minimal, it was important to determine the effect of freezing either a 
cell pellet or protein extract prior to use in 2-D gel analysis, relative to the use of fresh 
cell lysate. To this end, three aliquots of K562 cells were harvested and, from one pellet, 
native proteins were extracted (fresh lysate, figure 54), whilst the second pellet was 
frozen for two weeks and then native proteins extracted from the thawed pellet (frozen 
pellet, figure 54). Finally, protein was extracted from the third pellet and the lysate frozen 
for a two week period (frozen lysate, figure 54). The distribution of CSN5 containing 
protein complexes within these samples was then analysed by 2-D gel analysis and CSN5 
western blot analysis (figure 54). From these analyses it was determined that, at this 
exposure time of 10 minutes, CSN5 occurred only in complexes of approximately 
550kDa and greater in the fresh lysate and frozen pellet samples, whereas CSN5 occurred 
in smaller complexes (<480kDa) in the frozen lysate (figure 54). This data indicates that 
the use of cell lysate from a frozen cell pellet has no significant effect on native protein 
complexes relative to fresh lysate. However, the process of freezing and thawing cell 
lysate results in the significant degradation of protein complexes. Therefore, in order to  
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Figure 54. Optimisation of the 2-Dimensional NativePAGE gel protocol. 
Three aliquots of 1x106 K562 cells were harvested. Native protein was extracted 
from the first pellet for immediate use (top panel). The second pellet was snap 
frozen in liquid nitrogen and native protein extracted from the thawed pellet two 
weeks later for immediate use (middle panel). Native protein was extracted from 
the third pellet immediately, the protein frozen and then thawed two weeks later 
for use (lower panel). CSN5 distribution in these samples was determined by 2-
Dimensional Native-PAGE/SDS-PAGE and western blot analysis. 
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minimise any sample variation which may potentially have occurred frozen lysates were 
not used for native gel analysis.  
 
5.2.2 Determination of the effect of CSN2 knockdown on CSN complex integrity 
 
In order to determine the effect of CSN2 knockdown on CSN complex integrity, vector 
control and CSN2 knockdown cells were harvested day 3 post transfection, native 
proteins extracted and the distribution of CSN2 amongst cellular protein complexes 
determined by 2-D gel and western blot analysis. Figure 55 demonstrates that in CSN2 
knockdown cells there was significant loss of CSN2 from the CSN complex (~500kDa) 
and super complexes (~700kDa) relative to vector controls. Therefore, to study CSN 
complex formation in the absence of CSN2, the distribution of CSN5 containing 
complexes was assessed in vector control and CSN2 knockdown cell extracts. CSN5 
protein was also lost from the CSN complex in CSN2 knockdowns (figure 56), indicating 
the loss of the intact CSN complex in the absence of CSN2.  
 
As the loss of CSN5 protein from the CSN complex did not result in a concomitant 
increase in monomeric CSN5 (figure 56), the possibility of an effect of CSN2 loss on the 
level of CSN5 was investigated. Cells were harvested day 6 post transfection, protein 
extracted and CSN5 western blot carried out. Figure 57A shows that cells lacking CSN2 
have significantly less CSN5 protein relative to vector control cells. Densitometry was 
used to determine that on average cells lacking CSN2 had only 10.4±2.9% CSN5 relative 
to vector control cells (P=0.0001). This loss was also determined at the level of mRNA.  
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Figure 55. CSN2 knockdown results in a significant loss of CSN2 from the 
CSN complex.
Transfected cells were harvested day 3 post transfection and CSN2 distribution in 
vector control and CSN2 knockdown cells determined by 2-Dimensional Native-
PAGE/SDS-PAGE and western blot analysis. Data shown is representative of 
n=3 transfections. β-actin loading controls are also shown.
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Figure 56. CSN2 knockdown results in a significant loss of CSN5 from the 
CSN complex.
Trans fected cells were harvested day 3 post transfection and CSN5 distribution in 
vector control and CSN2 knockdown cells determined by 2-Dimensional Native-
PAGE/SDS-PAGE and western blot analysis. Data shown is representative of 
n=3 transfections. 
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Figure 57. CSN2 knockdown results in a significant reduction of both CSN5 
protein and mRNA.
A, Trans fected cells were harvested day 6 post transfection, protein extracted 
and CSN5 protein levels in vector control and CSN2 knockdown cells determined 
by western blot. Even western blot loading was determined by β-actin western 
blot. The image shown is of three independent vector control and CSN2 
knockdown transfections. B, Mock, vector control and CSN2 knockdown 
transfected cells were harvested day 6 post transfection, RNA extracted, cDNA
generated and QRT-PCR carried out. Data shown is the mean CSN5 mRNA 
expression relative to mock transfected cells of n=3 transfections ±SEM.              
* indicates p<0.05.
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The level of CSN5 mRNA in vector control cells did not differ from that of mock 
transfected cells, whereas CSN2 knockdown cells had a significant reduction in CSN5 
mRNA of ~50% (P=0.011) relative to vector control transfected cells (figure 57B).   
 
Interestingly, a longer exposure of the western blot in figure 56 demonstrated the 
formation of a CSN5 containing subcomplex (~242kDa) in cells lacking CSN2, which 
was not apparent in vector control cells (figure 58). Cumulatively, these data suggest that 
the loss of CSN2 results in the loss of the intact CSN complex, formation of a CSN5 
containing CSN subcomplex, and loss of CSN5. Thus, these data are indicative of a role 
for CSN2 in CSN complex integrity.  
 
5.2.3 Assessment of the effect of CSN2/5 double knockdown on CSN subcomplex 
formation and the occurrence of autophagy 
 
The occurrence of a CSN5 containing subcomplex in the absence of CSN2 raised the 
possibility that the difference between the phenotypes of CSN2 and CSN5 knockdown 
cells is a consequence of the activity of this subcomplex in cells lacking CSN2. If this 
were the case, then loss of both CSN2 and CSN5 should not be associated with 
autophagy. To investigate this possibility, CSN2/CSN5 double knockdown was 
attempted in K562 cells by triple transfection of cells with HKK, shCSN2 and shCSN5 
plasmids. Efficient double knockdown was confirmed by QRT-PCR which demonstrated 
97.2% loss of CSN2 mRNA (P=0.001; figure 59) and 87.1% loss of CSN5 mRNA 
(P=0.005; figure 59) relative to vector controls.  
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Figure 58. CSN2 knockdown results in the formation of a CSN5 containing 
CSN subcomplex.
Transfected cells were harvested day 3 post transfection and CSN5 distribution in 
vector control and CSN2 knockdown cells determined by 2-Dimensional Native-
PAGE/SDS-PAGE and western blot analysis. Data shown is representative of 
n=3 transfections. This is the same blot as in figure 56. However, the exposure 
time in figure 56 was 30 minutes whilst the exposure time here was 12 hours.  
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Figure 59. Determination of CSN2 and CSN5 mRNA knockdown in double 
knockdown cells.
Vector control and CSN2/CSN5 double knockdown transfected cells were 
harvested day 6 post trans fection, RNA extracted, cDNA generated and QRT-
PCR carried out. Data shown is the mean CSN2/CSN5 mRNA expression relative 
to vector control transfected cells of n=3 transfections ±SEM. * indicates p<0.05.
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The distribution of CSN5 in double knockdown cells was determined by 2-D gel and 
western blot analysis of native proteins extracted from vector control and double 
knockdown cells harvested day 3 post transfection. As observed in CSN2 knockdown 
cells, a significant reduction in the amount of the intact CSN complex was observed in 
double knockdown cells relative to vector control cells (figure 60A). However, a CSN5 
containing subcomplex could not be detected in double knockdown cells (figure 
60A).This finding was made with a 12 hour film exposure time as used to detect 
subcomplex formation in cells lacking CSN2 (figure 58). These data imply that, unlike 
CSN2 knockdown cells, cells lacking both CSN2 and CSN5 do not form a CSN5 
containing subcomplex.  
 
In order to determine the effect of CSN2/5 double knockdown on cell morphology, 
double knockdown cell cytospins were made day 6 post transfection and Jenner-Giemsa 
stained. Interestingly, this analysis demonstrated a vesicular morphology of a proportion 
of double knockdown cells (figure 60B); a morphology comparable to that of CSN2 
knockdown cells (figure 30A). This data suggests that the morphology associated with 
the loss of CSN2 is not a consequence of the activity of a CSN5 containing subcomplex. 
It should also be noted that within the double knockdown population a subset of cells also 
have what appears to be the same morphology as CSN5 knockdown cells (figure 60B).    
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Figure 60. Cells lacking both CSN2 and CSN5 do not form CSN5 containing 
subcomplexes but do have a mixed phenotype associated with the loss of 
these subunits.
A, Transfected cells were harvested day 3 post transfection and CSN5 
distribution in vector control and double knockdown cells determined by 2-
Dimensional Native-PAGE/SDS-PAGE and western blot analysis. Data shown is 
representative of n=3 trans fections. B, Cytospins were stained by Jenner-Giemsa
for visualisation of vector control and double knockdown cell morphology day 6 
post transfection. The images shown are representative of n=3 transfections. 
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5.2.4 Determination of the effect of CSN5 knockdown on CSN complex integrity 
 
In order to determine the effect of CSN5 knockdown on CSN complex integrity, vector 
control and CSN5 knockdown cells were harvested day 3 post transfection, native 
proteins extracted and the distribution of CSN5 amongst cellular protein complexes 
determined by 2-D gel and western blot analysis. Surprisingly, this analysis demonstrated 
that CSN5 knockdown had no significant effect on the level of CSN5 within the intact 
CSN complex (figure 61). Indeed, quantitative analysis of 2-D gels investigating the 
distribution of CSN5 in CSN2 and CSN5 knockdowns relative to vector controls 
indicates significant loss of the intact CSN complex in cells lacking CSN2 (P=0.015), 
whilst also demonstrating that CSN5 loss had no significant impact on the intact CSN 
complex (figure 62; P=0.619). However, interestingly CSN5 knockdown resulted in the 
significant loss of the free form of CSN5 (37kDa; figure 63). These observations were 
surprising given the finding of apparent complete CSN5 protein loss by SDS-PAGE 
western blot (figure 40). This finding raised the possibility that the RIPA buffer 
extraction used for SDS-PAGE failed to extract the entire cellular pool of CSN5. To 
investigate this possibility, vector control and shCSN5 transfected cells were harvested 
day 3 post transfection and proteins extracted using either the RIPA buffer extraction 
protocol or by directly boiling the harvested cell pellet in SDS gel loading buffer. 
Determination of the level of CSN5 protein in these samples by western blot analysis 
demonstrated that RIPA buffer does not appear to extract the entire cellular pool of CSN5 
(figure 64). Together, these data suggest that only the monomeric form of CSN5 may be 
present in RIPA buffer protein extractions.  
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Figure 61. CSN5 knockdown has no significant effect on CSN5 within the 
intact CSN complex.
Trans fected cells were harvested day 3 post transfection and CSN5 distribution in 
vector control and CSN5 knockdown cells determined by 2-Dimensional Native-
PAGE/SDS-PAGE and western blot analysis. Data shown is representative of 
n=3 transfections. 
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Figure 62. CSN2 knockdown results in a significant reduction of the intact 
CSN complex, whist CSN5 knockdown has no significant effect on the 
intact CSN complex.
Trans fected cells were harvested day 3 post transfection and CSN5 distribution in 
vector control, CSN2 knockdown and CSN5 knockdown cells determined by 2-
Dimensional Native-PAGE/SDS-PAGE and western blot analysis. Densitometry 
was carried out on these membranes and data plotted as average percentage of 
intact CSN complex relative to vector control ±SEM. * indicates p<0.05. Data 
shown is representative of n=3 transfections. 
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Figure 63. CSN5 knockdown results in loss of the free form of CSN5.
Trans fected cells were harvested day 3 post transfection and CSN5 distribution in 
vector control and CSN5 knockdown cells determined by 2-Dimensional Native-
PAGE/SDS-PAGE and western blot analysis. Data shown is representative of 
n=3 transfections. 
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CSN complex formation in CSN5 knockdown cells was further studied by assessment of 
CSN2 integration into the CSN complex in the absence of CSN5. There appears to be no 
significant difference in CSN2 incorporation into either the CSN complex or 
supercomplexes in CSN5 knockdown cells relative to vector controls (figure 65). 
Furthermore, conversely to the observation regarding CSN5 loss in CSN2 knockdown 
cells, there appeared to be no effect on the level of CSN2 protein in CSN5 knockdown 
cells. This was confirmed by western blot analysis. Cells were harvested day 4 post 
transfection, protein extracted and CSN2 levels determined by western blot. Figure 66A 
demonstrates that vector control cells and CSN5 knockdown cells contained similar 
amounts of CSN2 protein, with densitometry confirming that there was indeed no 
significant difference in the level of CSN2 protein in vector control and shCSN5 cell 
lysates (P=0.587). In addition, determination of the level of CSN2 mRNA by QRT-PCR 
in vector control and CSN5 knockdown cells demonstrated that there was no significant 
effect of CSN5 loss on the quantity of CSN2 mRNA in cells lacking CSN5 relative to 
vector controls (figure 66B; P=0.861).  
 
Collectively, 2-D gel analyses of CSN2 and CSN5 knockdown samples demonstrated that 
loss of these subunits differentially affects CSN complex and CSN subunit stability, and 
that the half life of monomeric CSN5 protein is significantly shorter than that of CSN 
complex bound CSN5 protein.     
 196
sh
VC
sh
CS
N
5
sh
VC
sh
CS
N
5
RIPA Whole cell
CSN5
β-actin
Figure 64. RIPA buffer does not extract the entire cellular CSN5 pool.
Trans fected cells were harvested day 3 post transfection and protein extracted 
using either RIPA buffer extraction or by boiling the cell pellet in gel loading 
buffer. The level of CSN5 protein in these samples was determined by western 
blot and even gel loading determined by β-actin western blot.
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Figure 65. CSN5 knockdown has no significant effect on CSN2 integration 
into the CSN complex. 
Trans fected cells were harvested day 3 post transfection and CSN2 distribution in 
vector control and CSN5 knockdown cells determined by 2-Dimensional Native-
PAGE/SDS-PAGE and western blot analysis. Data shown is representative of 
n=3 transfections. 
12
36
10
48
72
0
48
0
24
2
14
6
6612
36
10
48
72
0
48
0
24
2
14
6
66
 198
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Figure 66. CSN5 knockdown has no significant effect on the level of CSN2 
protein or mRNA.
A, Trans fected cells were harvested day 4 post transfection, protein extracted 
and CSN2 protein levels in vector control and CSN5 knockdown cells determined 
by western blot. Even western blot loading was determined by β-actin western 
blot. The image shown is of three independent vector control and CSN5 
knockdown transfections. B, Mock, vector control and CSN5 knockdown 
transfected cells were harvested day 4 post transfection, RNA extracted, cDNA
generated and QRT-PCR carried out. Data shown is the mean CSN2 mRNA 
expression relative to mock transfected cells of n=3 transfections ±SEM. 
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Chapter 6.0: 
Expression of wild-type and 
deneddylase dead CSN5 in shCSN5 
expressing cells 
 200
6.1 Introduction 
 
The results of the double knockdown study clearly indicated that the shCSN2 and 
shCSN5 associated phenotypes cannot be explained by the activity of a CSN5 containing 
subcomplex or remnant CSN complex, respectively. However, the findings of the 2-D gel 
analyses suggested that the CSN5 associated phenotype may occur as a result of the loss 
of monomeric CSN5 function. If this were the case then re-expression of deneddylase 
dead CSN5 which retains monomeric function would rescue the shCSN5 cell phenotype 
to the same extent as wild-type CSN5. In order to test this hypothesis, both wild-type and 
deneddylase dead CSN5 were re-expressed in a shCSN5 background and the rescue of 
the shCSN5 cell phenotype assessed. Unfortunately, due to time constraints, these 
experiments are only n=1, but they do provide interesting preliminary insights into the 
potential basis of the shCSN5 cell phenotype.  
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6.2 Results 
 
6.2.1 Preparation of plasmids 
 
The entire CSN5 protein coding sequence was amplified (figure 67) using CSN5 primers 
designed to include a BamHI and EcoRI restriction site, along with a GCAG cap, at the 
5’ end of the forward and reverse primers, respectively. The CSN5 coding sequence PCR 
product was purified, and this insert and pcDNA3.1 (+) vector digested with the 
restriction enzymes BamHI and EcoRI, the digestion products ligated and the ligation 
verified (figure 68A). The ligation reaction product was transformed into dH5α and 
plated onto ampicillin containing agar plates. Colonies were screened by BamHI/EcoRI 
digestion of miniprep plasmid DNA and separation of digestion products by 
electrophoresis (figure 68B). Correct insertion of CSN5 coding sequence was verified by 
sequencing of plasmid DNA (figure 68C).  
 
Site-directed mutagenesis was used to incorporate four silent mutations into the shRNA 
target sequence in the CSN5 coding sequence in pcDNA3.1-CSN5. This resulted in a 
mutated CSN5 expression plasmid which produces CSN5 mRNA which is not targeted 
for degradation by the CSN5 targeting shRNA, but also produces CSN5 protein with 
unaltered amino acid sequence. The mutation of four bases within the shRNA sequence 
was confirmed by plasmid sequencing (figure 69A). This plasmid was then used in a 
second round of plasmid mutation with a set of primers designed to generate a point 
mutation which resulted in aspartic acid 151 replacement with asparagine, culminating in  
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Figure 67. Amplification of CSN5 coding sequence.
The whole coding sequence (1004 bases) of CSN5 was amplified from Oligo dT
cDNA using pre-designed primers and Accuzyme.
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Figure 68. CSN5 re-expression pla smid preparation and validation.
(A) BamHI and EcoRI digested pcDNA3.1 vector and CSN5 coding sequence 
were ligated and the products separated by electrophoresis on a 1% agarose gel 
along with a vector only negative control to determine ligation. (B) Empty 
pcDNA3.1 and pcDNA3.1 plus insert were digested with BamHI and EcoRI and 
products separated by electrophoresis on a 1% agarose gel to determine plasmid 
insertion. (C) pcDNA3.1 plus insert was sequenced to determine the correct 
insertion. 
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Base mutations Point mutation
Figure 69. Determination of CSN5 re-expression plasmid shRNA sequence 
and deneddylation dead mutations.
Plasmid sequencing was carried out in order to determine that the required 
mutations of the CSN5 shRNA sequence (A) and the D151N mutation (B) were 
achieved.   
A B
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the production of CSN5 protein lacking deneddylase activity. This point mutation was 
confirmed by plasmid sequencing (figure 69B).  
 
6.2.2 Assessment of CSN5 protein levels 
 
In order to determine the CSN5 protein level in vector control, CSN5 knockdown and 
either wild-type (WT) or deneddylase dead (dd) CSN5 expressing cells, transfected cells 
were harvested day 7 post transfection, protein extracted and quantified and CSN5 
protein level assessed by western blot. The level of CSN5 protein was reduced in CSN5 
knockdown cells, whilst transfection of cells with shCSN5 plasmid plus either wild-type 
or deneddylase dead CSN5 expression plasmid rescued the level of CSN5 protein (figure 
70A). Quantitative analysis of this western blot demonstrated greater than 80% CSN5 
protein loss in shCSN5 cells and restoration of CSN5 protein level to a level comparable 
to that seen in vector control cells in both wild-type and deneddylase dead CSN5 re-
expressing cells (figure 70B).     
 
6.2.3 Assessment of the cumulative growth of cells expressing CSN5 in a shCSN5 
background 
 
Transfected cells were counted daily, the cumulative growth calculated and the data 
plotted as a line and dot plot. Expression of neither wild-type nor deneddylase dead 
CSN5 in shCSN5 expressing cells restored the cumulative growth to that of vector 
control cells (figure 71A). However, cells expressing either wild-type or deneddylase  
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Figure 70. CSN5 protein expression in a shCSN5 background.
(A) Transfected cells were harvested day 7 post transfection, protein extracted 
and CSN5 protein levels in vector control, CSN5 knockdown and both wild-type 
(+WT) and deneddylase dead (+dd) CSN5 re-expression cell extracts determined 
by western blot. Even loading was determined by β-actin western blot. (B) 
Densitometry was carried out on the CSN5 western blot and the percentage of 
CSN5 in CSN5 knockdown, WT CSN5 expressing and dd CSN5 expressing cells 
relative to vector control cells calculated and plotted.  
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Figure 71. Expression of either wild-type or deneddylase dead CSN5 
partially rescues cell growth.
Cell counts were taken daily and the cumulative growth calculated. The 
cumulative growth of wild-type CSN5 expressing and deneddylase dead CSN5 
expressing cells is shown relative to CSN5 knockdown cumulative cell growth in 
the presence (A) or absence (B) of the vector control cell cumulative growth 
curve. 
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dead CSN5 had a greater cumulative growth than that of shCSN5 cells at the latest time 
point investigated (day 6 post transfection; figure 71B). Given that this data is n=1 these 
findings should be interpreted with caution, and it is possible that this difference may 
hold no significance. Alternatively, the expression of either wild-type or deneddylase 
dead CSN5 in a shCSN5 background may have partially rescued cumulative cell growth 
relative to CSN5 knockdown cells by day 6 post transfection (figure 71B). If this were 
the case, the deneddylase dead form of CSN5 would appear to rescue the cumulative cell 
growth to the same extent as wild-type CSN5 (figure 71B). Importantly, the partial rescue 
of cell growth upon re-expression of either form of CSN5 is supported by the 
observations made regarding the morphology of cells in which either wild-type or 
deneddylase dead CSN5 is re-expressed (see below).   
  
6.2.4 Assessment of the morphology of cells expressing CSN5 in a shCSN5 background 
 
In order to compare the morphology of cells lacking CSN5 with cells expressing either 
wild-type or deneddylase dead CSN5, cytospins were made of transfected cells day 4 post 
transfection and these cytospins Jenner-Giemsa stained. Visualisation of this staining 
suggested that there may be fewer cells containing disorganised, fragmented DNA in 
cells expressing either form of CSN5 compared to shCSN5 cells (figure 72A). In order to 
confirm this initial observation, cell counts were taken from six fields of each slide and 
the average percentage of cells with aberrant nuclear staining calculated and plotted ± 
SEM. Less than 1% of vector control cells had aberrant nuclear staining, whilst almost 
20% of cells lacking CSN5 contained fragmented, disorganized DNA (figure 72B;  
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Figure 72. Expression of either wild-type or deneddylase dead CSN5 
reduces the proportion of cells with disorganised, fragmented DNA.
(A) Cytospins were stained by Jenner-Giemsa for visualisation of cell morphology 
day 4 post transfection. (B) Counts were taken from Jenner-Giemsa stained 
cytospins of the number of cells containing aberrant nuclear staining per 100 
cells. The data shown is the average count of 6 fields per slide ± SEM. * indicates 
p<0.05. 
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P=1.69x10-7). Expression of either wild-type or deneddylase dead CSN5 resulted in a 
significant reduction of cells with aberrant nuclear staining (9.5% P=0.0002 and 8.8% 
P=9.3x10-5, respectively), although, in accordance with the partial rescue of cell growth, 
neither wild-type nor deneddylase dead CSN5 rescued this phenotype completely (figure 
72B).    
 
6.2.5 Assessment of the effect of CSN5 protein expression in a shCSN5 background on 
SCFSkp2 activity  
 
In order to determine the effect on SCFSkp2 activity of wild-type and deneddylase dead 
CSN5 expression in a shCSN5 background, vector control, CSN5 knockdown and either 
wild-type or deneddylase dead CSN5 expressing cells were harvested, protein extracted 
and quantified and Nedd8, Skp2 and p27 protein levels assessed by western blot. CSN5 
knockdown resulted in the accumulation of a Nedd8 bound protein which migrated at a 
rate corresponding to that of neddylated Cul1 (figure 73A). Expression of wild-type 
CSN5 restored the level of what was predicted to be neddylated Cul1 to a level 
comparable to that of vector control cells (figure 73A). However, as would have been 
predicted, expression of deneddylase dead CSN5 failed to reduce the level of neddylated 
protein (figure 73A). Quantitative analysis of this western blot demonstrated a 4 fold 
increase in the level of supposed neddylated Cul1, which is restored by wild-type, but not 
deneddylase dead, CSN5 (figure 73B).  
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Figure 73. Expression of wild-type CSN5, but not deneddylase dead CSN5, 
restores Cul1 deneddylation. 
(A) Transfected cells were harvested day 3 post transfection, protein extracted 
and Nedd8-Cul1 protein levels in vector control, CSN5 knockdown and both wild-
type (+WT) and deneddylase dead (+dd) CSN5 re-expression cell extracts 
determined by western blot. β-actin western blot was used as a loading control. 
(B) Densitometry was carried out on the Nedd8 western blot and the percentage 
of Nedd8-Cul1 in CSN5 knockdown, WT CSN5 expressing and dd CSN5 
expressing cells relative to vector control cells calculated and plotted.  
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The level of Skp2 protein in vector control, shCSN5 and either wild-type or deneddylase 
dead CSN5 re-expressing cells was then determined by western blot. At an earlier time 
point, day 3 post transfection, both wild-type and deneddylase dead CSN5 protein 
expression rescued the Skp2 protein loss observed in CSN5 knockdown cells (figure 74). 
However, by day 7 post transfection, rescue of Skp2 protein was only observed in wild-
type CSN5 expressing cells, with deneddylase dead CSN5 expressing cells having a Skp2 
protein level comparable to that of CSN5 knockdown cells (figure 75). Finally, the level 
of p27 was determined by western blot. As determined previously, CSN5 knockdown 
resulted in the accumulation of p27 protein (figure 76). Interestingly, by day 7 post 
transfection, expression of neither wild-type nor deneddylase dead CSN5 reduced the 
level of p27 protein to that of vector control cells (figure 76).     
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Figure 74. Expression of either wild-type or deneddylase dead CSN5 
rescue s Skp2 protein day 3 post transfection.
Trans fected cells were harvested day 3 post transfection, protein extracted and 
the level of Skp2 protein in vector control, CSN5 knockdown and both wild-type 
(+WT) and deneddylase dead (+dd) CSN5 re-expression cell extracts determined 
by western blot. β-actin western blot was used as a loading control.
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Figure 75. Expression of wild-type, but not deneddylase dead, CSN5 
rescues Skp2 protein day 7 post transfection.
(A) Transfected cells were harvested day 7 post transfection, protein extracted 
and the level of Skp2 protein in vector control, CSN5 knockdown and both wild-
type (+WT) and deneddylase dead (+dd) CSN5 re-expression cell extracts 
determined by western blot. β-actin western blot was used as a loading control. 
(B) Densitometry was carried out on the Skp2 western blot and the percentage of 
Skp2 in CSN5 knockdown, WT CSN5 expressing and dd CSN5 expressing cells 
relative to vector control cells calculated and plotted.  
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Figure 76. Expression of either wild-type or deneddylase dead CSN5 fails to 
restore the basal level of p27 protein.
Trans fected cells were harvested day 7 post transfection, protein extracted and 
the level of p27 protein in vector control, CSN5 knockdown and both wild-type 
(+WT) and deneddylase dead (+dd) CSN5 re-expression cell extracts determined 
by western blot. β-actin western blot was used as a loading control.
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Chapter 7.0: 
General discussion 
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This study investigated the function and potential regulation of the CSN in the 
haematopoietic cell line and CML model, K562. Highly efficient knockdown of CSN2 
and CSN5 was achieved, with both knockdowns resulting in aberrant CRL activity and 
the sequential loss of F-box proteins. However, the phenotypes of the knockdowns were 
distinct. CSN2 loss resulted in autophagy inhibition and non-apoptotic cell death, whilst 
loss of CSN5 resulted in a mitotic block, aberrant mitotic spindle formation and apoptotic 
cell death. The intact CSN complex was shown to be lost in cells lacking CSN2, and a 
CSN5 containing subcomplex formed. The possible dependence of the CSN2 knockdown 
associated phenotype on the activity of this subcomplex was ruled out. Conversely, the 
intact CSN complex was shown to persist in CSN5 knockdown cells, with loss of only 
monomeric CSN5. Re-expression of either wild-type or deneddylase dead CSN5 in 
shCSN5 cells partially rescued the CSN5 knockdown associated phenotype.     
 
7.1 CSN subunit knockdown results in aberrant CRL activity 
  
The achievement of almost complete CSN2 and CSN5 knockdown in this study has 
provided a powerful tool to study the function of these subunits and the CSN complex in 
K562 cells. At the molecular level, CSN2 and CSN5 knockdowns resulted in identical 
aberrant SCF activity. This complements another report in which CSN4 and CSN5 
knockdown also resulted in increased neddylation of Cul-1 with a concomitant loss of 
Skp2 and increase in p27 protein in human epithelial cell lines rather than haemopoietic 
cells (Denti et al., 2006). Similar cullin hyperneddylation and aberrant CRL activity as a 
result of CSN subunit loss has also been observed in other organisms such as mice 
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(Lykke-Andersen et al., 2003), A. thaliana (Stuttmann et al., 2009) and S. pombe (Wee et 
al., 2005). The instability of cullin proteins has also been demonstrated in other 
organisms including Drosophila (Wu et al., 2005) and Neurospora (He et al., 2005). Thus 
it appears that the CSN complex has CRL regulatory activities which are conserved 
between organisms and across cells from different cell lineages, and that disruption of the 
complex by loss of any subunit causes derangement of CRL activity.   
 
7.2 Targeting the CSN results in the sequential loss of F-box proteins  
 
The finding that F-box protein levels were at least partially restored in both knockdowns 
upon treatment with the proteasome inhibitor MG132 are in accordance with the finding 
that F-box proteins are autocatalytically degraded in the presence of hyperneddylated 
Cul-1 (Cope and Deshaies, 2006). However, this study has been the first to identify the 
sequential loss of F-box proteins following knockdown of CSN subunits. This is of great 
interest as it may explain published results which document the loss of particular F-box 
proteins at a specific time point post CSN manipulation, but no reduction in other F-box 
proteins (Cope and Deshaies, 2006, Su et al., 2008).  
 
There are at least two explanations for the sequential loss of F-box proteins. First, given 
that binding of F-box proteins to the SCF has been suggested to be competitive (Patton et 
al., 1998, Bosu and Kipreos, 2008), it is possible that the rapid loss of Skp2 reflects high 
Skp2 expression in K562 cells and therefore preferential binding of Skp2 to the SCF. In 
support of this, the level of Skp2 mRNA in K562 was found to be greater than that of 
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Cdc4 and β-TrCP (data not shown). This finding was not surprising given that the fusion 
protein associated with CML, BCR-ABL, has been shown to induce Skp2 expression 
(Andreu et al., 2005). On the other hand, Cdc4 and β-TrCP were found to be expressed at 
the same level in K562 (data not shown). The disparate rates of Cdc4 and β-TrCP protein 
loss may be attributable to the potentially different affinities of these F-box proteins for 
the SCF. However, an alternative explanation is that some F-box proteins, such as β-
TrCP, may not be as susceptible to autocatalytic degradation. Recently, a similar 
hypothesis has been put forward regarding the Drosophila β-TrCP homolog, Slimb 
(Knowles et al., 2009). In favour of this is the finding herein that whilst β-TrCP mRNA 
was reduced day 4 post transfection in CSN5 knockdown cells the level of β-TrCP 
protein was unaltered, suggesting that this protein is relatively stable. If this were the case 
then it is possible that SCFβ-TrCP activity is retained in CSN subunit knockdowns, as 
presented by E.Bianchi at the recent Zomes symposium (Pick and Pintard, 2009), at early 
time points post transfection. Although further work would be necessary to test this 
hypothesis, the findings to date give rise to the possibility that the CSN may function in 
determining SCF target specificity in human cells, as has been postulated in Drosophila 
(Doronkin et al., 2003, Harari-Steinberg et al., 2007, Knowles et al., 2009).   
 
7.3 The CSN and F-box protein/CSN subunit transcription  
 
Both CSN2 and CSN5 knockdown resulted in temporal alterations to F-box protein 
mRNA. Further, CSN2 knockdown was associated with a significant loss of CSN5 
mRNA. Together with other recent reports (Su et al., 2008, Ullah et al., 2007), these data 
 220
suggest that the CSN complex may have a direct role in the transcriptional regulation of 
CSN subunits and F-box proteins, independent of CSN deneddylase activity. For 
instance, it is possible from the findings regarding Skp2 mRNA levels in both CSN2 and 
CSN5 knockdown cells that the intact CSN complex functions directly in the 
transcriptional activation of Skp2. In support of this, the identical effect of CSN2 and 
CSN5 loss on SCFSkp2 activity suggests that the different rates of Skp2 mRNA reduction 
observed between the knockdowns most likely results from the loss of a deneddylase 
independent function of the CSN complex. The same can also be said for the alterations 
in Cdc4 and β-TrCP mRNA levels. In addition, the slower rate of Skp2 mRNA loss in 
shCSN5 cells relative to shCSN2 cells may reflect a delayed loss of the intact CSN 
complex in these cells. Although this would further implicate the CSN in the deneddylase 
independent regulation of transcription, the stability of the intact CSN complex in 
shCSN5 cells at a later time point (such as day 6 post transfection) remains to be 
experimentally determined.  
 
It is important to note that the altered mRNA levels observed may be an indirect result of 
the aberrant degradation of proteins which may occur upon loss of other CSN functions 
such as protein phosphorylation and deubiquitination. In addition, the contribution of 
CSN subcomplexes or the CSN independent functions of CSN2 and CSN5 to the altered 
mRNA levels of Skp2, Cdc4 and β-TrCP cannot be ruled out. To further investigate the 
possibility that the CSN complex directly regulates CSN subunit and F-box protein 
transcription, chromatin immunoprecipitation (ChIP) could be used to determine 
promoter binding. MG132 and curcumin, which inhibit the proteasome and CSN 
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associated kinases respectively, could also be used to assess any contribution of aberrant 
protein degradation or CSN associated protein phosphorylation to altered CSN subunit or 
F-box protein mRNA levels.      
 
7.4 CSN2 knockdown  
 
This is the first study to show an association between the CSN complex and autophagy. 
The phenotype of K562 cells in which CSN2 had been knocked down included features 
of autophagy, and treatment of K562 cells with autophagy inhibitors recapitulated this 
phenotype. These findings suggest that CSN2 knockdown in K562 cells causes an 
arrested autophagic process resulting ultimately in cell death. 
 
The autophagy inhibition and mitotic defects which arose from the loss of CSN2 and 
CSN5, respectively, raised the question of why knockdown of two subunits of the same 
complex should result in divergent phenotypes? It was predicted that the disparate 
consequences of CSN2 and CSN5 knockdown may be attributable to the effect of the 
knockdowns on the intact CSN complex, as has been postulated for the divergent 
phenotypes observed in Drosophila CSN4 and CSN5 mutations (Oron et al., 2002, Oron 
et al., 2007). Initially, CSN2 knockdown was shown to result in significant loss of the 
intact CSN complex and CSN5 protein. Interestingly, cells lacking CSN2 were also 
shown to be associated with the formation of a CSN5 containing subcomplex. It was thus 
postulated that the phenotype of shCSN2 cells may arise as a result of aberrant CSN5 
activity within this subcomplex. However, a significant number of double knockdown  
 222
shCSN2 shCSN5
CSN CSN CSN5
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?
Figure 77. Diagram depicting the possible consequences of CSN2 or CSN5 
loss for the functions of the intact CSN complex.
Diagram to show that in CSN2 knockdown cells, in which the CSN complex is 
lost, all functions of the intact CSN are likely to be lost. Further, CSN5 knockdown 
cells, which retain the intact CSN complex until at least day 3 post transfection
but lose monomeric CSN5, may retain both deneddylase independent 
deubiquitinase and CSN associated kinase functions. It is thus postulated here 
that the inhibition of autophagy occurs as a result of the loss of a deneddylase
independent function of the CSN, whilst the CSN5 associated phenotype is 
mediated by loss of a CSN independent function of CSN5.   
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cells lacking both CSN2 and CSN5, in which this subcomplex was not detected, 
demonstrated a vacuolar morphology comparable to that of shCSN2 cells. These findings 
indicate that the phenotype of shCSN2 cells is not attributable to the function of this 
CSN5 containing subcomplex.  
 
As the intact CSN complex was lost in CSN2 targeted cells, it is possible that the CSN2 
knockdown phenotype is attributable to the loss of a function of the intact CSN complex. 
However, as both CSN2 and CSN5 knockdowns appear to have the same affect on CRL 
activity it seems unlikely that the shCSN2 associated phenotype occurs as a result of the 
loss of cullin deneddylation. Rather, autophagy inhibition may occur due to the loss of a 
deneddylase independent function of the intact CSN complex such as protein 
phosphorylation or deubiquitination (figure 77). These functions are possibly retained in 
shCSN5 cells with the retention of the intact CSN complex until at least day 3 post 
transfection (figure 77), thus potentially giving rise to the divergent phenotypes observed. 
Alternatively, the inhibition of autophagy may be a consequence of the loss of CSN2 
monomer function. In order to discern between these two possibilities, CSN2 re-
expression studies should be carried out.    
 
7.5 CSN5 knockdown 
 
Previous studies in Drosophila (Oron et al., 2002), Arabidopsis (Dohmann et al., 2005) 
and HeLa cells (Peth et al., 2007a) have demonstrated the retention of a high molecular 
weight complex in the absence of CSN5. However, this is the first study to demonstrate 
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the longevity of the intact CSN complex including CSN5 in CSN5 knockdown cells. 
Initially, these data suggested that the shCSN5 associated phenotype may occur as a 
result of an activity of the surviving CSN complex. However, this was proven to be 
unlikely with the finding that a proportion of double knockdown cells, which lack the 
intact CSN complex, demonstrated a morphology comparable to that of shCSN5 cells.  
 
Although the level of CSN complex bound CSN5 was unaltered in shCSN5 cells at day 3 
post transfection, a significant proportion of monomeric CSN5 was lost. This indicates 
that complex bound and monomeric CSN5 have different half lives, with CSN5 
potentially being protected from degradation when bound to the CSN complex. This 
finding also led to the hypothesis that the phenotype of CSN5 targeted K562 cells is 
mediated by the loss of a CSN complex independent function of CSN5. In support of this, 
Tomoda and colleagues demonstrated that a 22% CSN5 protein knockdown in K562 
cells, which did not affect the level of the intact CSN, resulted in a similar cell cycle 
profile to that reported here, with loss of cells from the S phase of the cell cycle and an 
accumulation of cells in the G2M phase (Tomoda et al., 2005). In order to test this 
hypothesis both wild-type and deneddylase dead CSN5 were expressed in a shCSN5 
background. Although performed only once, the cumulative growth and cell morphology 
data together suggest that re-expression of either WT or dd CSN5 rescues the CSN5 
knockdown phenotype to the same extent, independently of their ability to restore cullin 
deneddylation and rescue Skp2 protein. Together with the finding that shCSN5 cells 
retain the intact CSN complex and thus potentially the deneddylase independent 
functions associated with the CSN, these results suggest that the shCSN5 associated 
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phenotype most likely occurs as a result of the loss of a CSN independent function of 
CSN5.  
 
CSN5 knockdown was associated with reduced cell proliferation and apoptosis. These 
data complement previous studies demonstrating that CSN5 loss inhibits proliferation and 
induces apoptosis (Panattoni et al., 2008, Fukumoto et al., 2006). Closer analysis of 
CSN5 knockdown cells identified a G2/M cell cycle arrest and abnormal mitotic spindles.  
Microtubule stability (Peth et al., 2007b, Pintard et al., 2003) and progression through the 
G2/M phase of the cell cycle (Dohmann et al., 2008, Li et al., 2009) have been shown to 
be dependent on CSN deneddylase activity (Dohmann et al., 2008, Pintard et al., 2003) or 
CSN associated kinase activity (Li et al., 2009, Peth et al., 2007b). However, as the 
phenotype associated with the loss of CSN5 is most probably attributable to the loss of 
monomeric CSN5 function the precise mechanism accounting for the observed phenotype 
remains to be determined.    
 
It is important to note that both CSN2 and CSN5 have been shown to function in distinct 
subcomplexes (Mundt et al., 2002, Tomoda et al., 2002) and that CSN5 has been shown 
to function within a CSN subcomplex in K562 (Tomoda et al., 2005). Although such 
subcomplexes were not consistently detected in the NativePAGE/SDS-PAGE studies, the 
possible contribution of either the CSN independent function of CSN2 or CSN 
subcomplexes to the phenotypic differences observed between the knockdowns cannot be 
ruled out. Indeed, Tomoda and colleagues have published data to suggest that the loss of 
a CSN subcomplex in K562 cells results in a similar cell cycle profile to that 
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demonstrated here for shCSN5 K562 cells (Tomoda et al., 2005). However, importantly 
this study does not document the effect of CSN5 knockdown on monomeric CSN5 and 
thus does not rule out the possible contribution of monomeric CSN5 function to this cell 
cycle profile.   
 
7.6 CSN5 re-expression results in partial rescue of the shCSN5 phenotype 
 
It should be noted that expression of neither WT nor dd CSN5 rescued the shCSN5 
phenotype fully, even though the CSN5 protein level was comparable to that of vector 
control day 7 post transfection. This could be explained if CSN5 protein was found to be 
initially lost relatively rapidly in response to shRNA expression whereas vector-driven 
CSN5 re-expression only fully restored CSN5 protein at a later time point. In favour of 
this possibility, only partial rescue of Skp2 was observed day 3 post transfection, and 
although Skp2 protein was rescued day 7 post transfection, CSN5 re-expression failed to 
rescue p27 protein at this time point. However, further work would be needed to test this 
hypothesis. Such work may include earlier time point analysis of CSN5 protein, and an 
extended time course to confirm whether the re-expression of CSN5 restores p27 protein 
level and continues to rescue cumulative cell growth and cell morphology at later time 
points at which shCSN5 knockdown is lethal.   
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7.7 ddCSN5 expression rescues Skp2 protein levels 
 
It is interesting to note that dd CSN5 expression was also found to rescue Skp2 protein 
levels. Although the incorporation of dd CSN5 into the CSN complex has not been 
demonstrated here, the incorporation of mutant CSN5 into the CSN complex has been 
described previously (Cope et al., 2002). It is thus possible that the expression of dd 
CSN5 resulted in increased deneddylase independent CSN associated deubiquitinase 
activity. Such an activity may reverse Skp2 autoubiquitination within the SCF and thus 
prevent the autocatalytic degradation of Skp2, thereby rescuing Skp2 protein. However, 
the deneddylase independent deubiquitination of Skp2 by the CSN would have to be 
demonstrated in order to verify this possibility.  
 
7.8 A novel mechanism of CSN deneddylase activity regulation?  
 
An important observation made here is that although the intact CSN complex was 
retained in shCSN5 cells until at least day 3 post transfection, SCFSkp2 activity was found 
to be aberrant at this time point. Intriguingly, this data suggests that the sustained 
deneddylase activity of the CSN complex may be dependent on the availability of 
monomeric CSN5. This finding gives rise to a novel potential mechanism of CSN 
deneddylase activity regulation in which CSN5 subunit refreshment may be required for 
continued cullin deneddylation. If this were the case, the absence of monomeric CSN5 
would inhibit the deneddylase activity of the CSN, as is suggested by the findings of this 
study. However, in order to directly test this hypothesis the deneddylase activities of both 
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the shCSN5 and vector control CSN complex should be compared both in the presence 
and absence of recombinant CSN5.  
 
7.9 The CSN and CML 
 
Overall, the data presented here suggest that the CSN complex/CSN subunits may be 
viable targets in the treatment of CML. For instance, as ectopic CSN5 expression results 
in a myeloproliferative disorder resembling CML (Mori et al., 2008), the finding of a 
lethal phenotype of shCSN5 K562 cells implies that CSN5 may be a novel target in CML 
treatment. The modulation of autophagy in combination with imatinib as a possible CML 
treatment has been reported (Bellodi et al., 2009, Burchert et al., 2005, Dengler et al., 
2005). In particular, imatinib treatment of both CML cell lines and primary CML cells 
has been shown to induce BCR-ABL dependent autophagy as a survival mechanism. 
Autophagy inhibition was subsequently shown to potentiate imatinib induced cell death 
in CML cell lines, primary CML cells and importantly, the CML stem cell population 
(Bellodi et al., 2009). This study together with the finding of CSN2 knockdown induced 
autophagy inhibition suggest that targeting CSN activity in combination with imatinib 
treatment may represent a novel treatment in CML. However, a significant amount of 
work would be required in order to verify the CSN as a novel target in CML, including 
studies into the effect of CSN subunit knockdown on primary CML cells and their non-
malignant counterparts. Further, it would be of interest to determine the precise 
mechanism of autophagy inhibition in shCSN2 cells and mitotic defects in shCSN5 cells 
in order to allow more specific targeting of CSN function in CML.      
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Abstract
Background: The COP9/signalosome (CSN) is a highly conserved eight subunit complex that, by
deneddylating cullins in cullin-based E3 ubiquitin ligases, regulates protein degradation. Although
studied in model human cell lines such as HeLa, very little is known about the role of the CSN in
haemopoietic cells.
Results: Greater than 95% knockdown of the non-catalytic subunit CSN2 and the deneddylating
subunit CSN5 of the CSN was achieved in the human myeloid progenitor cell line K562. CSN2
knockdown led to a reduction of both CSN5 protein and mRNA whilst CSN5 knockdown had little
effect on CSN2. Both knockdowns inhibited CSN deneddylase function as demonstrated by
accumulation of neddylated Cul1. Furthermore, both knockdowns resulted in the sequential loss
of Skp2, Cdc4 and β-TrCP F-box proteins. These proteins were rescued by the proteasome
inhibitor MG132, indicating the autocatalytic degradation of F-box proteins upon loss of CSN2 or
CSN5. Interestingly, altered F-box protein gene expression was also observed in CSN2 and CSN5
knockdowns, suggesting a potential role of the CSN in regulating F-box protein transcription.
Loss of either CSN subunit dramatically reduced cell growth but resulted in distinct patterns of cell
death. CSN5 knockdown caused mitotic defects, G2/M arrest and apoptotic cell death. CSN2
knockdown resulted in non-apoptotic cell death associated with accumulation of both the
autophagy marker LC3-II and autophagic vacuoles. Treatment of vector control K562 cells with the
autophagy inhibitors 3-methyladenine and bafilomycin A1 recapitulated the growth kinetics,
vacuolar morphology and LC3-II accumulation of CSN2 knockdown cells indicating that the cellular
phenotype of CSN2 cells arises from autophagy inhibition. Finally, loss of CSN2 was associated with
the formation of a CSN5 containing subcomplex.
Conclusion: We conclude that CSN2 is required for CSN integrity and the stability of individual
CSN subunits, and postulate that CSN2 loss results in a phenotype distinct from that of cells lacking
CSN5 possibly as a consequence of altered CSN5 activity within a resultant CSN subcomplex. Our
data present the first evidence for the sequential loss of F-box proteins upon CSN manipulation
and are the first to identify a potential link between CSN function and autophagy.
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The regulated expression and degradation of proteins are
critical to all aspects of cell development and prolifera-
tion. The two main routes for eukaryotic intracellular pro-
tein clearance are the ubiquitin-proteasome system (UPS)
and the autophagy-lysosome pathway. A key component
involved in regulating degradation of proteins by the UPS
is the COP9 signalosome (CSN). The CSN is an eight-sub-
unit (CSN1-8) protein complex, highly conserved
amongst eukaryotes [1-5] originally identified in Arabi-
dopsis as a negative regulator of photomorphogenesis [6].
Through its function in the regulation of the UPS, the CSN
has been implicated in the regulation of biological proc-
esses as diverse as DNA replication and repair, cell-cycle
progression and cell development [7-9].
Degradation of cellular proteins by the 26S proteasome
[10-13] is preceded by ubiquitination of target proteins
[14], a process mediated by three enzyme complexes; a
ubiquitin activating enzyme (E1), a ubiquitin conjugating
enzyme (E2) and a ubiquitin ligase (E3) [15]. The E3
ligase interacts with the protein substrate and thus confers
the specificity of the UPS [16]. The largest known class of
E3 ubiquitin ligases comprises the Cullin-RING ligases
(CRLs) of which the best studied is the SCF (Skp1, Cul1,
F-box protein) complex [16]. The cullin subunit (Cul1) of
the SCF forms a scaffold to recruit and bring into close
proximity the E2 and its substrate, thereby facilitating
ubiquitin transfer from the E2 to target proteins (SCF
structure reviewed in [16]). The RING protein (Hrt1/
Roc1/Rbx1) is the fourth subunit of the SCF and is respon-
sible for E2 recruitment, whilst the variable F-box protein
subunit, recruited to the SCF complex via the adaptor pro-
tein Skp1, binds substrates selectively [17-19]. In yeast,
over 19 F-box proteins are known, over 400 in A. thaliana,
and ~70 in humans [16]. Since each cullin (Cul1-5) forms
complexes with a variable substrate recognition subunit
(SRS) (F-box proteins for Cul1 as above, VHL box proteins
for Cul2, BTB proteins for Cul3, WD40 proteins for Cul4
and SOCS box proteins for Cul5, reviewed in [20]) specif-
icity in CRL target protein recruitment is achieved by the
large number of variable SRS containing CRLs. It is
thought that, altogether, the human genome may have
the capacity to code for as many as 350 different CRLs.
Given the potential number and diversity of target pro-
teins requiring CRL mediated ubiquitination for degrada-
tion, dynamic regulation of the CRL complex repertoire in
a cell at any given time is essential. All cullins studied
(Cul1-5) have been shown to be modified by neddylation
[21], which facilitates their ubiquitin ligase activity [22]
possibly via increased E2 affinity [23,24]. The deneddyla-
tion of cullins is mediated by the CSN complex [25].
Although initial studies indicated a negative role for
deneddylation, further studies have implicated dened-
dylation in the positive regulation of CRL activity [3,4,26].
It has since been proposed by several groups that optimal
CRL activity requires the cyclic neddylation and dened-
dylation of the cullin subunit [4,7,27]. Although the exact
mechanisms are not fully understood, it is thought that F-
box proteins themselves are targeted for degradation in
part by autoubiquitination within the SCF complex [28].
The deneddylation of cullins by the CSN is believed to
regulate the autoubiquitination of SRSs [28,29], thereby
modulating CRL composition and activity. Furthermore,
the CSN has been shown to be associated with a deubiq-
uitinase activity which may further stabilize autoubiquiti-
nated SRSs [27,29]. The CSN complex is therefore an
integral regulator of CRL activity and subsequent protein
degradation.
In this present study we have investigated the effects of
knocking down CSN2 and CSN5 in the model K562 cell
line, a model of human erythrocyte and megakaryocyte
progenitors [30,31]. Whilst knockdown of either CSN2 or
CSN5 resulted in common changes including the sequen-
tial loss of F-box proteins Skp2, Cdc4 and β-TrCP other
important differences occurred. For example CSN5 knock-
down resulted in apoptotic cell death associated with
aberrant mitosis, whereas CSN2 knockdown cells under-
went non-apoptotic cell death that was associated with
both inhibition of autophagy and the formation of a
novel CSN5 containing CSN subcomplex.
Results
CSN2 and CSN5 knockdown and resulting aberrant SCF 
activity
Plasmids encoding short hairpin RNA (shRNA) to either
CSN2 or CSN5 were electroporated into K562 cells
together with H-2Kk plasmid and transfected cells sorted
by anti- H-2Kk magnetic beads. Three days post transfec-
tion, neither CSN2 nor CSN5 protein could be detected by
western blot analysis in their respective knockdown pro-
tein extracts (Fig. 1A). Furthermore, CSN2 knockdown of
over 99% and CSN5 knockdown of over 95% was
achieved at the mRNA level relative to mock transfectants
as measured by quantitative real-time PCR (QRT-PCR)
(Fig. 1B). This level of knockdown was maintained
throughout the time course of the experiments (data not
shown). Transfection with either the H-2Kk plasmid alone
or co-transfection with H-2Kk plasmid and empty vector
(shVC) had no effect on the level of CSN2 or CSN5 mRNA
or protein relative to mock transfected cells (Fig. 1A &1B
and data not shown). Co-transfections with H-2Kk and a
vector encoding a control scrambled shRNA sequence had
no effect on the level of CSN2 or CSN5 mRNA or protein
relative to cells co-transfected with empty vector (Addi-
tional file 1), demonstrating that the results were specific
and not due to off-target effects.Page 2 of 12
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BMC Cell Biology 2009, 10:31 http://www.biomedcentral.com/1471-2121/10/31The instability of particular CSN subunits in the absence
of another subunit has been reported previously. For
example, CSN8 knockdown has been shown to result in
the loss of CSN3, CSN5 and CSN7 protein [32]. We there-
fore determined CSN5 and CSN2 protein levels in CSN2
and CSN5 knockdown cells, respectively, by western blot-
ting. A significant reduction in CSN5 protein was
observed in cells lacking CSN2, whilst depletion of CSN5
had no effect on CSN2 protein or mRNA levels relative to
vector control cells (Fig. 1C and data not shown). Interest-
ingly, CSN2 knockdown not only resulted in loss of CSN5
protein, but also in the significant reduction of CSN5
mRNA as determined by QRT-PCR (Fig. 1D, P = 0.011).
Consistent with previous studies of CSN deregulation
[28,33], both CSN2 and CSN5 knockdowns were associ-
ated with accumulation of neddylated Cul1 (Fig. 1E) indi-
cating functional dysregulation of the CSN following
knockdown of either subunit. Studies demonstrating
Cul1 hyperneddylation in CSN deficient cells have also
demonstrated degradation of the F-box protein Skp2
[28,33]. In agreement with these observations, complete
loss of Skp2 protein was observed in both the CSN2 and
CSN5 knockdown cells (Fig. 1E). Skp2 binds to and medi-
ates the ubiquitination of multiple proteins, including the
cyclin dependent kinase inhibitor p27kip1 [34]. Consistent
with loss of Skp2, knockdown of CSN2 and CSN5
resulted in the accumulation of p27 (Fig. 1E).
Loss of CSN2 and CSN5 results in the sequential loss of F-
box proteins
Skp2 is one of many F-box proteins that can bind to the
Cul1/Roc1/Skp1 complex, thereby altering the substrate
specificity of the SCF (F-box proteins reviewed in [19]).
Analysis of three such F-box proteins, Skp2, Cdc4 and β-
TrCP revealed a sequential loss of protein in CSN2 and
CSN5 knockdown cells (Fig. 2A &2B and Additional file 1,
part D). In CSN2 knockdown cells, Skp2 protein was
reduced by ~60% by day 2 and over 90% by day 6,
whereas Cdc4 was lost at a slower rate with 30–40% lost
by day 3 increasing to ~70% by day 6 (Fig. 2B). Loss of β-
TrCP was still more retarded with ~70% protein remain-
ing at day 6 (Fig. 2B). By day 9, all three F-box proteins
were undetectable in CSN2 knockdown cells (Fig. 2A).
Similar sequential loss of F-box proteins was observed in
CSN5 knockdown cells. At day 4 post transfection Skp2
protein could not be detected, Cdc4 protein was greatly
reduced but remained detectable, and β-TrCP was largely
unaffected (Additional file 1, part D).
In order to determine the mechanism of F-box protein
loss in both CSN2 and CSN5 knockdown cells, we inves-
tigated the rescue of F-box proteins by the proteasome
CSN2 and CSN5 knockdowns result in Cul-1 hyperneddyla-tion, loss of Skp-2 and accumulation of p27Figure 1
CSN2 and CSN5 knockdowns result in Cul-1 hyper-
neddylation, loss of Skp-2 and accumulation of p27. 
K562 cells were transiently transfected in the absence of 
plasmid DNA (mock), with pMACS Kk.II plasmid alone 
(HKK) or transiently co-transfected with HKK plasmid 
together with either vector control (shVC), CSN2 knock-
down (shCSN2) or CSN5 knockdown (shCSN5) plasmid. 
HKK positive cells were sorted 24 hours post-transfection, 
re-cultured and harvested for analysis. (A) CSN2 (left) and 
CSN5 (right) protein knockdown was determined by west-
ern blot in three independent transfectants. (B) mRNA levels 
in vector control and knockdown cells were determined by 
QRT-PCR (CSN2, left, P = 0.0012; CSN5, right, P = 
0.000031). Data represents 3 independent sets of triplicate 
transfections. (C) CSN5 and CSN2 protein levels were 
determined by western blot in n = 3 CSN2 (top) and CSN5 
(bottom) knockdowns, respectively. (D) CSN5 mRNA levels 
in n = 3 vector control and CSN2 knockdown cells were 
determined by QRT-PCR (P = 0.011). (E) The level of Cul1 
neddylation (top panels, † indicates neddylated Cul-1), Skp2 
protein (second panels) and p27 protein (third panels) was 
determined in n = 3 shCSN2 (left) and shCSN5 (right) sam-
ples by western blot. Even gel loading was determined by β-
actin signal. Graphical data indicates the mean ± s.e.m. * indi-
cates significance with a p value of less than 0.05.
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BMC Cell Biology 2009, 10:31 http://www.biomedcentral.com/1471-2121/10/31inhibitor MG132 (Fig. 2C) and measured the levels of F-
box mRNA over time (Fig. 2D &2E). Treatment of both
CSN2 and CSN5 knockdown cells with MG132 resulted
in Skp2, Cdc4 and β-TrCP protein rescue (Fig. 2C), indi-
cating involvement of the proteasome in the loss of these
F-box proteins. However the strength of the observed res-
cue varied. Importantly, CSN subunit depletion also
affected levels of F-box mRNA. CSN2 knockdown resulted
in a significant reduction of Skp2 mRNA by day 2 post
transfection. Thus it is likely that transcriptional changes
also contribute to loss of Skp2 protein in these cells. In
contrast Cdc4 and β-TrCP mRNAs were significantly
increased following CSN2 knockdown despite clear loss
of protein (Fig. 2D). CSN5 depletion resulted in a modest
reduction of all three F-box protein mRNAs but not
enough to account for the observed loss of protein (Fig.
2E). Collectively these data indicate that, with the possi-
ble exception of Skp2 in CSN2 knockdown cells, proteas-
omal degradation rather than transcriptional repression
was the main driver of F-box protein loss in CSN2 and
CSN5 knockdown K562 cells.
Both CSN2 and CSN5 knockdowns result in reduced cell 
growth and cell death
Knockdown of either CSN2 or CSN5 dramatically dimin-
ished cell proliferation, followed by loss of cell viability
(Fig. 3A). Analysis of cumulative growth demonstrated
that proliferation of cells lacking CSN2 was significantly
reduced when compared to that of shVC cells by day 4
post transfection (Fig. 3A, P = 0.034), whilst loss of prolif-
eration following CSN5 knockdown was even more
marked (Fig. 3A insert, P = 0.0023). This difference in
diminished proliferation was corroborated by measure-
ment of thymidine incorporation. At day 3 post-transfec-
tion, there was no significant difference in the
incorporation of tritiated thymidine into cellular DNA
between shVC and CSN2 knockdown (Fig. 3B) whereas
the CSN5 knockdown cells already had markedly reduced
thymidine incorporation (Fig. 3C, P = 0.0012). However,
by day 5 the CSN2 knockdown cells also had a significant
decrease in thymidine incorporation (Fig. 3B, P = 0.0072)
which decreased even further by day 7 (P = 1.1 × 10-5).
Thus, although the changes in Cul1 neddylation and F-
box protein levels are very similar between the CSN2 and
CSN5 knockdowns, differences were apparent in the
growth kinetics of the cells.
Knockdown of CSN5 but not CSN2 is associated with cell 
cycle arrest and defects in mitotic spindle formation
Cell cycle analyses revealed striking differences between
the profiles of CSN2 and CSN5 knockdown cells. Despite
leading to significantly reduced cell proliferation, loss of
CSN2 did not affect the cell cycle distribution of K562
cells as compared to shVC K562 cells by day 6 post trans-
fection (Fig. 4A). Given the significantly reduced cell
numbers in CSN2 knockdown by day 6, this would sug-
gest that these cells are growing more slowly, rather than
arresting at any stage in the cell cycle. In contrast, CSN5
knockdown resulted in a reduction in cells in G1 (25.7%
compared to shVC 35.5%, P = 0.0044), loss of cells from
S phase (21% compared to shVC 45.7%, P = 3.4 × 10-5)
and accumulation in G2/M (33.5% compared to shVC
15.7%, P = 0.0011) by day 4 post transfection (Fig. 4A).
Morphological analysis of Jenner-Giemsa stained CSN5
knockdown cells identified a significant number of large
cells which appeared to be arrested in late mitosis with
chaotically organized condensed chromosomes (Fig. 4B).
Cells of these morphologies were not observed in either
shVC (Fig. 4B) or CSN2 knockdown (Fig. Six A) cells. To
investigate this morphology further, shCSN5 cells were
immunostained for tubulin. As can be seen in Fig. 4C,
shVC cells retained the ability to form a mitotic spindle
and correctly aligned chromosomes at various stages of
mitosis were observed. In striking contrast, cells lacking
CSN5 demonstrated either aberrant or absent microtu-
bule structures. In these cells, the condensed chromatids
appeared to be either misaligned or indeed not associated
with the spindle structures at all (Fig. 4C). This aberrant
cellular phenotype is in accordance with cell cycle arrest at
G2/M.
Knockdown of CSN5 but not CSN2 results in apoptotic cell 
death
In order to determine whether the subsequent loss of via-
bility in CSN2 and CSN5 knockdown cells was due to
apoptosis, cells were co-analysed for annexin V staining
and propidium iodide uptake day 7 and day 6 post trans-
fection, respectively (Fig. 5A). Annexin V binds phos-
phatidylserine, a phospholipid which is translocated from
the inner to the outer leaflet of the plasma membrane dur-
ing early apoptosis. Propidium iodide is taken up by all
cells but is efficiently effluxed by viable cells, whereas
dead/dying cells remain PI-positive. In accordance with
the marked increase in the sub-G1 fraction of shCSN5
cells (Fig. 4A), knockdown of CSN5 lead to significant
increases in both early apoptotic (annexin V+ve:PI-ve) (21.9
± 1.8%, P = 0.0015) and late apoptotic (annexin
V+ve:PI+ve) cells (42.3 ± 2.5%, P = 0.0006) compared to
shVC cells (5.9 ± 1.9% and 5.5 ± 2.2%, respectively; Fig.
5A). Furthermore, CSN5 knockdown cells demonstrated
cleavage of caspase 9 (Fig. 5B), consistent with death by
apoptosis in these cells. In marked contrast, CSN2 knock-
down showed only a relatively small increase in annexin
V positive cells (5.5 ± 0.8% and 12.5 ± 0.9%, respectively;
Fig. 5A) and no caspase 9 activation (Fig. 5B). Instead, the
CSN2 knockdown cells demonstrated increased retention
of PI in the annexin V-ve cell population (Fig. 5C, P = 3.3 ×
10-5). This large shift in PI single-positivity relative to
shVCs was not observed in CSN5 knockdown cells (Fig.
5A &5C). Thus knockdown of CSN2 in K562 cells did not
result in overt apoptosis. Taken together these data indi-
cate that knockdown in K562 cells of CSN5, but notPage 4 of 12
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BMC Cell Biology 2009, 10:31 http://www.biomedcentral.com/1471-2121/10/31CSN2, resulted in apoptotic cell death and that loss of cell
viability in the CSN2 knockdowns was likely to be by a
non-apoptotic mechanism.
CSN2 but not CSN5 knockdown is associated with 
autophagy
Whilst culturing the transfectants, marked differences in
cell morphology were noted in the CSN2 knockdown
cells. Jenner-Giemsa staining of cytospins identified large
vacuoles in a significant proportion of CSN2 knockdown
cells which were not present in either shVC or shCSN5
cells (Fig. 6A). Staining with the autophagosome/
autophagic vacuole marker monodansylcadaverine
(MDC, [35]) identified these large vacuoles as autophagic
bodies (Fig. 6B). Moreover, western blotting identified a
highly significant accumulation of the autophagy associ-
ated LC3-II protein [36] in CSN2 knockdown cells relative
to shVC cells (Fig. 6C). In contrast, no increase of LC3-II
was detected in CSN5 knockdown cells. To demonstrate
this we used a prolonged exposure (12 hours) of autora-
diographs that allowed detection of basal expression of
LC3-II in shVC cells and demonstrated that this was not
increased in shCSN5 knockdown cells (Fig. 6C). Thus,
knockdown of CSN2, but not CSN5, appeared strongly
associated with autophagy. However, LC3-II accumula-
tion can occur as a result of either enhanced autophagy or
inhibition of autophagy dependant LC3-II degradation
[37]. Indeed, treatment of vector control cells with the
autophagy inhibitor 3-methyladenine (3-MA) resulted in
a growth pattern almost identical to that of shCSN2 cells,
whilst having a relatively small additional effect on
shCSN2 cells (Fig. 6D). Furthermore, treatment of vector
control cells with the late stage autophagy inhibitor
bafilomycin A1 recapitulated both the vacuolar morphol-
ogy (Fig. 6E) and the LC3-II protein accumulation (Fig.
6F) observed in cells lacking CSN2 (Fig. 6A &6C). These
observations suggest that CSN2 knockdown is associated
with the inhibition of autophagy.
Loss of CSN2 results in the formation of an alternative 
CSN5 containing complex
The above data indicate that knockdown of CSN2 or
CSN5 in K562 cells results in common derangement of
SCF activity as measured by accumulation of hyperned-
dylated Cul1, accumulation of p27 and the sequential loss
of Skp-2, cdc4 and β-TrCP. However, the cellular
responses to CSN2 or CSN5 knockdown were markedly
different. Since it has previously been shown that deple-
tion of individual subunits can destabilize the CSN holo-
complex [38-40] we reasoned that one explanation for the
differences between CSN2 and CSN5 knockdown cellular
responses may be due to the generation, in CSN2 knock-
downs, of CSN5 containing CSN subcomplexes with
altered activities. To investigate this, 2-dimensional native
gel electrophoresis was performed on knockdown cells
day 3 post transfection (Fig. 7).
Immunoblotting of extracts from shVC cells with either
CSN2 or CSN5 antibody identified 2 major complexes,
one of approximately 500 KDa, correlating in size with
the CSN holocomplex, and the second of 750 KDa (Fig.
7A &7B). A multitude of proteins have been shown to
associate with CSN subunits [41] and larger complexes
have previously been observed. Monomeric CSN2 and
CSN5 were also observed in the shVC cell extracts (Fig. 7C
Loss of CSN2 and CSN5 results in sequential loss of F-box proteinsFigure 2
Loss of CSN2 and CSN5 results in sequential loss of 
F-box proteins. K562 cells were transiently co-transfected 
with HKK plasmid together with either shVC, shCSN2 or 
shCSN5 plasmid. HKK positive cells were sorted 24 hours 
post-transfection and cells re-cultured. (A) shVC and 
shCSN2 cells were harvested day 6 and 9 post transfection 
and the level of Skp2, Cdc4, β-TrCP and β-actin protein 
determined by western blot. (B) The level of Skp2, Cdc4 and 
β-TrCP proteins (normalised for loading using β-actin) in 
shCSN2 at each time point was normalised to expression in 
shVC cells and the data plotted as the mean ± s.e.m. (C) 
shVC, shCSN2 and shCSN5 cells were treated with DMSO 
(control) or the proteasome inhibitor MG132 (10 μM) for 
the final 18 hours of culturing and the level of Skp-2, Cdc4, β-
TrCP and β-actin protein determined by western blot. (D, E) 
The level of Skp2, Cdc4 and β-TrCP mRNA in shCSN2 (D) 
and shCSN5 (E) cells was determined at each time point post 
transfection relative to expression in vector control scram-
ble cells by QRT-PCR. Data shown is the mean ± s.e.m of n 
= 3 transfections. * indicates a significant difference to vector 
controls with a p value of less than 0.05.
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BMC Cell Biology 2009, 10:31 http://www.biomedcentral.com/1471-2121/10/31and data not shown). Following knockdown of CSN2,
CSN2 protein was no longer detectable (Fig. 7A). CSN5
protein, as also shown in Fig. 1C, was greatly reduced in
cells lacking CSN2, with significant loss of the CSN com-
plex relative to vector controls (Fig. 7B). Interestingly, a
longer exposure of the autoradiograph identified a CSN5
containing subcomplex of ~242 KDa in cells lacking
CSN2 (Fig. 7C).
Discussion
The achievement of almost complete CSN2 and CSN5
knockdown in this study has provided a powerful tool to
study the function of these CSN subunits more closely. At
the molecular level, CSN2 and CSN5 knockdowns
resulted in aberrant SCF activity, with the accumulation of
neddylated Cul-1, loss of the F-box protein Skp2 and an
increase in the Skp2 target protein, p27. This comple-
ments another report in which CSN4 and CSN5 knock-
down also resulted in increased neddylation of Cul-1 with
a concomitant loss of Skp2 and increase in p27 protein in
human epithelial cell lines rather than haemopoietic cells
[33]. Thus it appears that the CSN complex has highly
conserved activities across cells from different cell lineages
and that disruption of the complex by loss of any subunit
causes derangement of these activities.
It was also observed that CSN2 knockdown not only
results in loss of CSN5 protein but also results in a signif-
icant reduction of CSN5 mRNA. Moreover, both CSN2
and CSN5 knockdown resulted in temporal alterations of
F-box protein mRNA. Together with other recent reports
[32,42], this data suggests that CSN subunits or the CSN
complex as a whole may have a direct role in transcrip-
tional regulation of CSN subunits and F-box proteins.
However, it is also possible that the altered mRNA levels
observed are due to secondary effects of aberrant CRL
mediated protein degradation such as accumulation of
proteins involved in transcriptional regulation.
Here we show for the first time sequential loss of F-box
proteins following knockdown of CSN subunits. Moreo-
ver, protein levels were at least partially restored in both
knockdowns upon treatment with the proteasome inhib-
itor MG132. These observations are in accordance with
the finding that F-box proteins are autocatalytically
degraded in the presence of hyperneddylated Cul-1 [28].
However, the three f-box proteins studied were each lost
at a different rate, with the loss of Skp2 protein being the
most rapid. The sequential loss of F-box proteins is of
great interest as it may explain published results which
document the loss of particular F-box proteins at a specific
time point post CSN manipulation, but no reduction in
other F-box proteins [28,32].
The CSN5 knockdown cultures contained aberrantly large
cells and were associated with G2/M arrest and apoptosis.
This data complements previous studies demonstrating
that CSN5 loss inhibits proliferation and induces apopto-
sis [43-45]. Closer analysis of CSN5 knockdown cells
identified disorganized condensed chromatids and
abnormal mitotic spindles in the large cells. A recent
report described stabilization of the microtubule end-
binding protein 1 (EB1) by the CSN complex in human
cells [46]. EB1, which is a master regulator of microtubule
dynamics, was shown to bind the CSN via CSN5, and was
also shown to be reduced in cells lacking CSN1 or CSN3
[46]. EB1 has recently been shown to directly interact with
and regulate the activity of Aurora B, one essential compo-
nent of the chromosomal passenger complex that is
required for correct chromosomal alignment and spindle
assembly checkpoint [47,48]. Furthermore, the dynamic
behaviour of Aurora B on mitotic chromosomes has been
shown to be regulated by a Cul3 E3 ligase [48]. Given that
we observed hyperneddylated Cul3 in the CSN5 knock-
down cells (data not shown), our data suggests that
CSN5/the CSN complex is integral to the regulation of
multiple components of the mitotic machinery.
K562 cells in which CSN2 had been knocked down did
not display apoptosis markers as in CSN5 knockdown
cells, but were instead associated with features of
autophagy. Interestingly, autophagy inhibitors recapitu-
lated the cell growth kinetics, vacuolar morphology and
LC3-II accumulation of cells lacking CSN2, whilst treat-
ment of CSN2 knockdown cells with one of these inhibi-
tors (3-MA) had a comparatively mild effect on cell
growth. These findings suggest that CSN2 knockdown
K562 cells undergo autophagy inhibition resulting in
non-apoptotic cell death. This is the first data to show an
association between the CSN complex and autophagy.
The distinct phenotypes observed between CSN2 and
CSN5 knockdowns may arise as a result of aberrant CSN5
activity within the observed CSN subcomplex in cells lack-
ing CSN2. However, it is important to note that both the
CSN subunits studied here have CSN independent func-
tions [49-54], and that CSN5 has been shown to function
within a CSN subcomplex in K562 [55]. Therefore, we
cannot rule out the possible contribution of the inde-
pendent functions of CSN2 and CSN5 to the phenotypic
differences observed between the knockdowns. It is also
noteworthy that the subcomplex observed in this study
may be a result of CSN complex breakdown in the
absence of CSN2 [54], rather than a functional complex
contributing to the observed phenotypic differences
between knockdowns. Moreover, as we see no effect of
CSN5 loss on the level of CSN2 protein, one possibility
not investigated here is the formation of a CSN2 contain-
ing subcomplex in the absence of CSN5. This is an intrigu-
ing possibility, particularly given the recent findings of Su
et al who demonstrated an increase in the proportion of
CSN2 residing in mini-complexes upon CSN8 knock-Page 6 of 12
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cise mechanism accounting for the divergent phenotypes
encountered here, and is something which is currently
under investigation.
Conclusion
In conclusion, we have shown that loss of either CSN2 or
CSN5 in human K562 cells results in significant loss of
viability but by very different mechanisms, potentially
attributable to the formation of a CSN5 containing sub-
complex in the absence of CSN2. Furthermore, we have
provided data to suggest a possible function of the CSN
complex in the transcriptional regulation of both its own
components and CRL subunits. Finally, we have demon-
strated here for the first time the sequential loss of F-box
proteins in the absence of the CSN complex and have pro-
vided the first evidence of a link between the CSN com-
plex and autophagy.
Methods
Cell culture and treatments
K562 cells were cultured in RPMI 1640 supplemented
with 100 U/ml penicillin, 100 μg/ml streptomycin and
10% v/v foetal bovine serum (Invitrogen, Gibco) and
maintained at 37°C with 5% CO2. For proteasome inhi-
bition, cells were treated with 10 μM MG132 for the final
18 hours of culturing. For autophagy inhibition, cells
were treated in culture with either 10 mM 3-methylade-
nine from day 3-day 7 post transfection or 1 μM bafilomy-
cin A1 for 48 hours day 5-day 7 post transfection.
shRNA constructs
The shRNA vector used was a modified pcDNA3.1 vector
(pcDNA3.1-H1) developed by Heiko Lickert [56] (kind
gift from Heiner Schrewe) in which the CMV promoter
has been replaced by the human RNAse P RNA H1 pro-
moter [56]. CSN2 and CSN5 silencing sequences were
selected using a siRNA design tool available on
http:www1.qiagen.com/products/genesilencing/custom
siRNA/siRNA designer.aspx and cloned into the Asp718
and XbaI restriction enzyme sites of pcDNA3.1-H1. The
target sequences are as follows:
CSN2 knockdown 5'AAGCGGCATTAAGCAGTTTCC3'
CSN5 knockdown – 5'AAGGGCTACAAACCTCCTGAT3'
shRNA scramble control – 5'AAGCGG GATTCAGTAGT
TACG3'
Transfections and cell sorting
Transfection efficiencies in K562 cells vary between 20–
50%. Therefore, to allow enrichment of transfected cells,
5 × 106 K562 cells were electroporated in Nucleofector kit
V solution (Amaxa) using a Nucleofector I (Amaxa) and
Both CSN2 and CSN5 knockdowns result in reduced cell growthFigure 3
Both CSN2 and CSN5 knockdowns result in reduced 
cell growth. K562 cells were transiently co-transfected with 
HKK plasmid together with either shVC, shCSN2 or 
shCSN5 plasmid. HKK positive cells were sorted 24 hours 
post-transfection and cells re-cultured. (A) Cell counts were 
taken daily and the cumulative growth calculated. The cumu-
lative growth of shCSN2 and shCSN5 cells is shown relative 
to shVC. The insert graph has a different Y scale to highlight 
the differences between shCSN2 and shCSN5 cumulative 
growth profiles. Data shown are the mean ± s.e.m. of n = 3. * 
indicates a significant difference to shVC cell growth with a p 
value of less than 0.05. (B) Thymidine incorporation in 
shCSN2 cells relative to shVC cells was measured day 3, 5 
and 7 post transfection. Data shown are the mean ± s.e.m. of 
n = 3. (C) Thymidine incorporation in shCSN5 cells relative 
to shVC cells was measured day 3 and 4 post transfection. 
Data shown are the mean ± s.e.m. of n = 3. * indicates signif-
icance with a p value of less than 0.05.
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BMC Cell Biology 2009, 10:31 http://www.biomedcentral.com/1471-2121/10/31file T16, with 5 μg pMACS Kk.II and 10 μg of the relevant
knockdown pcDNA3.1-H1 plasmid according to manu-
facturer guidelines. The pMACS Kk.II produces a truncated
murine MHC class I cell surface protein, H-2Kk, which
lacks the cytoplasmic domain and is transiently expressed
on the cell surface of transfected cells between 6 and 48
hours post-transfection. Transfected cells were sorted 24
hours post transfection using anti-H-2Kk antibody conju-
gated to magnetic beads, MACS MS columns and a MACS
magnet (Miltenyi Biotec) according to manufacturer
instructions. Post sorting, cells were set at 3 × 105/ml daily
and cells harvested for protein and mRNA analysis as indi-
cated in results.
Thymidine incorporation assay
2 × 104 cells were pulsed with 2 μCi/ml 3H-thymidine
(Amersham) for the final 18 hours of culture leading up
to each time point. Samples were transferred to a filter mat
(Wallac) using a Skatron cell harvester (Skatron Instru-
ments) and read using a beta-plate scintillation counter
(Skatron Instruments).
Immunofluorescence and Jenner-Giemsa staining
Cytospins were made with 5 × 104 cells in 80 μl, using a
Shandon cytospin 3 (Shandon). For immunofluorescence
staining, cytospins were fixed in 4% paraformaldehyde
and stained using anti-β-tubulin antibody (Sigma, 1/500
dilution) followed by FITC labelled secondary antibody
(Jackson Laboratories, 1/500 dilution). DNA was counter-
stained using Hoescht 33342 (Sigma, 1/1000 dilution).
All reagents were diluted in PBS and slides mounted using
Mowiol (6 g glycerol, 2.4 g Moviol-4-88 (Sigma), 12 ml
0.2 M Tris HCl pH8.5, anti-fade crystal (Sigma), 6 ml dis-
tilled water). Slides were viewed using an Axioskop2
microscope (Zeiss) and images captured with a Q-imaging
12-bit QICAM (Media Cybernetics) and Openlab soft-
ware (Improvision).
For Jenner-Giemsa staining, cytospins were air-dried,
methanol fixed and stained; First with Jenner staining
solution (VWR, UK) diluted 1/3 in 1 mM sodium phos-
phate buffer pH5.6 (5 mins) and second with Giemsa
stain (VWR, UK) diluted 1/20 in 1 mM sodium phosphate
buffer pH5.6 (10 mins). Slides were dried and then
mounted onto coverslips using DePex (VWR, UK). Slides
were viewed with an Olympus BX40 microscope (Olym-
pus) and images captured using an Olympus Chameleon
digital SLR (Olympus).
Staining of autophagosomes
For visualisation of autophagic vacuoles, 5 × 104 cells were
incubated with 0.05 mM monodansylcadaverine (MDC,
Sigma) in 0.5 ml PBS for 10 minutes at 37°C. Cells were
washed four times with PBS, cytospins made as above and
cells viewed immediately using a Leica DMIRE2 system.
Fluorescence flow cytometry
For Annexin V labelling, 1 × 105 cells were stained using
Annexin V-FITC Apoptosis Detection Kit I (BD Bio-
sciences) according to manufacturer instructions, and
staining analysed within 1 hour by flow cytometry. For
cell cycle analysis 1 × 105 cells were resuspended in cell
Cell cycle arrest in CSN5 knockdowns is associated with mitotic defectsFigure 4
Cell cycle arrest in CSN5 knockdowns is associated 
with mitotic defects. K562 cells were transiently co-trans-
fected with HKK plasmid together with shVC, shCSN2 or 
shCSN5 plasmid. HKK positive cells were sorted 24 hours 
post-transfection and cells re-cultured. (A) Representative 
images of shCSN2 (left, dark grey line) and shCSN5 (right, 
dark grey line) cell cycle profiles relative to shVC cells (light 
grey fill). Pie charts show data as the mean ± s.e.m. of n = 3. 
* indicates significance with a p value of less than 0.05. (B) 
Cytospins of shVC and shCSN5 cells were stained by Jenner-
Giemsa day 4 post transfection. (C) Cytospins were immu-
nostained for tubulin (FITC) and Hoescht (blue) for visualisa-
tion of DNA in shVC and shCSN5 cells day 4 post 
transfection. All images shown are representative of n = 3 
transfections.
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chloride, 1% Triton X100) and samples analysed within
24 hours by flow cytometry. All staining was analysed
using a FACS Calibur (Becton Dickinson) and the data
evaluated using Cell Quest Pro software (Becton Dickin-
son).
Western blot analysis
Whole cell lysates were prepared using RIPA buffer (1% v/
v NP40, 0.5% w/v sodium deoxycholate, 0.1% w/v 10%
SDS, in distilled water) and protein quantified using the
Dc protein assay according to manufacturer instructions
(Bio-Rad). Forty micrograms of protein were boiled for 10
minutes in 1× SDS gel loading buffer (15.6 mM Tris HCl
pH6.8, 6.25% v/v glycerol, 0.5% SDS, 1.25% v/v 2-mer-
captoethanol, Bromophenol Blue, in distilled water). Pro-
teins were separated by SDS-PAGE and transferred to
PVDF membrane (Millipore). For western blot analysis,
the following antibodies were used at 1:1000 dilution:
CSN2 (Bethyl), CSN5 (Bethyl), Cul-1 (Zymed), Skp2
(Zymed), p27 (Santa Cruz), caspase-9 (Cell Signalling),
LC-3 (Novus Biologicals) and β-actin (Sigma). Proteins
recognized by these antibodies were detected using ant-
mouse (Sigma, 1/1000 dilution) or anti-rabbit (Pierce, 1/
1000 dilution) HRP conjugated secondary antibody fol-
lowed by enhanced chemiluminescence (SuperSignal
West Pico Chemiluminescent Substrate, Pierce) and auto-
radiography (Kodak X-Omat LS film, Sigma). Quantita-
tive analysis of western blots was carried out using ImageJ
software http://rsb.info.nih.gov/ij/download.html and
protein levels normalized by comparison to β-actin sig-
nals on the same membrane.
2-Dimensional gel analysis
Native protein extracts were obtained from 2.5 × 105 cells
by resuspending cells in 50 μl mild lysis buffer (25% 4×
NativePAGE sample buffer (Invitrogen), 1% digitonin,
10% 10× protease inhibitor, in distilled water). Extracts
were separated out in the first dimension using a
NativePAGE Novex Bis-Tris Gel System (Invitrogen)
according to manufacturer instructions. The gel was then
cut into individual lanes, proteins denatured by incuba-
tion in 1× SDS gel loading buffer and resolved in the sec-
ond dimension by electrophoresis through 12.5% SDS-
polyacrylamide gels. Proteins were transferred to PVDF
membrane (Millipore) and immunoblotting performed
as above.
Quantitative real-time PCR analysis (QRT-PCR)
RNA was extracted using the Qiagen RNeasy kit according
to manufacturer instructions and cDNA generated using 1
μg RNA, random hexamers (Promega) and Superscript II
reverse transcriptase (Invitrogen). Quantitative real-time
PCR was carried out using either TAQMAN or SYBR-Green
based assays. For TAQMAN assays, QRT-PCR was carried
out in duplicate 20 μl reactions containing 1× qPCR Mas-
termix Plus (Eurogentec), 20–40 ng cDNA, 18 pmoles
each primer and 2.5 pmoles FAM/TAMRA dual labeled
probes. For SYBR-Green assays, QRT-PCR was carried out
in duplicate 25 μl reactions containing 1× Sensimix
(Quantace), 20–40 ng cDNA, 9 pmoles each primer, 1×
SYBR-Green solution (Quantace), 4 mM MgCl2 and 0.5
units UNG (Quantace). QRT-PCR was carried out on an
ABI Prism 7000 sequence detector (Applied Biosystems).
The following primers (Sigma Genosys) and FAM/TAMRA
labeled probes (Eurogentec) were used:
CSN2, 5'-CCTCATCCACTGATTATGGGAGT-3' (forward),
5'-CATCATAATTCTTGAAGGCTTCAAAA-3' (reverse),
CSN5, but not CSN2, knockdown results in apoptotic cell deathFigure 5
CSN5, but not CSN2, knockdown results in apoptotic 
cell death. K562 cells were transiently co-transfected with 
HKK plasmid together with either shVC, shCSN2 or 
shCSN5 plasmid. HKK positive cells were sorted 24 hours 
post-transfection and re-cultured. (A) Binding of Annexin V 
and uptake of propidium iodide were analysed by flow 
cytometry. The lower left quadrant encompasses the viable 
population of cells, the lower right quadrant contains early 
apoptotic cells, the upper right quadrant contains late apop-
totic cells and the upper left quadrant contains the necrotic 
cell population. Dot plots shown are representative of n = 3 
transfections. The mean of three data sets was taken and the 
values shown in the corresponding quadrant ± s.e.m. * indi-
cates significance with a p value of less than 0.05. (B) Cells 
were harvested day 6 (shCSN2, top panels) or day 4 
(shCSN5, bottom panels) post transfection and the level of 
caspase-9 cleavage determined by western blot. (C) Propid-
ium iodide uptake was determined day 6 post transfection. 
The histogram shown is representative of n = 3 shVC (light 
grey in fill), shCSN2 (dark grey line) and shCSN5 (black line). 
The significant shift in propidium iodide staining in shCSN2 
cells is shown ± s.e.m. * indicates significance with a p value 
of less than 0.05.
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(probe);
CSN5, 5'-ATATCCGCAGGGAAAG-3' (forward),
5'-GGTCCTTCATCAGGAGGTTTGT-3' (reverse),
5'- TGGCGCCTTTAGGACATACCCAAAGG-3' (probe);
Skp2, 5'-CGCTGCCCACGATCATTT-3' (forward),
5'-CCATGTGCTGTACACGAAAAGG-3' (reverse);
Cdc4, 5'-ACGACGCCGAATTACATCTGT-3' (forward),
5'-ACTCCAGCTCTGAAACATTTTTAGC-3' (reverse);
β-Trcp, 5'-GAGGCATTGCCTGTTTGCA-3' (forward)
5'-TGTCCCATAATCTGATAGTGTTGTCA-3' (reverse)
18S, 5'-GCCGCTAGAGGTGAAATTCTTG-3' (forward),
5'-CATTCTTGGCAAATGCTTTCG-3' (reverse).
Preoptimised primers and probes to 18S ribosomal RNA
were used as internal standards in TAQMAN QRT-PCR
(Applied Biosystems). Cycle threshold (Ct) values were
Loss of CSN2 results in the formation of CSN5 containing CSN subcomplexesFigure 7
Loss of CSN2 results in the formation of CSN5 con-
taining CSN subcomplexes. K562 cells were transiently 
co-transfected with HKK plasmid together with either shVC 
or shCSN2 plasmid. HKK positive cells were sorted 24 hours 
post-transfection, re-cultured and harvested day 3 post 
transfection. Both CSN2 (A) and CSN5 (B, short exposure; 
C, long exposure) distribution in shVC and shCSN2 cells was 
determined by 2-Dimensional Native-PAGE/SDS-PAGE and 
western blot analysis. All data shown is representative of n = 
3 transfections.
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Cells lacking CSN2, but not CSN5, are associated with autophagyFigure 6
Cells lacking CSN2, but not CSN5, are associated 
with autophagy. K562 cells were transiently co-transfected 
with HKK plasmid together with either shVC, shCSN2 or 
shCSN5 plasmid. HKK positive cells were sorted 24 hours 
post-transfection and re-cultured. (A) Jenner-Giemsa staining 
of shVC and shCSN2 cytospins day 6 post transfection. (B) 
shVC and shCSN2 cells were stained with the autophago-
some marker monodansylcadaverine day 6 post transfection. 
All images shown are representative of n = 3 transfections. 
(C) Cells were harvested day 6 (shCSN2, top panels) or day 
4 (shCSN5, bottom panels) post transfection and the level of 
LC3-II protein determined by western blot. Even loading was 
determined by β-actin signal. (D) Cell counts were taken 
daily and the cumulative growth of shVC cells and shCSN2 
cells +/- 3-MA calculated. The insert has had the untreated 
shVC data removed in order to demonstrate the similarity 
between the shVC +3-MA and shCSN2 cumulative growth 
profiles. Data shown is the mean of n = 3 ± s.e.m. (E) Jenner-
Giemsa staining of shVC +/- 1 μM bafilomycin A1 cytospins 
day 7 post transfection. Images shown are representative of 
n = 3 transfections. (F) Cells were harvested day 7 post 
transfection and the level of LC3-II and β-actin protein deter-
mined by western blot.
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BMC Cell Biology 2009, 10:31 http://www.biomedcentral.com/1471-2121/10/31obtained graphically for test genes and 18S internal stand-
ards. ΔCt values were calculated by subtracting 18S Ct
from test gene Ct, and average ΔCt values obtained from
duplicates. Relative mRNA levels were determined by sub-
traction of mock transfection ΔCt values from shVC/
shCSN2/shCSN5 ΔCt values to give a ΔΔCt value and con-
version through 2-ΔΔCt.
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